BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schulte-Schrepping J, Reusch N, Paclik D, Baßler K, Schlickeiser S, Zhang B, Krämer B, Krammer T, Brumhard S, Bonaguro L, De Domenico E, Wendisch D, Grasshoff M, Kapellos TS, Beckstette M, Pecht T, Saglam A, Dietrich O, Mei HE, Schulz AR, Conrad C, Kunkel D, Vafadarnejad E, Xu CJ, Horne A, Herbert M, Drews A, Thibeault C, Pfeiffer M, Hippenstiel S, Hocke A, Müller-Redetzky H, Heim KM, Machleidt F, Uhrig A, Bosquillon de Jarcy L, Jürgens L, Stegemann M, Glösenkamp CR, Volk HD, Goffinet C, Landthaler M, Wyler E, Georg P, Schneider M, Dang-Heine C, Neuwinger N, Kappert K, Tauber R, Corman V, Raabe J, Kaiser KM, Vinh MT, Rieke G, Meisel C, Ulas T, Becker M, Geffers R, Witzenrath M, Drosten C, Suttorp N, von Kalle C, Kurth F, Händler K, Schultze JL, Aschenbrenner AC, Li Y, Nattermann J, Sawitzki B, Saliba AE, Sander LE; Deutsche COVID-19 OMICS Initiative (DeCOI). Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell 2020;182:1419-1440.e23. [PMID: 32810438 DOI: 10.1016/j.cell.2020.08.001] [Cited by in Crossref: 322] [Cited by in F6Publishing: 533] [Article Influence: 161.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Yin X, Zhang B, Liu C, Lin Y, Huang X, Li Y, Shen C, Zheng W, Fu G, Chen J, Wen Y, Zhang W, Pan BS, Fang M, Zheng Z, Zhang Z, Yuan Q, Fu G, Li S, Zhang J, Chen Y, Xia N, Zhao Q. A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity. Emerg Microbes Infect 2022;11:914-25. [PMID: 35254215 DOI: 10.1080/22221751.2022.2050951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
2 Ma Q, Li X, Xu G. New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination. Viruses 2022;14:2143. [DOI: 10.3390/v14102143] [Reference Citation Analysis]
3 De Sanctis F, Adamo A, Canè S, Ugel S. Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy. Semin Immunopathol 2022. [PMID: 36161514 DOI: 10.1007/s00281-022-00965-1] [Reference Citation Analysis]
4 Liu Z, Meng M, Ding S, Zhou X, Feng K, Huang T, Cai Y. Identification of methylation signatures and rules for predicting the severity of SARS-CoV-2 infection with machine learning methods. Front Microbiol 2022;13:1007295. [DOI: 10.3389/fmicb.2022.1007295] [Reference Citation Analysis]
5 Montaldo E, Lusito E, Bianchessi V, Caronni N, Scala S, Basso-Ricci L, Cantaffa C, Masserdotti A, Barilaro M, Barresi S, Genua M, Vittoria FM, Barbiera G, Lazarevic D, Messina C, Xue E, Marktel S, Tresoldi C, Milani R, Ronchi P, Gattillo S, Santoleri L, Di Micco R, Ditadi A, Belfiori G, Aleotti F, Naldini MM, Gentner B, Gardiman E, Tamassia N, Cassatella MA, Hidalgo A, Kwok I, Ng LG, Crippa S, Falconi M, Pettinella F, Scapini P, Naldini L, Ciceri F, Aiuti A, Ostuni R. Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress. Nat Immunol 2022. [PMID: 36138183 DOI: 10.1038/s41590-022-01311-1] [Reference Citation Analysis]
6 Bonaguro L, Schulte-Schrepping J, Ulas T, Aschenbrenner AC, Beyer M, Schultze JL. A guide to systems-level immunomics. Nat Immunol 2022. [PMID: 36138185 DOI: 10.1038/s41590-022-01309-9] [Reference Citation Analysis]
7 Shaymardanov AM, Antonova OA, Sokol AD, Deinichenko KA, Kazakova PG, Milovanov MM, Zakubansky AV, Akinshina AI, Tsypkina AV, Romanova SV, Muhin VE, Mitrofanov SI, Yudin VS, Yudin SM, Makhotenko AV, Keskinov AA, Kraevoy SA, Snigir EA, Svetlichnyy DV, Skvortsova VI. Single-Cell Gene Expression Analysis Revealed Immune Cell Signatures of Delta COVID-19. Cells 2022;11:2950. [DOI: 10.3390/cells11192950] [Reference Citation Analysis]
8 Belchamber KBR, Thein OS, Hazeldine J, Grudzinska FS, Faniyi AA, Hughes MJ, Jasper AE, Yip KP, Crowley LE, Lugg ST, Sapey E, Parekh D, Thickett DR, Scott A. Dysregulated Neutrophil Phenotype and Function in Hospitalised Non-ICU COVID-19 Pneumonia. Cells 2022;11:2901. [PMID: 36139476 DOI: 10.3390/cells11182901] [Reference Citation Analysis]
9 Daamen AR, Bachali P, Bonham CA, Somerville L, Sturek JM, Grammer AC, Kadl A, Lipsky PE. COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity. Front Immunol 2022;13:989556. [DOI: 10.3389/fimmu.2022.989556] [Reference Citation Analysis]
10 Margiana R, Sharma SK, Khan BI, Alameri AA, Opulencia MJC, Hammid AT, Hamza TA, Babakulov SK, Abdelbasset WK, Jawhar ZH. The pathogenicity of COVID-19 and the role of pentraxin-3: An updated review study. Pathol Res Pract 2022;238:154128. [PMID: 36137396 DOI: 10.1016/j.prp.2022.154128] [Reference Citation Analysis]
11 Chen ST, Park MD, Del Valle DM, Buckup M, Tabachnikova A, Thompson RC, Simons NW, Mouskas K, Lee B, Geanon D, D’souza D, Dawson T, Marvin R, Nie K, Zhao Z, Leberichel J, Chang C, Jamal H, Akturk G, Chaddha U, Mathews K, Acquah S, Brown S, Reiss M, Harkin T, Feldmann M, Powell CA, Hook JL, Kim-schulze S, Rahman AH, Brown BD, Beckmann ND, Gnjatic S, Kenigsberg E, Charney AW, Merad M; The Mount Sinai COVID-19 Biobank Team. A shift in lung macrophage composition is associated with COVID-19 severity and recovery. Sci Transl Med 2022;14:eabn5168. [DOI: 10.1126/scitranslmed.abn5168] [Reference Citation Analysis]
12 Han W, Cheng Y, Chen J, Zhong H, Hu Z, Chen S, Zong L, Hong L, Chan T, King I, Gao X, Li Y. Self-supervised contrastive learning for integrative single cell RNA-seq data analysis. Briefings in Bioinformatics. [DOI: 10.1093/bib/bbac377] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen K, Huang Y, Wu W, Chang L, Chu C, Kuo H. Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19. Front Immunol 2022;13:995886. [DOI: 10.3389/fimmu.2022.995886] [Reference Citation Analysis]
14 Joshi B, Joshi JC, Mehta D. Regulation of cGAS Activity and Downstream Signaling. Cells 2022;11:2812. [DOI: 10.3390/cells11182812] [Reference Citation Analysis]
15 Aznaourova M, Schmerer N, Janga H, Zhang Z, Pauck K, Bushe J, Volkers SM, Wendisch D, Georg P, Ntini E, Aillaud M, Gündisch M, Mack E, Skevaki C, Keller C, Bauer C, Bertrams W, Marsico A, Nist A, Stiewe T, Gruber AD, Ruppert C, Li Y, Garn H, Sander LE, Schmeck B, Schulte LN. Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19. Proc Natl Acad Sci U S A 2022;119:e2120680119. [PMID: 35998224 DOI: 10.1073/pnas.2120680119] [Reference Citation Analysis]
16 Jonny J, Putranto TA, Irfon R, Sitepu EC. Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic. Front Immunol 2022;13:989685. [DOI: 10.3389/fimmu.2022.989685] [Reference Citation Analysis]
17 Stamoula E, Sarantidi E, Dimakopoulos V, Ainatzoglou A, Dardalas I, Papazisis G, Kontopoulou K, Anagnostopoulos AK. Serum Proteome Signatures of Anti-SARS-CoV-2 Vaccinated Healthcare Workers in Greece Associated with Their Prior Infection Status. Int J Mol Sci 2022;23:10153. [PMID: 36077551 DOI: 10.3390/ijms231710153] [Reference Citation Analysis]
18 Saleki K, Shirzad M, Javanian M, Mohammadkhani S, Alijani MH, Miri N, Oladnabi M, Azadmehr A. Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients. Front Immunol 2022;13:947401. [DOI: 10.3389/fimmu.2022.947401] [Reference Citation Analysis]
19 Yi J, Miao J, Zuo Q, Owusu F, Dong Q, Lin P, Wang Q, Gao R, Kong X, Yang L. COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses. Front Immunol 2022;13:978619. [DOI: 10.3389/fimmu.2022.978619] [Reference Citation Analysis]
20 Sun Q, Li X, Kuang E. Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses. Autophagy 2022. [PMID: 36005882 DOI: 10.1080/15548627.2022.2116677] [Reference Citation Analysis]
21 Yang M, Yang Y, Xie C, Ni M, Liu J, Yang H, Mu F, Wang J. Contrastive learning enables rapid mapping to multimodal single-cell atlas of multimillion scale. Nat Mach Intell. [DOI: 10.1038/s42256-022-00518-z] [Reference Citation Analysis]
22 Upadhyai P, Shenoy PU, Banjan B, Albeshr MF, Mahboob S, Manzoor I, Das R. Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry. Life 2022;12:1300. [DOI: 10.3390/life12091300] [Reference Citation Analysis]
23 Casalini G, Giacomelli A, Galimberti L, Colombo R, Ballone E, Pozza G, Zacheo M, Galimberti M, Oreni L, Carsana L, Longo M, Gismondo MR, Tonello C, Nebuloni M, Antinori S. Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data. JoF 2022;8:894. [DOI: 10.3390/jof8090894] [Reference Citation Analysis]
24 Khare K, Pandey R. Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key. Front Immunol 2022;13:973070. [DOI: 10.3389/fimmu.2022.973070] [Reference Citation Analysis]
25 Zhong Y, Ashley CL, Steain M, Ataide SF. Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection. Front Mol Biosci 2022;9:975322. [DOI: 10.3389/fmolb.2022.975322] [Reference Citation Analysis]
26 Tappe B, Lauruschkat CD, Strobel L, Pantaleón García J, Kurzai O, Rebhan S, Kraus S, Pfeuffer-jovic E, Bussemer L, Possler L, Held M, Hünniger K, Kniemeyer O, Schäuble S, Brakhage AA, Panagiotou G, White PL, Einsele H, Löffler J, Wurster S. COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds. Front Immunol 2022;13:954985. [DOI: 10.3389/fimmu.2022.954985] [Reference Citation Analysis]
27 Beltrami AP, De Martino M, Dalla E, Malfatti MC, Caponnetto F, Codrich M, Stefanizzi D, Fabris M, Sozio E, D’aurizio F, Pucillo CEM, Sechi LA, Tascini C, Curcio F, Foresti GL, Piciarelli C, De Nardin A, Tell G, Isola M. Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery. IJMS 2022;23:9161. [DOI: 10.3390/ijms23169161] [Reference Citation Analysis]
28 Islamuddin M, Mustfa SA, Ullah SNMN, Omer U, Kato K, Parveen S. Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection. Inflammation 2022. [PMID: 35953688 DOI: 10.1007/s10753-022-01651-y] [Reference Citation Analysis]
29 Ioannou M, Hoving D, Aramburu IV, Temkin MI, De Vasconcelos NM, Tsourouktsoglou TD, Wang Q, Boeing S, Goldstone R, Vernardis S, Demichev V, Ralser M, David S, Stahl K, Bode C, Papayannopoulos V. Microbe capture by splenic macrophages triggers sepsis via T cell-death-dependent neutrophil lifespan shortening. Nat Commun 2022;13:4658. [PMID: 35945238 DOI: 10.1038/s41467-022-32320-1] [Reference Citation Analysis]
30 Barturen G, Carnero-Montoro E, Martínez-Bueno M, Rojo-Rello S, Sobrino B, Porras-Perales Ó, Alcántara-Domínguez C, Bernardo D, Alarcón-Riquelme ME. Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection. Nat Commun 2022;13:4597. [PMID: 35933486 DOI: 10.1038/s41467-022-32357-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Maskarinec SA, McKelvy M, Boyle K, Hotchkiss H, Duarte ME, Addison B, Amato N, Khandelwal S, Arepally GM, Lee GM. Neutrophil functional heterogeneity is a fixed phenotype and is associated with distinct gene expression profiles. J Leukoc Biol 2022. [PMID: 35916035 DOI: 10.1002/JLB.4A0322-164R] [Reference Citation Analysis]
32 Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, Ibrahim AS, Carvalho A. COVID-19-associated fungal infections. Nat Microbiol 2022;7:1127-40. [PMID: 35918423 DOI: 10.1038/s41564-022-01172-2] [Reference Citation Analysis]
33 Zacchetti L, Longhi L, Bianchi I, Di Matteo M, Russo F, Gandini L, Manesso L, Monti M, Cosentini R, Di Marco F, Fagiuoli S, Grazioli L, Gritti P, Previdi F, Senni M, Ranieri M, Lorini L; Bergamo COVID-19 Group. Characterization of compliance phenotypes in COVID-19 acute respiratory distress syndrome. BMC Pulm Med 2022;22:296. [PMID: 35915487 DOI: 10.1186/s12890-022-02087-8] [Reference Citation Analysis]
34 Scozzi D, Liao F, Krupnick AS, Kreisel D, Gelman AE. The role of neutrophil extracellular traps in acute lung injury. Front Immunol 2022;13:953195. [DOI: 10.3389/fimmu.2022.953195] [Reference Citation Analysis]
35 Van der Sluis RM, Holm CK, Jakobsen MR. Plasmacytoid dendritic cells during COVID-19: Ally or adversary? Cell Rep 2022;40:111148. [PMID: 35858624 DOI: 10.1016/j.celrep.2022.111148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Landoni G, Zangrillo A, Piersanti G, Scquizzato T, Piemonti L. The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials. Front Immunol 2022;13:932251. [DOI: 10.3389/fimmu.2022.932251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Pandori WJ, Padgett LE, Alimadadi A, Gutierrez NA, Araujo DJ, Huh CJ, Olingy CE, Dinh HQ, Wu R, Vijayanand P, Chee SJ, Ottensmeier CH, Hedrick CC. Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9+ monocytes associated with COVID-19 hospitalization. J Leukoc Biol 2022. [PMID: 35866369 DOI: 10.1002/JLB.4COVA0122-076R] [Reference Citation Analysis]
38 Guimarães-Pinto K, Maia EP, Ferreira JRM, Filardy AA. Efferocytosis in lung mucosae: implications for health and disease. Immunol Lett 2022;248:109-18. [PMID: 35843361 DOI: 10.1016/j.imlet.2022.07.005] [Reference Citation Analysis]
39 Belchior-Bezerra M, Lima RS, Medeiros NI, Gomes JAS. COVID-19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances. Obes Rev 2022;:e13496. [PMID: 35837843 DOI: 10.1111/obr.13496] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Aoyama K, Itokawa N, Oshima M, Iwama A. Epigenetic Memories in Hematopoietic Stem and Progenitor Cells. Cells 2022;11:2187. [DOI: 10.3390/cells11142187] [Reference Citation Analysis]
41 Taylor E. Casting a wide NET: an update on uncontrolled NETosis in response to COVID-19 infection. Clinical Science 2022;136:1047-52. [DOI: 10.1042/cs20220039] [Reference Citation Analysis]
42 Campbell GR, Rawat P, Spector SA. Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA. J Innate Immun 2022;:1-11. [PMID: 35785771 DOI: 10.1159/000525292] [Reference Citation Analysis]
43 Karu N, Kindt A, Lamont L, van Gammeren AJ, Ermens AAM, Harms AC, Portengen L, Vermeulen RCH, Dik WA, Langerak AW, van der Velden VHJ, Hankemeier T. Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers. Metabolites 2022;12:619. [DOI: 10.3390/metabo12070619] [Reference Citation Analysis]
44 Solopov PA, Colunga Biancatelli RML, Catravas JD. Alcohol Increases Lung Angiotensin-Converting Enzyme 2 Expression and Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Subunit 1-Induced Acute Lung Injury in K18-hACE2 Transgenic Mice. Am J Pathol 2022;192:990-1000. [PMID: 35483427 DOI: 10.1016/j.ajpath.2022.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Verdonk F, Feyaerts D, Badenes R, Bastarache JA, Bouglé A, Ely W, Gaudilliere B, Howard C, Kotfis K, Lautrette A, Le Dorze M, Mankidy BJ, Matthay MA, Morgan CK, Mazeraud A, Patel BV, Pattnaik R, Reuter J, Schultz MJ, Sharshar T, Shrestha GS, Verdonk C, Ware LB, Pirracchio R, Jabaudon M. Upcoming and urgent challenges in critical care research based on COVID-19 pandemic experience. Anaesth Crit Care Pain Med 2022;:101121. [PMID: 35781076 DOI: 10.1016/j.accpm.2022.101121] [Reference Citation Analysis]
46 Rovito R, Augello M, Ben-Haim A, Bono V, d'Arminio Monforte A, Marchetti G. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors. Front Immunol 2022;13:912336. [PMID: 35757770 DOI: 10.3389/fimmu.2022.912336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Moga E, Lynton-pons E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Front Immunol 2022;13:904686. [DOI: 10.3389/fimmu.2022.904686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Rybkina K, Davis-Porada J, Farber DL. Tissue immunity to SARS-CoV-2: Role in protection and immunopathology. Immunol Rev 2022. [PMID: 35752871 DOI: 10.1111/imr.13112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Beliakova-bethell N, Maruthai K, Xu R, Salvador LCM, Garg A. Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals. Front Immunol 2022;13:894543. [DOI: 10.3389/fimmu.2022.894543] [Reference Citation Analysis]
50 McKenna E, Wubben R, Isaza-Correa JM, Melo AM, Mhaonaigh AU, Conlon N, O'Donnell JS, Ní Cheallaigh C, Hurley T, Stevenson NJ, Little MA, Molloy EJ. Neutrophils in COVID-19: Not Innocent Bystanders. Front Immunol 2022;13:864387. [PMID: 35720378 DOI: 10.3389/fimmu.2022.864387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
51 Frishberg A, Kooistra E, Nuesch-Germano M, Pecht T, Milman N, Reusch N, Warnat-Herresthal S, Bruse N, Händler K, Theis H, Kraut M, van Rijssen E, van Cranenbroek B, Koenen HJ, Heesakkers H, van den Boogaard M, Zegers M, Pickkers P, Becker M, Aschenbrenner AC, Ulas T, Theis FJ, Shen-Orr SS, Schultze JL, Kox M. Mature neutrophils and a NF-κB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19. Cell Rep Med 2022;3:100652. [PMID: 35675822 DOI: 10.1016/j.xcrm.2022.100652] [Reference Citation Analysis]
52 Schultheiß C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, Höll JI, Gekle M, Mikolajczyk R, Binder M. The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 2022;3:100663. [PMID: 35732153 DOI: 10.1016/j.xcrm.2022.100663] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
53 Wang G, Xiong Z, Yang F, Zheng X, Zong W, Li R, Bao Y. Identification of COVID-19-Associated DNA Methylation Variations by Integrating Methylation Array and scRNA-Seq Data at Cell-Type Resolution. Genes 2022;13:1109. [DOI: 10.3390/genes13071109] [Reference Citation Analysis]
54 Veenith T, Martin H, Le Breuilly M, Whitehouse T, Gao-Smith F, Duggal N, Lord JM, Mian R, Sarphie D, Moss P. High generation of reactive oxygen species from neutrophils in patients with severe COVID-19. Sci Rep 2022;12:10484. [PMID: 35729319 DOI: 10.1038/s41598-022-13825-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Hoang TH, Vu GM, Tran MH, Tran TTH, Le QD, Tran KV, Nguyen TT, Nguyen LTN, Tran TH, Ta VT, Vo NS. Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam. BMC Infect Dis 2022;22:558. [PMID: 35718768 DOI: 10.1186/s12879-022-07415-1] [Reference Citation Analysis]
56 O'Driscoll DN. Emergency myelopoiesis in critical illness: lessons from the COVID-19 pandemic. Ir J Med Sci 2022. [PMID: 35711011 DOI: 10.1007/s11845-022-03068-w] [Reference Citation Analysis]
57 Kramer KJ, Wilfong EM, Voss K, Barone SM, Shiakolas AR, Raju N, Roe CE, Suryadevara N, Walker LM, Wall SC, Paulo A, Schaefer S, Dahunsi D, Westlake CS, Crowe JE Jr, Carnahan RH, Rathmell JC, Bonami RH, Georgiev IS, Irish JM. Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine. Nat Commun 2022;13:3466. [PMID: 35710908 DOI: 10.1038/s41467-022-31142-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Bruiners N, Guerrini V, Ukey R, Dikdan RJ, Yang JH, Mishra PK, Onyuka A, Handler D, Vieth J, Carayannopoulos M, Guo S, Pollen M, Pinter A, Tyagi S, Feingold D, Philipp C, Libutti SK, Gennaro ML. Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report. Front Med 2022;9:915367. [DOI: 10.3389/fmed.2022.915367] [Reference Citation Analysis]
59 Stevens J, Steinmeyer S, Bonfield M, Peterson L, Wang T, Gray J, Lewkowich I, Xu Y, Du Y, Guo M, Wynn JL, Zacharias W, Salomonis N, Miller L, Chougnet C, O'Connor DH, Deshmukh H. The balance between protective and pathogenic immune responses to pneumonia in the neonatal lung is enforced by gut microbiota. Sci Transl Med 2022;14:eabl3981. [PMID: 35704600 DOI: 10.1126/scitranslmed.abl3981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Li X, Zhang Z, Wang Z, Gutiérrez-Castrellón P, Shi H. Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19. Signal Transduct Target Ther 2022;7:186. [PMID: 35697684 DOI: 10.1038/s41392-022-01043-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Voiriot G, Dorgham K, Bachelot G, Fajac A, Morand-Joubert L, Parizot C, Gerotziafas G, Farabos D, Trugnan G, Eguether T, Blayau C, Djibré M, Elabbadi A, Gibelin A, Labbé V, Parrot A, Turpin M, Cadranel J, Gorochov G, Fartoukh M, Lamazière A. Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients. Sci Rep 2022;12:9502. [PMID: 35681070 DOI: 10.1038/s41598-022-13179-0] [Reference Citation Analysis]
62 Balandrán JC, Zamora-Herrera G, Romo-Rodríguez R, Pelayo R. Emergency Hematopoiesis in the Pathobiology of COVID-19: The Dark Side of an Early Innate Protective Mechanism. J Interferon Cytokine Res 2022. [PMID: 35675647 DOI: 10.1089/jir.2022.0028] [Reference Citation Analysis]
63 Bline K, Andrews A, Moore-clingenpeel M, Mertz S, Ye F, Best V, Sayegh R, Tomatis-souverbielle C, Quintero AM, Maynard Z, Glowinski R, Mejias A, Ramilo O. Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19. Front Pediatr 2022;10:893045. [DOI: 10.3389/fped.2022.893045] [Reference Citation Analysis]
64 Yu F, Cato LD, Weng C, Liggett LA, Jeon S, Xu K, Chiang CWK, Wiemels JL, Weissman JS, de Smith AJ, Sankaran VG. Variant to function mapping at single-cell resolution through network propagation. Nat Biotechnol 2022. [PMID: 35668323 DOI: 10.1038/s41587-022-01341-y] [Reference Citation Analysis]
65 Fava VM, Bourgey M, Nawarathna PM, Orlova M, Cassart P, Vinh DC, Cheng MP, Bourque G, Schurr E, Langlais D. A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19. Sci Adv 2022;8:eabm2510. [PMID: 35648852 DOI: 10.1126/sciadv.abm2510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Kuijpers Y, Chu X, Jaeger M, Moorlag SJCFM, Koeken VACM, Zhang B, de Nooijer A, Grondman I, Gupta MK, Janssen N, Mourits VP, de Bree LCJ, de Mast Q, van de Veerdonk FL, Joosten LAB, Li Y, Netea MG, Xu CJ. The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses. Front Immunol 2022;13:859387. [PMID: 35634344 DOI: 10.3389/fimmu.2022.859387] [Reference Citation Analysis]
67 Margraf A, Perretti M. Immune Cell Plasticity in Inflammation: Insights into Description and Regulation of Immune Cell Phenotypes. Cells 2022;11:1824. [DOI: 10.3390/cells11111824] [Reference Citation Analysis]
68 Goh D, Lee JN, Tien T, Lim JCT, Lim S, Tan AS, Liu J, Tan B, Yeong J. Comparison between non-pulmonary and pulmonary immune responses in a HIV decedent who succumbed to COVID-19. Gut 2022;71:1231-4. [PMID: 34376518 DOI: 10.1136/gutjnl-2021-324754] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L, Jiang J, Shao C, Li P, He X, Hua F, Niu Z, Ma C, Zhu Y, Ippolito G, Piacentini M, Estaquier J, Melino S, Weiss FD, Andreano E, Latz E, Schultze JL, Rappuoli R, Mantovani A, Mak TW, Melino G, Shi Y. Immune response in COVID-19: what is next? Cell Death Differ 2022;29:1107-22. [PMID: 35581387 DOI: 10.1038/s41418-022-01015-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
70 Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov 2022. [PMID: 35650427 DOI: 10.1038/s41573-022-00470-y] [Reference Citation Analysis]
71 Yao RQ, Ren C, Zheng LY, Xia ZF, Yao YM. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression. Front Immunol 2022;13:891024. [PMID: 35619710 DOI: 10.3389/fimmu.2022.891024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Mcleish KR, Shrestha R, Vashishta A, Rane MJ, Barati MT, Brier ME, Lau MG, Hu X, Chen O, Wessel CR, Spalding T, Bush SE, Ijemere K, Hopkins CD, Cooke EA, Tandon S, Manning T, Uriarte SM, Huang J, Yan J. Differential Functional Responses of Neutrophil Subsets in Severe COVID-19 Patients. Front Immunol 2022;13:879686. [DOI: 10.3389/fimmu.2022.879686] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Loyer C, Lapostolle A, Urbina T, Elabbadi A, Lavillegrand JR, Chaigneau T, Simoes C, Dessajan J, Desnos C, Morin-Brureau M, Chantran Y, Aucouturier P, Guidet B, Voiriot G, Ait-Oufella H, Elbim C. Impairment of neutrophil functions and homeostasis in COVID-19 patients: association with disease severity. Crit Care 2022;26:155. [PMID: 35637483 DOI: 10.1186/s13054-022-04002-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
74 Schultze JL, Büttner M, Becker M. Swarm immunology: harnessing blockchain technology and artificial intelligence in human immunology. Nat Rev Immunol 2022. [PMID: 35624333 DOI: 10.1038/s41577-022-00740-1] [Reference Citation Analysis]
75 Jonny J, Putranto TA, Sitepu EC, Irfon R. Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo? Expert Rev Vaccines 2022;:1-10. [PMID: 35593184 DOI: 10.1080/14760584.2022.2080658] [Reference Citation Analysis]
76 Li D, Wang X, Liao Y, Wang S, Shan J, Ji J. Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components. Front Immunol 2022;13:842453. [PMID: 35592339 DOI: 10.3389/fimmu.2022.842453] [Reference Citation Analysis]
77 Repapi E, Agarwal D, Napolitani G, Sims D, Taylor S. Integration of single-cell RNA-Seq and CyTOF data characterises heterogeneity of rare cell subpopulations. F1000Res 2022;11:560. [DOI: 10.12688/f1000research.121829.1] [Reference Citation Analysis]
78 Yang S, Tong Y, Chen L, Yu W. Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. Mol Biomed 2022;3:15. [PMID: 35593963 DOI: 10.1186/s43556-022-00077-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Wang Z, Zhang Y, Yang R, Wang Y, Guo J, Sun R, Zhou Y, Su L, Ge Q, Feng Y. Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development. Front Immunol 2022;13:831194. [PMID: 35558069 DOI: 10.3389/fimmu.2022.831194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Grassi G, Notari S, Gili S, Bordoni V, Casetti R, Cimini E, Tartaglia E, Mariotti D, Agrati C, Sacchi A. Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good. Front Immunol 2022;13:842949. [PMID: 35572540 DOI: 10.3389/fimmu.2022.842949] [Reference Citation Analysis]
81 Kudryavtsev I, Rubinstein A, Golovkin A, Kalinina O, Vasilyev K, Rudenko L, Isakova-sivak I. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. Viruses 2022;14:1082. [DOI: 10.3390/v14051082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
82 Smith AP, Williams EP, Plunkett TR, Selvaraj M, Lane LC, Zalduondo L, Xue Y, Vogel P, Channappanavar R, Jonsson CB, Smith AM. Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2. Front Immunol 2022;13:894534. [DOI: 10.3389/fimmu.2022.894534] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Romano A, Parrinello NL, Barchitta M, Manuele R, Puglisi F, Maugeri A, Barbato A, Triolo AM, Giallongo C, Tibullo D, La Ferla L, Botta C, Siragusa S, Iacobello C, Montineri A, Volti GL, Agodi A, Palumbo GA, Di Raimondo F. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection. Sci Rep 2022;12:7237. [PMID: 35508575 DOI: 10.1038/s41598-022-11157-0] [Reference Citation Analysis]
84 Wang Y, Wu M, Li Y, Yuen HH, He ML. The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy. J Biomed Sci 2022;29:27. [PMID: 35505345 DOI: 10.1186/s12929-022-00811-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Guo C, Wu M, Huang B, Zhao R, Jin L, Fu B, Wang P, Wang D, Zheng M, Fang J, Wei H, Qu K, Ni F. Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19. Genome Med 2022;14:46. [PMID: 35501841 DOI: 10.1186/s13073-022-01049-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
86 Haschka D, Petzer V, Burkert FR, Fritsche G, Wildner S, Bellmann-Weiler R, Tymoszuk P, Weiss G. Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID-19 inpatients. Eur J Immunol 2022. [PMID: 35491910 DOI: 10.1002/eji.202149680] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. The Lancet 2022. [DOI: 10.1016/s0140-6736(22)00470-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
89 Costanza A, Amerio A, Aguglia A, Serafini G, Amore M, Hasler R, Ambrosetti J, Bondolfi G, Sampogna G, Berardelli I, Fiorillo A, Pompili M, Nguyen KD. Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision? Neurosci Biobehav Rev 2022;136:104606. [PMID: 35289272 DOI: 10.1016/j.neubiorev.2022.104606] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Hammad R, Kotb HG, Eldesoky GA, Mosaad AM, El-nasser AM, Abd El Hakam FE, Eldesoky NA, Mashaal A, Farhoud H. Utility of Monocyte Expression of HLA-DR versus T Lymphocyte Frequency in the Assessment of COVID-19 Outcome. IJGM 2022;Volume 15:5073-87. [DOI: 10.2147/ijgm.s359690] [Reference Citation Analysis]
91 Calzetti F, Finotti G, Tamassia N, Bianchetto-Aguilera F, Castellucci M, Canè S, Lonardi S, Cavallini C, Matte A, Gasperini S, Signoretto I, Benedetti F, Bonifacio M, Vermi W, Ugel S, Bronte V, Tecchio C, Scapini P, Cassatella MA. CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors. Nat Immunol 2022;23:679-91. [PMID: 35484408 DOI: 10.1038/s41590-022-01189-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
92 Perfilyeva YV, Ostapchuk YO, Tleulieva R, Kali A, Abdolla N, Krasnoshtanov VK, Perfilyeva AV, Belyaev NN. Myeloid-derived suppressor cells in COVID-19: A review. Clin Immunol 2022;:109024. [PMID: 35489643 DOI: 10.1016/j.clim.2022.109024] [Reference Citation Analysis]
93 Deng X, Terunuma H, Nieda M. Exploring the Utility of NK Cells in COVID-19. Biomedicines 2022;10:1002. [DOI: 10.3390/biomedicines10051002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Levy G, Guglielmelli P, Langmuir P, Constantinescu S. JAK inhibitors and COVID-19. J Immunother Cancer 2022;10:e002838. [PMID: 35459733 DOI: 10.1136/jitc-2021-002838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
95 Temerozo JR, Fintelman-Rodrigues N, Dos Santos MC, Hottz ED, Sacramento CQ, de Paula Dias da Silva A, Mandacaru SC, Dos Santos Moraes EC, Trugilho MRO, Gesto JSM, Ferreira MA, Saraiva FB, Palhinha L, Martins-Gonçalves R, Azevedo-Quintanilha IG, Abrantes JL, Righy C, Kurtz P, Jiang H, Tan H, Morel C, Bou-Habib DC, Bozza FA, Bozza PT, Souza TML. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome 2022;10:65. [PMID: 35459226 DOI: 10.1186/s40168-022-01260-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
96 Zhang N, Gao X, Zhang W, Xiong J, Cao X, Fu ZF, Cui M. JEV Infection Induces M-MDSC Differentiation Into CD3+ Macrophages in the Brain. Front Immunol 2022;13:838990. [DOI: 10.3389/fimmu.2022.838990] [Reference Citation Analysis]
97 Turnbull IR, Fuchs A, Remy KE, Kelly MP, Frazier EP, Ghosh S, Chang SW, Mazer MB, Hess A, Leonard JM, Hoofnagle MH, Colonna M, Hotchkiss RS. Dysregulation of the leukocyte signaling landscape during acute COVID-19. PLoS One 2022;17:e0264979. [PMID: 35421120 DOI: 10.1371/journal.pone.0264979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Yu L, Wang A, Li T, Jin W, Tian G, Yun C, Gao F, Fan X, Wang H, Zhang H, Sun D. A Retrospective and Multicenter Study on COVID-19 in Inner Mongolia: Evaluating the Influence of Sampling Locations on Nucleic Acid Test and the Dynamics of Clinical and Prognostic Indexes. Front Med (Lausanne) 2022;9:830484. [PMID: 35433742 DOI: 10.3389/fmed.2022.830484] [Reference Citation Analysis]
99 Albayrak N, Orte Cano C, Karimi S, Dogahe D, Van Praet A, Godefroid A, Del Marmol V, Grimaldi D, Bondue B, Van Vooren JP, Mascart F, Corbière V. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection. Front Immunol 2022;13:769839. [PMID: 35422799 DOI: 10.3389/fimmu.2022.769839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Rutkowska E, Kwiecień I, Kłos K, Rzepecki P, Chciałowski A. Intermediate Monocytes with PD-L1 and CD62L Expression as a Possible Player in Active SARS-CoV-2 Infection. Viruses 2022;14:819. [PMID: 35458548 DOI: 10.3390/v14040819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Ahmad R, Haque M. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction. Vaccines (Basel) 2022;10:614. [PMID: 35455363 DOI: 10.3390/vaccines10040614] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
102 Chan L, Morovati S, Karimi N, Alizadeh K, Vanderkamp S, Kakish JE, Bridle BW, Karimi K. Neutrophil Functional Heterogeneity and Implications for Viral Infections and Treatments. Cells 2022;11:1322. [DOI: 10.3390/cells11081322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Shao MM, Shi M, Du J, Pei XB, Gu BB, Yi FS. Metabolic Landscape of Bronchoalveolar Lavage Fluid in Coronavirus Disease 2019 at Single Cell Resolution. Front Immunol 2022;13:829760. [PMID: 35350779 DOI: 10.3389/fimmu.2022.829760] [Reference Citation Analysis]
104 Xu AM, Li D, Ebinger JE, Mengesha E, Elyanow R, Gittelman RM, Chapman H, Joung S, Botwin GJ, Pozdnyakova V, Debbas P, Mujukian A, Prostko JC, Frias EC, Stewart JL, Horizon AA, Merin N, Sobhani K, Figueiredo JC, Cheng S, Kaplan IM, Mcgovern DPB, Merchant A, Melmed GY, Braun J. Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease. Front Immunol 2022;13:880190. [DOI: 10.3389/fimmu.2022.880190] [Reference Citation Analysis]
105 Herrera VLM, Walkey AJ, Nguyen MQ, Gromisch CM, Mosaddhegi JZ, Gromisch MS, Jundi B, Lukassen S, Carstensen S, Denis R, Belkina AC, Baron RM, Pinilla-vera M, Mueller M, Kimberly WT, Goldstein JN, Lehmann I, Shih AR, Eils R, Levy BD, Ruiz-opazo N. A targetable ‘rogue’ neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-09343-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
106 Bain CR, Myles PS, Taylor R, Trahair H, Lee YP, Croft L, Peyton PJ, Painter T, Chan M, Wallace S, Corcoran T, Shaw A, Paul E, Ziemann M, Bozaoglu K. Methylomic and transcriptomic characterisation of postoperative systemic inflammatory dysregulation. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.04.004] [Reference Citation Analysis]
107 Townsend L, Dyer AH, Naughton A, Imangaliyev S, Dunne J, Kiersey R, Holden D, Mooney A, Leavy D, Ridge K, Sugrue J, Aldoseri M, Kelliher JH, Hennessy M, Byrne D, Browne P, Bacon CL, Doyle C, O’riordan R, Mclaughlin A, Bannan C, Martin-loeches I, White A, Mcloughlin RM, Bergin C, Bourke NM, O’farrelly C, Conlon N, Cheallaigh CN. Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression. Heliyon 2022;8:e09230. [DOI: 10.1016/j.heliyon.2022.e09230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
108 Kheshtchin N, Bakhshi P, Arab S, Nourizadeh M. Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host. International Immunopharmacology 2022;105:108531. [DOI: 10.1016/j.intimp.2022.108531] [Reference Citation Analysis]
109 Paget C, Doz-deblauwe E, Winter N, Briard B. Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases. Cells 2022;11:1188. [DOI: 10.3390/cells11071188] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Zhao P, Zou J, Zhou F, Zhu Y, Song Q, Yu D, Li X. Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.108767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 33.0] [Reference Citation Analysis]
112 Supino D, Minute L, Mariancini A, Riva F, Magrini E, Garlanda C. Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease. Front Immunol 2022;13:804641. [PMID: 35211118 DOI: 10.3389/fimmu.2022.804641] [Reference Citation Analysis]
113 Stoian A, Stoian M, Bajko Z, Maier S, Andone S, Cioflinc RA, Motataianu A, Barcutean L, Balasa R. Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature. Biomedicines 2022;10:774. [DOI: 10.3390/biomedicines10040774] [Reference Citation Analysis]
114 Sabbatinelli J, Matacchione G, Giuliani A, Ramini D, Rippo MR, Procopio AD, Bonafè M, Olivieri F. Circulating biomarkers of inflammaging as potential biomarkers of COVID-19 severe outcomes. Mech Ageing Dev 2022;:111667. [PMID: 35341896 DOI: 10.1016/j.mad.2022.111667] [Reference Citation Analysis]
115 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
116 Munansangu BSM, Kenyon C, Walzl G, Loxton AG, Kotze LA, du Plessis N. Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology. Int J Mol Sci 2022;23:3512. [PMID: 35408873 DOI: 10.3390/ijms23073512] [Reference Citation Analysis]
117 Wang X, Bai H, Ma J, Qin H, Zeng Q, Hu F, Jiang T, Mao W, Zhao Y, Chen X, Qi X, Li M, Xu J, Hao J, Wang Y, Ding X, Liu Y, Huang T, Fang C, Ge C, Li D, Hu K, Ren X, Zhang B, Zhang B, Shi B, Zhang C. Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients. Front Immunol 2022;13:812514. [PMID: 35281000 DOI: 10.3389/fimmu.2022.812514] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Li YR, Dunn ZS, Garcia G Jr, Carmona C, Zhou Y, Lee D, Yu J, Huang J, Kim JT, Arumugaswami V, Wang P, Yang L. Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention. Stem Cell Res Ther 2022;13:112. [PMID: 35313965 DOI: 10.1186/s13287-022-02787-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
119 Bader SM, Cooney JP, Pellegrini M, Doerflinger M. Programmed cell death: the pathways to severe COVID-19? Biochem J 2022;479:609-28. [PMID: 35244141 DOI: 10.1042/BCJ20210602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
120 Fassan M, Collesei A, Angerilli V, Sbaraglia M, Fortarezza F, Pezzuto F, De Gaspari M, Businello G, Moni M, Rizzo S, Traverso G, Colosso V, Taschin E, Lunardi F, Valls AF, Schiavi F, Basso C, Calabrese F, Dei Tos AP. Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription. Cells 2022;11:1011. [DOI: 10.3390/cells11061011] [Reference Citation Analysis]
121 Bohnacker S, Hartung F, Henkel F, Quaranta A, Kolmert J, Priller A, Ud-Dean M, Giglberger J, Kugler LM, Pechtold L, Yazici S, Lechner A, Erber J, Protzer U, Lingor P, Knolle P, Chaker AM, Schmidt-Weber CB, Wheelock CE, Esser-von Bieren J. Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages. Mucosal Immunol 2022. [PMID: 35288643 DOI: 10.1038/s41385-021-00482-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
122 Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04220-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
123 Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science 2022;375:1122-7. [PMID: 35271343 DOI: 10.1126/science.abm8108] [Cited by in Crossref: 65] [Cited by in F6Publishing: 39] [Article Influence: 65.0] [Reference Citation Analysis]
124 Pastorek M, Dúbrava M, Celec P. On the Origin of Neutrophil Extracellular Traps in COVID-19. Front Immunol 2022;13:821007. [DOI: 10.3389/fimmu.2022.821007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
125 Nelson CE, Namasivayam S, Foreman TW, Kauffman KD, Sakai S, Dorosky DE, Lora NE, Brooks K, Potter EL, Garza NL, Lafont BAP, Johnson RF, Roederer M, Sher A, Weiskopf D, Sette A, de Wit E, Hickman HD, Brenchley JM, Via LE, Barber DL, Abdi A, Dayao EK, Fleegle JD, Gomez F, Piazza MK, Repoli KM, Sloan BY, Butler AL, Walker AM, Weiner DM, Woodcock MJ, Vatthauer A; NIAID/DIR Tuberculosis Imaging Program 3 †. Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Sci Immunol 2022;:eabo0535. [PMID: 35271298 DOI: 10.1126/sciimmunol.abo0535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
126 Griffin AJ, O'Donnell KL, Shifflett K, Lavik JP, Russell PM, Zimmerman MK, Relich RF, Marzi A. Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern. Sci Rep 2022;12:3954. [PMID: 35273264 DOI: 10.1038/s41598-022-07960-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Gheware A, Ray A, Rana D, Bajpai P, Nambirajan A, Arulselvi S, Mathur P, Trikha A, Arava S, Das P, Mridha AR, Singh G, Soneja M, Nischal N, Lalwani S, Wig N, Sarkar C, Jain D. ACE2 protein expression in lung tissues of severe COVID-19 infection. Sci Rep 2022;12:4058. [PMID: 35260724 DOI: 10.1038/s41598-022-07918-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
128 Park SJ, Nam DE, Seong HC, Hahn YS. New Discovery of Myeloid-Derived Suppressor Cell's Tale on Viral Infection and COVID-19. Front Immunol 2022;13:842535. [PMID: 35185933 DOI: 10.3389/fimmu.2022.842535] [Reference Citation Analysis]
129 COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk., COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 2022;185:916-938.e58. [PMID: 35216673 DOI: 10.1016/j.cell.2022.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
130 Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR; ISB-Swedish COVID-19 Biobanking Unit. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185:881-895.e20. [PMID: 35216672 DOI: 10.1016/j.cell.2022.01.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 68] [Article Influence: 45.0] [Reference Citation Analysis]
131 Papadopoulou G, Manoloudi E, Repousi N, Skoura L, Hurst T, Karamitros T. Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence. Pathogens 2022;11:311. [DOI: 10.3390/pathogens11030311] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
132 Schimke LF, Marques AHC, Baiocchi GC, de Souza Prado CA, Fonseca DLM, Freire PP, Rodrigues Plaça D, Salerno Filgueiras I, Coelho Salgado R, Jansen-Marques G, Rocha Oliveira AE, Peron JPS, Cabral-Miranda G, Barbuto JAM, Camara NOS, Calich VLG, Ochs HD, Condino-Neto A, Overmyer KA, Coon JJ, Balnis J, Jaitovich A, Schulte-Schrepping J, Ulas T, Schultze JL, Nakaya HI, Jurisica I, Cabral-Marques O. Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States. Cells 2022;11:847. [PMID: 35269470 DOI: 10.3390/cells11050847] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
133 Fisher BA, Veenith T, Slade D, Gaskell C, Rowland M, Whitehouse T, Scriven J, Parekh D, Balasubramaniam MS, Cooke G, Morley N, Gabriel Z, Wise MP, Porter J, Mcshane H, Ho L, Newsome PN, Rowe A, Sharpe R, Thickett DR, Bion J, Gates S, Richards D, Kearns P, Williams B, Turner R, Libri V, Mussai F, Middleton G, Bowden S, Bangash M, Gao-smith F, Patel J, Sapey E, Thomas M, Coles M, Watkinson P, Rahman N, Angus B, Mentzer AJ, Novak A, Feldman M, Richter A, Faustini S, Bathurst C, Van de Wiel J, Mee S, James K, Rahman B, Turner K, Hill A, Gordon A, Yap C, Matthay M, Mcauley D, Hall A, Dark P, Mcmichael A. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial. The Lancet Respiratory Medicine 2022;10:255-66. [DOI: 10.1016/s2213-2600(21)00460-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
134 Fang H, Zeng Y, Zhang L, Chen C, Powell CA, Wang X. Can single‐cell RNA sequencing reshape the clinical biochemistry of haematology? New clusters of circulating blood cells. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.19] [Reference Citation Analysis]
135 Ahmadi E, Bagherpour Z, Zarei E, Omidkhoda A. Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function. Pathology - Research and Practice 2022;231:153782. [DOI: 10.1016/j.prp.2022.153782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
136 Pekayvaz K, Leunig A, Kaiser R, Joppich M, Brambs S, Janjic A, Popp O, Nixdorf D, Fumagalli V, Schmidt N, Polewka V, Anjum A, Knottenberg V, Eivers L, Wange LE, Gold C, Kirchner M, Muenchhoff M, Hellmuth JC, Scherer C, Rubio-Acero R, Eser T, Deák F, Puchinger K, Kuhl N, Linder A, Saar K, Tomas L, Schulz C, Wieser A, Enard W, Kroidl I, Geldmacher C, von Bergwelt-Baildon M, Keppler OT, Munschauer M, Iannacone M, Zimmer R, Mertins P, Hubner N, Hoelscher M, Massberg S, Stark K, Nicolai L. Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection. Nat Commun 2022;13:1018. [PMID: 35197461 DOI: 10.1038/s41467-022-28508-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
137 Lee HK, Knabl L, Knabl L Sr, Wieser M, Mur A, Zabernigg A, Schumacher J, Kapferer S, Kaiser N, Furth PA, Hennighausen L. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module. Sci Rep 2022;12:2784. [PMID: 35181735 DOI: 10.1038/s41598-022-06752-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
138 Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C, Kaplan IM, Alehashemi S, Burbelo PD, Bhuyan F, de Jesus AA, Dobbs K, Rosen LB, Cheng A, Shaw E, Vakkilainen MS, Pala F, Lack J, Zhang Y, Fink DL, Oikonomou V, Snow AL, Dalgard CL, Chen J, Sellers BA, Montealegre Sanchez GA, Barron K, Rey-Jurado E, Vial C, Poli MC, Licari A, Montagna D, Marseglia GL, Licciardi F, Ramenghi U, Discepolo V, Lo Vecchio A, Guarino A, Eisenstein EM, Imberti L, Sottini A, Biondi A, Mató S, Gerstbacher D, Truong M, Stack MA, Magliocco M, Bosticardo M, Kawai T, Danielson JJ, Hulett T, Askenazi M, Hu S, Cohen JI, Su HC, Kuhns DB, Lionakis MS, Snyder TM, Holland SM, Goldbach-Mansky R, Tsang JS, Notarangelo LD; NIAID Immune Response to COVID Group., Chile MIS-C Group., Pavia Pediatric COVID-19 Group. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med 2022. [PMID: 35177862 DOI: 10.1038/s41591-022-01724-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 23.0] [Reference Citation Analysis]
139 Ma Y, Qiu F, Deng C, Li J, Huang Y, Wu Z, Zhou Y, Zhang Y, Xiong Y, Yao Y, Zhong Y, Qu J, Su J. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19. Genome Med 2022;14:16. [PMID: 35172892 DOI: 10.1186/s13073-022-01021-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
140 Chen C, Lin S, Shen C, Hsieh K, Cheng C. Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes. Diagnostics 2022;12:509. [DOI: 10.3390/diagnostics12020509] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
141 Hu Z, Bhattacharya S, Butte AJ. Application of Machine Learning for Cytometry Data. Front Immunol 2021;12:787574. [PMID: 35046945 DOI: 10.3389/fimmu.2021.787574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Nagaoka K, Kawasuji H, Murai Y, Kaneda M, Ueno A, Miyajima Y, Fukui Y, Morinaga Y, Yamamoto Y. Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure. Front Immunol 2022;13:844304. [DOI: 10.3389/fimmu.2022.844304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
143 Xu G, Qi F, Wang H, Liu Y, Wang X, Zou R, Yuan J, Liao X, Liu Y, Zhang S, Zhang Z. The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19. Front Immunol 2021;12:816745. [PMID: 35095917 DOI: 10.3389/fimmu.2021.816745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
144 Ma Z, Li X, Fan RLY, Yang KY, Ng CSH, Lau RWH, Wong RHL, Ng KK, Wang CC, Ye P, Fu Z, Chin AWH, Lai MYA, Huang Y, Tian XY, Poon LLM, Lui KO. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Reports 2022:S2213-6711(22)00059-5. [PMID: 35180397 DOI: 10.1016/j.stemcr.2022.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
145 Georg P, Astaburuaga-García R, Bonaguro L, Brumhard S, Michalick L, Lippert LJ, Kostevc T, Gäbel C, Schneider M, Streitz M, Demichev V, Gemünd I, Barone M, Tober-Lau P, Helbig ET, Hillus D, Petrov L, Stein J, Dey HP, Paclik D, Iwert C, Mülleder M, Aulakh SK, Djudjaj S, Bülow RD, Mei HE, Schulz AR, Thiel A, Hippenstiel S, Saliba AE, Eils R, Lehmann I, Mall MA, Stricker S, Röhmel J, Corman VM, Beule D, Wyler E, Landthaler M, Obermayer B, von Stillfried S, Boor P, Demir M, Wesselmann H, Suttorp N, Uhrig A, Müller-Redetzky H, Nattermann J, Kuebler WM, Meisel C, Ralser M, Schultze JL, Aschenbrenner AC, Thibeault C, Kurth F, Sander LE, Blüthgen N, Sawitzki B; PA-COVID-19 Study Group. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell 2022;185:493-512.e25. [PMID: 35032429 DOI: 10.1016/j.cell.2021.12.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
146 Hu Z, van der Ploeg K, Chakraborty S, Arunachalam P, Mori D, Jacobson K, Bonilla H, Parsonnet J, Andrews J, Hedlin H, de la Parte L, Dantzler K, Ty M, Tan G, Blish C, Takahashi S, Rodriguez-Barraquer I, Greenhouse B, Butte A, Singh U, Pulendran B, Wang T, Jagannathan P. Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19. Res Sq 2022:rs. [PMID: 35132407 DOI: 10.21203/rs.3.rs-847082/v1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
147 Mitamura Y, Schulz D, Oro S, Li N, Kolm I, Lang C, Ziadlou R, Tan G, Bodenmiller B, Steiger P, Marzano A, de Prost N, Caudin O, Levesque M, Stoffel C, Schmid-Grendelmeier P, Maverakis E, Akdis CA, Brüggen MC. Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients. Allergy 2022;77:595-608. [PMID: 34157151 DOI: 10.1111/all.14983] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
148 Ning X, Wang W, Jin H, Fang W. Low-Density Granulocytes in Immune-Mediated Inflammatory Diseases. Journal of Immunology Research 2022;2022:1-11. [DOI: 10.1155/2022/1622160] [Reference Citation Analysis]
149 Naler LB, Hsieh Y, Geng S, Zhou Z, Li L, Lu C. Epigenomic and transcriptomic analyses reveal differences between low-grade inflammation and severe exhaustion in LPS-challenged murine monocytes. Commun Biol 2022;5. [DOI: 10.1038/s42003-022-03035-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
150 Izquierdo JL, Soriano JB, González Y, Lumbreras S, Ancochea J, Echeverry C, Rodríguez JM. Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19. Sci Prog 2022;105:368504221074574. [PMID: 35084258 DOI: 10.1177/00368504221074574] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
151 Huang K, Wang C, Vagts C, Raguveer V, Finn PW, Perkins DL. Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis. PLoS One 2022;17:e0261242. [PMID: 35007307 DOI: 10.1371/journal.pone.0261242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
152 Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Adamo S, Raeber ME, Bächli E, Rudiger A, Stüssi-helbling M, Huber LC, Nilsson J, Held U, Puhan MA, Boyman O. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun 2022;13. [DOI: 10.1038/s41467-021-27797-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 35.0] [Reference Citation Analysis]
153 Zhang M, Liu S, Miao Z, Han F, Gottardo R, Sun W. IDEAS: individual level differential expression analysis for single-cell RNA-seq data. Genome Biol 2022;23. [DOI: 10.1186/s13059-022-02605-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
154 Unterman A, Sumida TS, Nouri N, Yan X, Zhao AY, Gasque V, Schupp JC, Asashima H, Liu Y, Cosme C Jr, Deng W, Chen M, Raredon MSB, Hoehn KB, Wang G, Wang Z, DeIuliis G, Ravindra NG, Li N, Castaldi C, Wong P, Fournier J, Bermejo S, Sharma L, Casanovas-Massana A, Vogels CBF, Wyllie AL, Grubaugh ND, Melillo A, Meng H, Stein Y, Minasyan M, Mohanty S, Ruff WE, Cohen I, Raddassi K, Niklason LE, Ko AI, Montgomery RR, Farhadian SF, Iwasaki A, Shaw AC, van Dijk D, Zhao H, Kleinstein SH, Hafler DA, Kaminski N, Dela Cruz CS; Yale IMPACT Research Team. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nat Commun 2022;13:440. [PMID: 35064122 DOI: 10.1038/s41467-021-27716-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
155 Amado-rodríguez L, Salgado del Riego E, Gomez de Ona J, López Alonso I, Gil-pena H, López-martínez C, Martín-vicente P, Lopez-vazquez A, Gonzalez Lopez A, Cuesta-llavona E, Rodriguez-garcia R, Boga JA, Elena alvarez-Arguelles M, Mayordomo-colunga J, Vidal-castineira JR, Crespo I, Fernandez M, Criado L, Salvadores V, Jimeno-demuth FJ, Blanch L, Prieto B, Fernandez-fernandez A, Lopez-larrea C, Coto E, Albaiceta GM. Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study. eLife 2022;11:e73012. [DOI: 10.7554/elife.73012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
156 Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP, Barkema HW. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic. Front Immunol 2021;12:789317. [PMID: 34975885 DOI: 10.3389/fimmu.2021.789317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
157 Bi X, Liu W, Ding X, Liang S, Zheng Y, Zhu X, Quan S, Yi X, Xiang N, Du J, Lyu H, Yu D, Zhang C, Xu L, Ge W, Zhan X, He J, Xiong Z, Zhang S, Li Y, Xu P, Zhu G, Wang D, Zhu H, Chen S, Li J, Zhao H, Zhu Y, Liu H, Xu J, Shen B, Guo T. Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Rep 2022;38:110271. [PMID: 35026155 DOI: 10.1016/j.celrep.2021.110271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
158 Garcia-Flores V, Romero R, Xu Y, Theis KR, Arenas-Hernandez M, Miller D, Peyvandipour A, Bhatti G, Galaz J, Gershater M, Levenson D, Pusod E, Tao L, Kracht D, Florova V, Leng Y, Motomura K, Para R, Faucett M, Hsu CD, Zhang G, Tarca AL, Pique-Regi R, Gomez-Lopez N. Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nat Commun 2022;13:320. [PMID: 35042863 DOI: 10.1038/s41467-021-27745-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 26.0] [Reference Citation Analysis]
159 Demichev V, Tober-lau P, Nazarenko T, Lemke O, Kaur Aulakh S, Whitwell HJ, Röhl A, Freiwald A, Mittermaier M, Szyrwiel L, Ludwig D, Correia-melo C, Lippert LJ, Helbig ET, Stubbemann P, Olk N, Thibeault C, Grüning N, Blyuss O, Vernardis S, White M, Messner CB, Joannidis M, Sonnweber T, Klein SJ, Pizzini A, Wohlfarter Y, Sahanic S, Hilbe R, Schaefer B, Wagner S, Machleidt F, Garcia C, Ruwwe-glösenkamp C, Lingscheid T, Bosquillon de Jarcy L, Stegemann MS, Pfeiffer M, Jürgens L, Denker S, Zickler D, Spies C, Edel A, Müller NB, Enghard P, Zelezniak A, Bellmann-weiler R, Weiss G, Campbell A, Hayward C, Porteous DJ, Marioni RE, Uhrig A, Zoller H, Löffler-ragg J, Keller MA, Tancevski I, Timms JF, Zaikin A, Hippenstiel S, Ramharter M, Müller-redetzky H, Witzenrath M, Suttorp N, Lilley K, Mülleder M, Sander LE, Kurth F, Ralser M, Bauer R; PA-COVID-19 Study group. A proteomic survival predictor for COVID-19 patients in intensive care. PLOS Digit Health 2022;1:e0000007. [DOI: 10.1371/journal.pdig.0000007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Won T, Wood MK, Hughes DM, Talor MV, Ma Z, Schneider J, Skinner JT, Asady B, Goerlich E, Halushka MK, Hays AG, Kim DH, Parikh CR, Rosenberg AZ, Coppens I, Johns RA, Gilotra NA, Hooper JE, Pekosz A, Čiháková D. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine 2022;75:103812. [PMID: 35033854 DOI: 10.1016/j.ebiom.2022.103812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
161 Calvet J, Berenguer-Llergo A, Gay M, Massanella M, Domingo P, Llop M, Sánchez-Jiménez E, Arévalo M, Carrillo J, Albiñana N, Arauz-Garofalo G, Orellana C, Delgado JF, Serrano A, Llobell A, Graell E, García-Manrique M, Moreno M, Galisteo C, Casado E, Navarro N, Gómez A, Garcia-Cirera S, Rusiñol M, Costa E, Clotet B, Vilaseca M, Blanco J, Gratacós J. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Sci Rep 2022;12:640. [PMID: 35022497 DOI: 10.1038/s41598-021-04683-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
162 Wu H, He P, Ren Y, Xiao S, Wang W, Liu Z, Li H, Wang Z, Zhang D, Cai J, Zhou X, Jiang D, Fei X, Zhao L, Zhang H, Liu Z, Chen R, Li W, Wang C, Zhang S, Qin J, Nashan B, Sun C. Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation. Nat Commun 2022;13:269. [PMID: 35022412 DOI: 10.1038/s41467-021-27723-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
163 Chen ST, Park MD, Del Valle DM, Buckup M, Tabachnikova A, Simons NW, Mouskas K, Lee B, Geanon D, D'Souza D, Dawson T, Marvin R, Nie K, Thompson RC, Zhao Z, LeBerichel J, Chang C, Jamal H, Chaddha U, Mathews K, Acquah S, Brown SA, Reiss M, Harkin T, Feldmann M, Powell CA, Hook JL, Kim-Schulze S, Rahman AH, Brown BD, Beckmann ND, Gnjatic S, Kenigsberg E, Charney AW, Merad M; Mount Sinai COVID-19 Biobank Team. Shift of lung macrophage composition is associated with COVID-19 disease severity and recovery. bioRxiv 2022:2022. [PMID: 35043110 DOI: 10.1101/2022.01.11.475918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
164 Kraus G, Weigelt M, Reinhardt S, Petzold A, Dahl A, Bonifacio E. Reproducibility of 10x Genomics single cell RNA sequencing method in the immune cell environment. J Immunol Methods 2022;:113227. [PMID: 35031279 DOI: 10.1016/j.jim.2022.113227] [Reference Citation Analysis]
165 Mi Z, Wang Z, Xue X, Liu T, Wang C, Sun L, Yu G, Zhang Y, Shi P, Sun Y, Yang Y, Ma S, Wang Z, Yu Y, Liu J, Liu H, Zhang F. The immune-suppressive landscape in lepromatous leprosy revealed by single-cell RNA sequencing. Cell Discov 2022;8:2. [PMID: 35013182 DOI: 10.1038/s41421-021-00353-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
166 Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol 2022;7:eabm5505. [PMID: 34995097 DOI: 10.1126/sciimmunol.abm5505] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 34.0] [Reference Citation Analysis]
167 Leon J, Michelson DA, Olejnik J, Chowdhary K, Oh HS, Hume AJ, Galván-Peña S, Zhu Y, Chen F, Vijaykumar B, Yang L, Crestani E, Yonker LM, Knipe DM, Mühlberger E, Benoist C. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface. Proc Natl Acad Sci U S A 2022;119:e2116853118. [PMID: 34969849 DOI: 10.1073/pnas.2116853118] [Reference Citation Analysis]
168 Shen Q, Li J, Zhang Z, Guo S, Wang Q, An X, Chang H. COVID-19: systemic pathology and its implications for therapy. Int J Biol Sci 2022;18:386-408. [PMID: 34975340 DOI: 10.7150/ijbs.65911] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
169 Olivarria G, Lane TE. Evaluating the role of chemokines and chemokine receptors involved in coronavirus infection. Expert Rev Clin Immunol 2021. [PMID: 34964406 DOI: 10.1080/1744666X.2022.2017282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Wilson JC, Kealy D, James SR, Plowman T, Newling K, Jagger C, Filbey K, Mann ER, Konkel JE, Menon M, Knight SB, Simpson A, Prihartadi A, Forshaw G, Todd N, Yates DR, Grainger JR, Hussell T, Kaye PM, Signoret N, Lagos D. Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19. iScience 2022;25:103672. [DOI: 10.1016/j.isci.2021.103672] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
171 Lotfollahi M, Naghipourfar M, Luecken MD, Khajavi M, Büttner M, Wagenstetter M, Avsec Ž, Gayoso A, Yosef N, Interlandi M, Rybakov S, Misharin AV, Theis FJ. Mapping single-cell data to reference atlases by transfer learning. Nat Biotechnol 2022;40:121-30. [DOI: 10.1038/s41587-021-01001-7] [Reference Citation Analysis]
172 Rea IM, Alexander HD. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing. Ageing Res Rev 2022;73:101494. [PMID: 34688926 DOI: 10.1016/j.arr.2021.101494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
173 Biagini D, Franzini M, Oliveri P, Lomonaco T, Ghimenti S, Bonini A, Vivaldi F, Macera L, Balas L, Durand T, Oger C, Galano J, Maggi F, Celi A, Paolicchi A, Di Francesco F. MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.01.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
174 Meher R, Wadhwa V, Kumar V, Shisha Phanbuh D, Sharma R, Singh I, Rathore PK, Goel R, Arora R, Garg S, Kumar S, Kumar J, Agarwal M, Singh M, Khurana N, Sagar T, Manchanda V, Saxena S. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi. Am J Otolaryngol 2022;43:103220. [PMID: 34547717 DOI: 10.1016/j.amjoto.2021.103220] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
175 Mairpady Shambat S, Gómez-Mejia A, Schweizer TA, Huemer M, Chang CC, Acevedo C, Bergada-Pijuan J, Vulin C, Hofmaenner DA, Scheier TC, Hertegonne S, Parietti E, Miroshnikova N, Wendel Garcia PD, Hilty MP, Buehler PK, Schuepbach RA, Brugger SD, Zinkernagel AS. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19. PLoS Pathog 2022;18:e1010176. [PMID: 35007290 DOI: 10.1371/journal.ppat.1010176] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
176 Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, Mache C, Chua RL, Knoll R, Timm S, Brumhard S, Krammer T, Zauber H, Hiller AL, Pascual-Reguant A, Mothes R, Bülow RD, Schulze J, Leipold AM, Djudjaj S, Erhard F, Geffers R, Pott F, Kazmierski J, Radke J, Pergantis P, Baßler K, Conrad C, Aschenbrenner AC, Sawitzki B, Landthaler M, Wyler E, Horst D, Hippenstiel S, Hocke A, Heppner FL, Uhrig A, Garcia C, Machleidt F, Herold S, Elezkurtaj S, Thibeault C, Witzenrath M, Cochain C, Suttorp N, Drosten C, Goffinet C, Kurth F, Schultze JL, Radbruch H, Ochs M, Eils R, Müller-Redetzky H, Hauser AE, Luecken MD, Theis FJ, Conrad C, Wolff T, Boor P, Selbach M, Saliba AE, Sander LE; Deutsche COVID-19 OMICS Initiative (DeCOI). SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 2021;184:6243-6261.e27. [PMID: 34914922 DOI: 10.1016/j.cell.2021.11.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
177 Melton A, Doyle-Meyers LA, Blair RV, Midkiff C, Melton HJ, Russell-Lodrigue K, Aye PP, Schiro F, Fahlberg M, Szeltner D, Spencer S, Beddingfield BJ, Goff K, Golden N, Penney T, Picou B, Hensley K, Chandler KE, Plante JA, Plante KS, Weaver SC, Roy CJ, Hoxie JA, Gao H, Montefiori DC, Mankowski JL, Bohm RP, Rappaport J, Maness NJ. The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease. PLoS Pathog 2021;17:e1010162. [PMID: 34929014 DOI: 10.1371/journal.ppat.1010162] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
178 Chen C, Amelia A, Ashdown GW, Mueller I, Coussens AK, Eriksson EM. Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection. Mol Med 2021;27. [DOI: 10.1186/s10020-021-00422-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
179 Sefik E, Israelow B, Mirza H, Zhao J, Qu R, Kaffe E, Song E, Halene S, Meffre E, Kluger Y, Nussenzweig M, Wilen CB, Iwasaki A, Flavell RA. A humanized mouse model of chronic COVID-19. Nat Biotechnol. [DOI: 10.1038/s41587-021-01155-4] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
180 Garcia-Carretero R, Vazquez-Gomez O, Ordoñez-Garcia M. Delayed Immune Reconstitution Inflammatory Syndrome in an Immunosuppressed Patient With SARS-CoV-2. Cureus 2021;13:e19481. [PMID: 34912622 DOI: 10.7759/cureus.19481] [Reference Citation Analysis]
181 Cossarizza A, Chang HD, Radbruch A, Abrignani S, Addo R, Akdis M, Andrä I, Andreata F, Annunziato F, Arranz E, Bacher P, Bari S, Barnaba V, Barros-Martins J, Baumjohann D, Beccaria CG, Bernardo D, Boardman DA, Borger J, Böttcher C, Brockmann L, Burns M, Busch DH, Cameron G, Cammarata I, Cassotta A, Chang Y, Chirdo FG, Christakou E, Čičin-Šain L, Cook L, Corbett AJ, Cornelis R, Cosmi L, Davey MS, De Biasi S, De Simone G, Del Zotto G, Delacher M, Di Rosa F, Santo JD, Diefenbach A, Dong J, Dörner T, Dress RJ, Dutertre CA, Eckle SBG, Eede P, Evrard M, Falk CS, Feuerer M, Fillatreau S, Fiz-Lopez A, Follo M, Foulds GA, Fröbel J, Gagliani N, Galletti G, Gangaev A, Garbi N, Garrote JA, Geginat J, Gherardin NA, Gibellini L, Ginhoux F, Godfrey DI, Gruarin P, Haftmann C, Hansmann L, Harpur CM, Hayday AC, Heine G, Hernández DC, Herrmann M, Hoelsken O, Huang Q, Huber S, Huber JE, Huehn J, Hundemer M, Hwang WYK, Iannacone M, Ivison SM, Jäck HM, Jani PK, Keller B, Kessler N, Ketelaars S, Knop L, Knopf J, Koay HF, Kobow K, Kriegsmann K, Kristyanto H, Krueger A, Kuehne JF, Kunze-Schumacher H, Kvistborg P, Kwok I, Latorre D, Lenz D, Levings MK, Lino AC, Liotta F, Long HM, Lugli E, MacDonald KN, Maggi L, Maini MK, Mair F, Manta C, Manz RA, Mashreghi MF, Mazzoni A, McCluskey J, Mei HE, Melchers F, Melzer S, Mielenz D, Monin L, Moretta L, Multhoff G, Muñoz LE, Muñoz-Ruiz M, Muscate F, Natalini A, Neumann K, Ng LG, Niedobitek A, Niemz J, Almeida LN, Notarbartolo S, Ostendorf L, Pallett LJ, Patel AA, Percin GI, Peruzzi G, Pinti M, Pockley AG, Pracht K, Prinz I, Pujol-Autonell I, Pulvirenti N, Quatrini L, Quinn KM, Radbruch H, Rhys H, Rodrigo MB, Romagnani C, Saggau C, Sakaguchi S, Sallusto F, Sanderink L, Sandrock I, Schauer C, Scheffold A, Scherer HU, Schiemann M, Schildberg FA, Schober K, Schoen J, Schuh W, Schüler T, Schulz AR, Schulz S, Schulze J, Simonetti S, Singh J, Sitnik KM, Stark R, Starossom S, Stehle C, Szelinski F, Tan L, Tarnok A, Tornack J, Tree TIM, van Beek JJP, van de Veen W, van Gisbergen K, Vasco C, Verheyden NA, von Borstel A, Ward-Hartstonge KA, Warnatz K, Waskow C, Wiedemann A, Wilharm A, Wing J, Wirz O, Wittner J, Yang JHM, Yang J. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur J Immunol 2021;51:2708-3145. [PMID: 34910301 DOI: 10.1002/eji.202170126] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
182 Fang H, Zeng Y, Zhang L, Chen C, Powell CA, Wang X. Can single cell RNA sequencing reshape the clinical biochemistry of hematology: New clusters of circulating blood cells. Clin Transl Med 2021;11:e671. [PMID: 34898038 DOI: 10.1002/ctm2.671] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
183 Udovicic I, Stanojevic I, Djordjevic D, Zeba S, Rondovic G, Abazovic T, Lazic S, Vojvodic D, To K, Abazovic D, Khan W, Surbatovic M. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19. J Clin Med 2021;10:5815. [PMID: 34945111 DOI: 10.3390/jcm10245815] [Reference Citation Analysis]
184 Leung E, Crass RL, Jorgensen SCJ, Raybardhan S, Langford BJ, Moore WJ, Rhodes NJ. Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19. Clin Pharmacokinet 2021. [PMID: 34894345 DOI: 10.1007/s40262-021-01092-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Patnaik SK, Petrucci C, Barbi J, Seager RJ, Pabla S, Yendamuri S. Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC. JTO Clin Res Rep 2021;2:100254. [PMID: 34877556 DOI: 10.1016/j.jtocrr.2021.100254] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
186 Mather MW, Jardine L, Talks B, Gardner L, Haniffa M. Complexity of immune responses in COVID-19. Semin Immunol 2021;55:101545. [PMID: 34865933 DOI: 10.1016/j.smim.2021.101545] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
187 Lim J, Puan KJ, Wang LW, Teng KWW, Loh CY, Tan KP, Carissimo G, Chan YH, Poh CM, Lee CY, Fong SW, Yeo NK, Chee RS, Amrun SN, Chang ZW, Tay MZ, Torres-Ruesta A, Leo Fernandez N, How W, Andiappan AK, Lee W, Duan K, Tan SY, Yan G, Kalimuddin S, Lye DC, Leo YS, Ong SWX, Young BE, Renia L, Ng LFP, Lee B, Rötzschke O. Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals. Front Immunol 2021;12:710217. [PMID: 34867943 DOI: 10.3389/fimmu.2021.710217] [Reference Citation Analysis]
188 Bauer W, Weber M, Diehl-wiesenecker E, Galtung N, Prpic M, Somasundaram R, Tauber R, Schwenk JM, Micke P, Kappert K. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection. Viruses 2021;13:2456. [DOI: 10.3390/v13122456] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
189 Borella R, De Biasi S, Paolini A, Boraldi F, Lo Tartaro D, Mattioli M, Fidanza L, Neroni A, Caro-Maldonado A, Meschiari M, Franceschini E, Quaglino D, Guaraldi G, Bertoldi C, Sita M, Busani S, Girardis M, Mussini C, Cossarizza A, Gibellini L. Metabolic reprograming shapes neutrophil functions in severe COVID-19. Eur J Immunol 2021. [PMID: 34870329 DOI: 10.1002/eji.202149481] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
190 Cory TJ, Emmons RS, Yarbro JR, Davis KL, Pence BD. Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1. Front Immunol 2021;12:733921. [PMID: 34858397 DOI: 10.3389/fimmu.2021.733921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
191 Siwicki M, Pittet MJ. Versatile neutrophil functions in cancer. Semin Immunol 2021;:101538. [PMID: 34876331 DOI: 10.1016/j.smim.2021.101538] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
192 Astle JM, Huang H. Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications. Front Oncol 2021;11:704464. [PMID: 34858804 DOI: 10.3389/fonc.2021.704464] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Burkert FR, Lanser L, Bellmann-Weiler R, Weiss G. Coronavirus Disease 2019: Clinics, Treatment, and Prevention. Front Microbiol 2021;12:761887. [PMID: 34858373 DOI: 10.3389/fmicb.2021.761887] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
194 De Zuani M, Lazničková P, Tomašková V, Dvončová M, Forte G, Stokin GB, Šrámek V, Helán M, Frič J. High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19. Scand J Immunol 2021;:e13125. [PMID: 34861051 DOI: 10.1111/sji.13125] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
195 Li X, Yan M, Chen J, Luo Y. The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19. Biomed Res Int 2021;2021:3178796. [PMID: 34840969 DOI: 10.1155/2021/3178796] [Reference Citation Analysis]
196 Sansico F, Miroballo M, Bianco DS, Tamiro F, Colucci M, Santis E, Rossi G, Rosati J, Di Mauro L, Miscio G, Mazza T, Vescovi AL, Mazzoccoli G, Giambra V, On Behalf Of Css-Covid Group. COVID-19 Specific Immune Markers Revealed by Single Cell Phenotypic Profiling. Biomedicines 2021;9:1794. [PMID: 34944610 DOI: 10.3390/biomedicines9121794] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
197 Gu R, Mao T, Lu Q, Tianjiao Su T, Wang J. Myeloid dysregulation and therapeutic intervention in COVID-19. Semin Immunol 2021;55:101524. [PMID: 34823995 DOI: 10.1016/j.smim.2021.101524] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
198 Galani IE, Andreakos E. Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities. Semin Immunol 2021;55:101522. [PMID: 34815163 DOI: 10.1016/j.smim.2021.101522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
199 Del Molino Del Barrio I, Hayday TS, Laing AG, Hayday AC, Di Rosa F. COVID-19: Using high-throughput flow cytometry to dissect clinical heterogeneity. Cytometry A 2021. [PMID: 34811890 DOI: 10.1002/cyto.a.24516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Parthasarathy U, Martinelli R, Vollmann EH, Best K, Therien AG. The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders. Biochem Pharmacol 2022;195:114847. [PMID: 34801526 DOI: 10.1016/j.bcp.2021.114847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
201 Gao KM, Derr AG, Guo Z, Nündel K, Marshak-Rothstein A, Finberg RW, Wang JP. Human nasal wash RNA-Seq reveals distinct cell-specific innate immune responses in influenza versus SARS-CoV-2. JCI Insight 2021;6:e152288. [PMID: 34618691 DOI: 10.1172/jci.insight.152288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Müller L, Di Benedetto S. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19. Int J Mol Sci 2021;22:12539. [PMID: 34830421 DOI: 10.3390/ijms222212539] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
203 Chan L, Karimi N, Morovati S, Alizadeh K, Kakish JE, Vanderkamp S, Fazel F, Napoleoni C, Alizadeh K, Mehrani Y, Minott JA, Bridle BW, Karimi K. The Roles of Neutrophils in Cytokine Storms. Viruses 2021;13:2318. [PMID: 34835125 DOI: 10.3390/v13112318] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
204 Syrimi E, Fennell E, Richter A, Vrljicak P, Stark R, Ott S, Murray PG, Al-Abadi E, Chikermane A, Dawson P, Hackett S, Jyothish D, Kanthimathinathan HK, Monaghan S, Nagakumar P, Scholefield BR, Welch S, Khan N, Faustini S, Davies K, Zelek WM, Kearns P, Taylor GS. The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery. iScience 2021;24:103215. [PMID: 34632327 DOI: 10.1016/j.isci.2021.103215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
205 Schmiedel BJ, Rocha J, Gonzalez-Colin C, Bhattacharyya S, Madrigal A, Ottensmeier CH, Ay F, Chandra V, Vijayanand P. COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types. Nat Commun 2021;12:6760. [PMID: 34799557 DOI: 10.1038/s41467-021-26888-3] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
206 deKay JT, Emery IF, Rud J, Eldridge A, Lord C, Gagnon DJ, May TL, Herrera VLM, Ruiz-Opazo N, Riker RR, Sawyer DB, Ryzhov S, Seder DB. DEspRhigh neutrophils are associated with critical illness in COVID-19. Sci Rep 2021;11:22463. [PMID: 34789851 DOI: 10.1038/s41598-021-01943-7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
207 Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev 2021;:e0009421. [PMID: 34788127 DOI: 10.1128/CMR.00094-21] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
208 Tsalik EL, Fiorino C, Aqeel A, Liu Y, Henao R, Ko ER, Burke TW, Reller ME, Bodinayake CK, Nagahawatte A, Arachchi WK, Devasiri V, Kurukulasooriya R, McClain MT, Woods CW, Ginsburg GS, Tillekeratne LG, Schughart K. The Host Response to Viral Infections Reveals Common and Virus-Specific Signatures in the Peripheral Blood. Front Immunol 2021;12:741837. [PMID: 34777354 DOI: 10.3389/fimmu.2021.741837] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
209 Sarif J, Raychaudhuri D, D'Rozario R, Bandopadhyay P, Singh P, Mehta P, Hoque MA, Sinha BP, Kushwaha M, Sahni S, Devi P, Chattopadhyay P, Paul SR, Ray Y, Chaudhuri K, Banerjee S, Majumdar D, Saha B, Sarkar BS, Bhattacharya P, Chatterjee S, Paul S, Ghosh P, Pandey R, Sengupta S, Ganguly D. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19. Front Immunol 2021;12:738093. [PMID: 34777349 DOI: 10.3389/fimmu.2021.738093] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
210 Pradhan K, Yi Z, Geng S, Li L. Development of Exhausted Memory Monocytes and Underlying Mechanisms. Front Immunol 2021;12:778830. [PMID: 34777396 DOI: 10.3389/fimmu.2021.778830] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
211 Mösbauer K, Fritsch VN, Adrian L, Bernhardt J, Gruhlke MCH, Slusarenko AJ, Niemeyer D, Antelmann H. The Effect of Allicin on the Proteome of SARS-CoV-2 Infected Calu-3 Cells. Front Microbiol 2021;12:746795. [PMID: 34777295 DOI: 10.3389/fmicb.2021.746795] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
212 Sinha S, Rosin NL, Arora R, Labit E, Jaffer A, Cao L, Farias R, Nguyen AP, de Almeida LGN, Dufour A, Bromley A, McDonald B, Gillrie MR, Fritzler MJ, Yipp BG, Biernaskie J. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19. Nat Med 2021. [PMID: 34782790 DOI: 10.1038/s41591-021-01576-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
213 Yang J, Yan Y, Zhong W. Application of omics technology to combat the COVID-19 pandemic. MedComm (2020) 2021;2:381-401. [PMID: 34766152 DOI: 10.1002/mco2.90] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
214 Chen Y, Zhang N, Zhang J, Guo J, Dong S, Sun H, Gao S, Zhou T, Li M, Liu X, Guo Y, Ye B, Zhao Y, Yu T, Zhan J, Jiang Y, Wong CCL, Gao GF, Liu WJ. Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19. Biochim Biophys Acta Proteins Proteom 2021;1870:140736. [PMID: 34774760 DOI: 10.1016/j.bbapap.2021.140736] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
215 Chakravarty N, Senthilnathan T, Paiola S, Gyani P, Castillo Cario S, Urena E, Jeysankar A, Jeysankar P, Ignatius Irudayam J, Natesan Subramanian S, Lavretsky H, Joshi S, Garcia G Jr, Ramaiah A, Arumugaswami V. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis. FEBS Lett 2021. [PMID: 34757622 DOI: 10.1002/1873-3468.14227] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
216 Bartleson JM, Radenkovic D, Covarrubias AJ, Furman D, Winer DA, Verdin E. SARS-CoV-2, COVID-19 and the Ageing Immune System. Nat Aging 2021;1:769-82. [PMID: 34746804 DOI: 10.1038/s43587-021-00114-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
217 Agrawal S, Salazar J, Tran TM, Agrawal A. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2. Front Immunol 2021;12:739757. [PMID: 34745109 DOI: 10.3389/fimmu.2021.739757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
218 Vanderheiden A, Thomas J, Soung AL, Davis-Gardner ME, Floyd K, Jin F, Cowan DA, Pellegrini K, Shi PY, Grakoui A, Klein RS, Bosinger SE, Kohlmeier JE, Menachery VD, Suthar MS. CCR2 Signaling Restricts SARS-CoV-2 Infection. mBio 2021;:e0274921. [PMID: 34749524 DOI: 10.1128/mBio.02749-21] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
219 García-González P, Tempio F, Fuentes C, Merino C, Vargas L, Simon V, Ramirez-Pereira M, Rojas V, Tobar E, Landskron G, Araya JP, Navarrete M, Bastias C, Tordecilla R, Varas MA, Maturana P, Marcoleta AE, Allende ML, Naves R, Hermoso MA, Salazar-Onfray F, Lopez M, Bono MR, Osorio F. Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements. Front Immunol 2021;12:769059. [PMID: 34745145 DOI: 10.3389/fimmu.2021.769059] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
220 Krämer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-García R, Schulte-Schrepping J, Kaiser KM, Rieke GJ, Bischoff J, Monin MB, Hoffmeister C, Schlabe S, De Domenico E, Reusch N, Händler K, Reynolds G, Blüthgen N, Hack G, Finnemann C, Nischalke HD, Strassburg CP, Stephenson E, Su Y, Gardner L, Yuan D, Chen D, Goldman J, Rosenstiel P, Schmidt SV, Latz E, Hrusovsky K, Ball AJ, Johnson JM, Koenig PA, Schmidt FI, Haniffa M, Heath JR, Kümmerer BM, Keitel V, Jensen B, Stubbemann P, Kurth F, Sander LE, Sawitzki B, Aschenbrenner AC, Schultze JL, Nattermann J; Deutsche COVID-19 OMICS Initiative (DeCOI). Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity 2021;54:2650-2669.e14. [PMID: 34592166 DOI: 10.1016/j.immuni.2021.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 39] [Article Influence: 1.0] [Reference Citation Analysis]
221 Shrivastava S, Chelluboina S, Jedge P, Doke P, Palkar S, Mishra AC, Arankalle VA. Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients. Front Cell Infect Microbiol 2021;11:751232. [PMID: 34746027 DOI: 10.3389/fcimb.2021.751232] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
222 Kennedy AE, Cook L, Breznik JA, Cowbrough B, Wallace JG, Huynh A, Smith JW, Son K, Stacey H, Ang J, McGeer A, Coleman BL, Larché M, Larché M, Hambly N, Nair P, Ask K, Miller MS, Bramson J, Levings MK, Nazy I, Svenningsen S, Mukherjee M, Bowdish DME. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections. Viruses 2021;13:2239. [PMID: 34835045 DOI: 10.3390/v13112239] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Mouchemore KA, Anderson RL. Immunomodulatory effects of G-CSF in cancer: Therapeutic implications. Semin Immunol 2021;:101512. [PMID: 34763974 DOI: 10.1016/j.smim.2021.101512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
224 Kim CY, Baek S, Cha J, Yang S, Kim E, Marcotte EM, Hart T, Lee I. HumanNet v3: an improved database of human gene networks for disease research. Nucleic Acids Res 2021:gkab1048. [PMID: 34747468 DOI: 10.1093/nar/gkab1048] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
225 Matute JD, Finander B, Pepin D, Ai X, Smith NP, Li JZ, Edlow AG, Villani AC, Lerou PH, Kalish BT. Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation. Pediatr Res 2021. [PMID: 34750520 DOI: 10.1038/s41390-021-01793-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
226 Effah CY, Drokow EK, Agboyibor C, Ding L, He S, Liu S, Akorli SY, Nuamah E, Sun T, Zhou X, Liu H, Xu Z, Feng F, Wu Y, Zhang X. Neutrophil-Dependent Immunity During Pulmonary Infections and Inflammations. Front Immunol 2021;12:689866. [PMID: 34737734 DOI: 10.3389/fimmu.2021.689866] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
227 Khwatenge CN, Pate M, Miller LC, Sang Y. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19. Front Immunol 2021;12:732913. [PMID: 34737743 DOI: 10.3389/fimmu.2021.732913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
228 Mukund K, Nayak P, Ashokkumar C, Rao S, Almeda J, Betancourt-Garcia MM, Sindhi R, Subramaniam S. Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape. Front Immunol 2021;12:738073. [PMID: 34721400 DOI: 10.3389/fimmu.2021.738073] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
229 Neeland MR, Bannister S, Clifford V, Nguyen J, Dohle K, Overmars I, Toh ZQ, Anderson J, Donato CM, Sarkar S, Do LAH, McCafferty C, Licciardi PV, Ignjatovic V, Monagle P, Bines JE, Mulholland K, Curtis N, McNab S, Steer AC, Burgner DP, Saffery R, Tosif S, Crawford NW. Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure. Front Immunol 2021;12:741639. [PMID: 34721408 DOI: 10.3389/fimmu.2021.741639] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
230 Hsieh WC, Lai EY, Liu YT, Wang YF, Tzeng YS, Cui L, Lai YJ, Huang HC, Huang JH, Ni HC, Tsai DY, Liang JJ, Liao CC, Lu YT, Jiang L, Liu MT, Wang JT, Chang SY, Chen CY, Tsai HC, Chang YM, Wernig G, Li CW, Lin KI, Lin YL, Tsai HK, Huang YT, Chen SY. NK cell receptor and ligand composition influences the clearance of SARS-CoV-2. J Clin Invest 2021;131:e146408. [PMID: 34720095 DOI: 10.1172/JCI146408] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
231 Lewis SA, Sureshchandra S, Zulu MZ, Doratt B, Jankeel A, Ibraim IC, Pinski AN, Rhoades NS, Curtis M, Jiang X, Tifrea D, Zaldivar F, Shen W, Edwards RA, Chow D, Cooper D, Amin A, Messaoudi I. Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults. Nat Aging 2021;1:1038-52. [DOI: 10.1038/s43587-021-00127-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
232 Ghanem M, Homps-Legrand M, Garnier M, Morer L, Goletto T, Frija-Masson J, Wicky PH, Jaquet P, Bancal C, Hurtado-Nedelec M, de Chaisemartin L, Jaillet M, Mailleux A, Quesnel C, Poté N, Debray MP, de Montmollin E, Neukirch C, Borie R, Taillé C, Crestani B; French COVID Cohort Study Group. Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia. Am J Physiol Lung Cell Mol Physiol 2021;321:L847-58. [PMID: 34496650 DOI: 10.1152/ajplung.00105.2021] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
233 Fong SW, Yeo NK, Chan YH, Goh YS, Amrun SN, Ang N, Rajapakse MP, Lum J, Foo S, Lee CY, Carissimo G, Chee RS, Torres-Ruesta A, Tay MZ, Chang ZW, Poh CM, Young BE, Tambyah PA, Kalimuddin S, Leo YS, Lye DC, Lee B, Biswas S, Howland SW, Renia L, Ng LFP. Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection. J Clin Immunol 2021. [PMID: 34716845 DOI: 10.1007/s10875-021-01142-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
234 Qin G, Liu S, Yang L, Yu W, Zhang Y. Myeloid cells in COVID-19 microenvironment. Signal Transduct Target Ther 2021;6:372. [PMID: 34707085 DOI: 10.1038/s41392-021-00792-0] [Reference Citation Analysis]
235 Coleman C, Doyle-Meyers LA, Russell-Lodrigue KE, Golden N, Threeton B, Song K, Pierre G, Baribault C, Bohm RP, Maness NJ, Kolls JK, Rappaport J, Mudd JC. Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys. Front Immunol 2021;12:754642. [PMID: 34691074 DOI: 10.3389/fimmu.2021.754642] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
236 Mazzoni A, Salvati L, Maggi L, Annunziato F, Cosmi L. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion. Semin Immunol 2021;:101508. [PMID: 34728121 DOI: 10.1016/j.smim.2021.101508] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
237 Carapito R, Li R, Helms J, Carapito C, Gujja S, Rolli V, Guimaraes R, Malagon-Lopez J, Spinnhirny P, Lederle A, Mohseninia R, Hirschler A, Muller L, Bastard P, Gervais A, Zhang Q, Danion F, Ruch Y, Schenck M, Collange O, Chamaraux-Tran TN, Molitor A, Pichot A, Bernard A, Tahar O, Bibi-Triki S, Wu H, Paul N, Mayeur S, Larnicol A, Laumond G, Frappier J, Schmidt S, Hanauer A, Macquin C, Stemmelen T, Simons M, Mariette X, Hermine O, Fafi-Kremer S, Goichot B, Drenou B, Kuteifan K, Pottecher J, Mertes PM, Kailasan S, Aman MJ, Pin E, Nilsson P, Thomas A, Viari A, Sanlaville D, Schneider F, Sibilia J, Tharaux PL, Casanova JL, Hansmann Y, Lidar D, Radosavljevic M, Gulcher JR, Meziani F, Moog C, Chittenden TW, Bahram S. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort. Sci Transl Med 2021;:eabj7521. [PMID: 34698500 DOI: 10.1126/scitranslmed.abj7521] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 21.0] [Reference Citation Analysis]
238 Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, Frischbutter S, Angermair S, Hohnstein T, Mattiola I, Nawrath P, Mc Ewen S, Zocche S, Viviano E, Heinz GA, Maurer M, Kölsch U, Chua RL, Aschman T, Meisel C, Radke J, Sawitzki B, Roehmel J, Allers K, Moos V, Schneider T, Hanitsch L, Mall MA, Conrad C, Radbruch H, Duerr CU, Trapani JA, Marcenaro E, Kallinich T, Corman VM, Kurth F, Sander LE, Drosten C, Treskatsch S, Durek P, Kruglov A, Radbruch A, Mashreghi MF, Diefenbach A. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. Nature 2021. [PMID: 34695836 DOI: 10.1038/s41586-021-04142-6] [Cited by in F6Publishing: 35] [Reference Citation Analysis]
239 Bonnet B, Cosme J, Dupuis C, Coupez E, Adda M, Calvet L, Fabre L, Saint-Sardos P, Bereiziat M, Vidal M, Laurichesse H, Souweine B, Evrard B. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation. EBioMedicine 2021;73:103622. [PMID: 34678611 DOI: 10.1016/j.ebiom.2021.103622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
240 Koushki K, Salemi M, Miri SM, Arjeini Y, Keshavarz M, Ghaemi A. Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19. Biomed Pharmacother 2021;144:112346. [PMID: 34678727 DOI: 10.1016/j.biopha.2021.112346] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
241 Changirwa D, Schlechte J, McDonald B. A Multi-Modal Toolkit for Studying Neutrophils in Cancer and Beyond. Cancers (Basel) 2021;13:5331. [PMID: 34771495 DOI: 10.3390/cancers13215331] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
242 Garg M, Li X, Moreno P, Papatheodorou I, Shu Y, Brazma A, Miao Z. Meta-analysis of COVID-19 single-cell studies confirms eight key immune responses. Sci Rep 2021;11:20833. [PMID: 34675242 DOI: 10.1038/s41598-021-00121-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
243 Li X, Shao M, Zeng X, Qian P, Huang H. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy. Signal Transduct Target Ther 2021;6:367. [PMID: 34667157 DOI: 10.1038/s41392-021-00764-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
244 Siemińska I, Węglarczyk K, Surmiak M, Kurowska-Baran D, Sanak M, Siedlar M, Baran J. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions. Front Immunol 2021;12:748097. [PMID: 34659245 DOI: 10.3389/fimmu.2021.748097] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
245 Mellett L, Khader SA. S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes. Cytokine Growth Factor Rev 2021:S1359-6101(21)00076-9. [PMID: 34728150 DOI: 10.1016/j.cytogfr.2021.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
246 Sananez I, Raiden SC, Algieri SC, Uranga M, Grisolía NA, Filippo D, De Carli N, Lalla SD, Cairoli H, Chiolo MJ, Meregalli CN, Cohen E, Mosquera G, Marcó Del Pont M, Giménez LI, Gregorio G, Sarli M, Alcalde AL, Davenport C, Bruera MJ, Simaz N, Pérez MF, Nivela V, Bayle C, Alvarez L, Revetria M, Tuccillo P, Agosta MT, Pérez H, Nova SV, Suárez P, Takata EM, García M, Lattner J, Rolón MJ, Coll P, Salvatori M, Piccardo C, Russo C, Varese A, Seery V, Holgado MP, Polo ML, Ceballos A, Nuñez M, Penedo JMG, Ferrero F, Geffner J, Arruvito L. A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children. EBioMedicine 2021;72:103615. [PMID: 34649078 DOI: 10.1016/j.ebiom.2021.103615] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
247 Myari A, Papapetrou E, Tsaousi C. Diagnostic value of white blood cell parameters for COVID-19: Is there a role for HFLC and IG? Int J Lab Hematol 2021. [PMID: 34623763 DOI: 10.1111/ijlh.13728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
248 Combadière B, Adam L, Guillou N, Quentric P, Rosenbaum P, Dorgham K, Bonduelle O, Parizot C, Sauce D, Mayaux J, Luyt CE, Boissonnas A, Amoura Z, Pourcher V, Miyara M, Gorochov G, Guihot A, Combadière C. LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications. Front Immunol 2021;12:752612. [PMID: 34616409 DOI: 10.3389/fimmu.2021.752612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
249 Winheim E, Rinke L, Lutz K, Reischer A, Leutbecher A, Wolfram L, Rausch L, Kranich J, Wratil PR, Huber JE, Baumjohann D, Rothenfusser S, Schubert B, Hilgendorff A, Hellmuth JC, Scherer C, Muenchhoff M, von Bergwelt-Baildon M, Stark K, Straub T, Brocker T, Keppler OT, Subklewe M, Krug AB. Impaired function and delayed regeneration of dendritic cells in COVID-19. PLoS Pathog 2021;17:e1009742. [PMID: 34614036 DOI: 10.1371/journal.ppat.1009742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
250 Kalyanaraman B. Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: overlapping biology with cancer. RSC Chem Biol 2021;2:1402-14. [PMID: 34704045 DOI: 10.1039/d1cb00042j] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
251 Lourda M, Dzidic M, Hertwig L, Bergsten H, Palma Medina LM, Sinha I, Kvedaraite E, Chen P, Muvva JR, Gorin JB, Cornillet M, Emgård J, Moll K, García M, Maleki KT, Klingström J, Michaëlsson J, Flodström-Tullberg M, Brighenti S, Buggert M, Mjösberg J, Malmberg KJ, Sandberg JK, Henter JI, Folkesson E, Gredmark-Russ S, Sönnerborg A, Eriksson LI, Rooyackers O, Aleman S, Strålin K, Ljunggren HG, Björkström NK, Svensson M, Ponzetta A, Norrby-Teglund A, Chambers BJ; Karolinska KI/K COVID-19 Study Group. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19. Proc Natl Acad Sci U S A 2021;118:e2109123118. [PMID: 34548411 DOI: 10.1073/pnas.2109123118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
252 LaSalle TJ, Gonye ALK, Freeman SS, Kaplonek P, Gushterova I, Kays KR, Manakongtreecheep K, Tantivit J, Rojas-Lopez M, Russo BC, Sharma N, Thomas MF, Lavin-Parsons KM, Lilly BM, Mckaig BN, Charland NC, Khanna HK, Lodenstein CL, Margolin JD, Blaum EM, Lirofonis PB, Sonny A, Bhattacharyya RP, Parry BA, Goldberg MB, Alter G, Filbin MR, Villani AC, Hacohen N, Sade-Feldman M. Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patients. bioRxiv 2021:2021. [PMID: 34642692 DOI: 10.1101/2021.10.04.463121] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
253 Liu N, Jiang C, Cai P, Shen Z, Sun W, Xu H, Fang M, Yao X, Zhu L, Gao X, Fang J, Lin J, Guo C, Qu K. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes. Cell Rep 2021;37:109793. [PMID: 34587478 DOI: 10.1016/j.celrep.2021.109793] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
254 Vázquez-Jiménez A, Avila-Ponce De León UE, Matadamas-Guzman M, Muciño-Olmos EA, Martínez-López YE, Escobedo-Tapia T, Resendis-Antonio O. On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers. Front Immunol 2021;12:705646. [PMID: 34603282 DOI: 10.3389/fimmu.2021.705646] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
255 Abdallah F, Coindre S, Gardet M, Meurisse F, Naji A, Suganuma N, Abi-Rached L, Lambotte O, Favier B. Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics. Front Immunol 2021;12:717998. [PMID: 34594332 DOI: 10.3389/fimmu.2021.717998] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
256 Jiang P, Zhang Y, Ru B, Yang Y, Vu T, Paul R, Mirza A, Altan-Bonnet G, Liu L, Ruppin E, Wakefield L, Wucherpfennig KW. Systematic investigation of cytokine signaling activity at the tissue and single-cell levels. Nat Methods 2021;18:1181-91. [PMID: 34594031 DOI: 10.1038/s41592-021-01274-5] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
257 Coleman MJ, Zimmerly KM, Yang XO. Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients. Biomolecules 2021;11:1425. [PMID: 34680058 DOI: 10.3390/biom11101425] [Reference Citation Analysis]
258 Torres-Ruiz J, Pérez-Fragoso A, Maravillas-Montero JL, Llorente L, Mejía-Domínguez NR, Páez-Franco JC, Romero-Ramírez S, Sosa-Hernández VA, Cervantes-Díaz R, Absalón-Aguilar A, Nuñez-Aguirre M, Juárez-Vega G, Meza-Sánchez D, Kleinberg-Bid A, Hernández-Gilsoul T, Ponce-de-León A, Gómez-Martín D. Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes. Front Immunol 2021;12:689966. [PMID: 34566957 DOI: 10.3389/fimmu.2021.689966] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
259 Felsenstein S, Reiff AO. A hitchhiker's guide through the COVID-19 galaxy. Clin Immunol 2021;232:108849. [PMID: 34563684 DOI: 10.1016/j.clim.2021.108849] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
260 Herr C, Mang S, Mozafari B, Guenther K, Speer T, Seibert M, Srikakulam SK, Beisswenger C, Ritzmann F, Keller A, Mueller R, Smola S, Eisinger D, Zemlin M, Danziger G, Volk T, Hoersch S, Krawczyk M, Lammert F, Adams T, Wagenpfeil G, Kindermann M, Marcu C, Ataya ZWD, Mittag M, Schwarzkopf K, Custodis F, Grandt D, Schaefer H, Eltges K, Lepper PM, Bals R; CORSAAR Study Group. Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19. J Inflamm Res 2021;14:4651-67. [PMID: 34552347 DOI: 10.2147/JIR.S320685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
261 Nassir N, Tambi R, Bankapur A, Al Heialy S, Karuvantevida N, Khansaheb HH, Zehra B, Begum G, Hameid RA, Ahmed A, Deesi Z, Alkhajeh A, Uddin KMF, Akter H, Safizadeh Shabestari SA, Almidani O, Islam A, Gaudet M, Kandasamy RK, Loney T, Tayoun AA, Nowotny N, Woodbury-Smith M, Rahman P, Kuebler WM, Yaseen Hachim M, Casanova JL, Berdiev BK, Alsheikh-Ali A, Uddin M. Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19. iScience 2021;24:103030. [PMID: 34458692 DOI: 10.1016/j.isci.2021.103030] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
262 Kaiser R, Leunig A, Pekayvaz K, Popp O, Joppich M, Polewka V, Escaig R, Anjum A, Hoffknecht ML, Gold C, Brambs S, Engel A, Stockhausen S, Knottenberg V, Titova A, Haji M, Scherer C, Muenchhoff M, Hellmuth JC, Saar K, Schubert B, Hilgendorff A, Schulz C, Kääb S, Zimmer R, Hübner N, Massberg S, Mertins P, Nicolai L, Stark K. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight 2021;6:e150862. [PMID: 34403366 DOI: 10.1172/jci.insight.150862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
263 van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Mann SA, Lynch KL, Yun C, Havlir DV, Chamie G, Marquez C, Greenhouse B, Lionakis MS, Norris PJ, Dumont LJ, Kelly K, Zhang P, Zhang Q, Gervais A, Le Voyer T, Whatley A, Si Y, Byrne A, Combes AJ, Rao AA, Song YS, Fragiadakis GK, Kangelaris K, Calfee CS, Erle DJ, Hendrickson C, Krummel MF, Woodruff PG, Langelier CR, Casanova JL, Derisi JL, Anderson MS, Ye CJ; UCSF COMET consortium. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med 2021;13:eabh2624. [PMID: 34429372 DOI: 10.1126/scitranslmed.abh2624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
264 Daix T, Jeannet R, Hernandez Padilla AC, Vignon P, Feuillard J, François B. Immature granulocytes can help the diagnosis of pulmonary bacterial infections in patients with severe COVID-19 pneumonia. J Intensive Care 2021;9:58. [PMID: 34544474 DOI: 10.1186/s40560-021-00575-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
265 Utrero-Rico A, González-Cuadrado C, Chivite-Lacaba M, Cabrera-Marante O, Laguna-Goya R, Almendro-Vazquez P, Díaz-Pedroche C, Ruiz-Ruigómez M, Lalueza A, Folgueira MD, Vázquez E, Quintas A, Berges-Buxeda MJ, Martín-Rodriguez M, Dopazo A, Serrano-Hernández A, Aguado JM, Paz-Artal E. Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery. Biomedicines 2021;9:1253. [PMID: 34572439 DOI: 10.3390/biomedicines9091253] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
266 Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, Nold-Petry CA, Nold MF. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Sci Immunol 2021;6:eabd0205. [PMID: 34533977 DOI: 10.1126/sciimmunol.abd0205] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
267 Zhao XN, You Y, Cui XM, Gao HX, Wang GL, Zhang SB, Yao L, Duan LJ, Zhu KL, Wang YL, Li L, Lu JH, Wang HB, Fan JF, Zheng HW, Dai EH, Tian LY, Ma MJ. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. Signal Transduct Target Ther 2021;6:342. [PMID: 34531370 DOI: 10.1038/s41392-021-00753-7] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
268 Galván-Peña S, Leon J, Chowdhary K, Michelson DA, Vijaykumar B, Yang L, Magnuson AM, Chen F, Manickas-Hill Z, Piechocka-Trocha A, Worrall DP, Hall KE, Ghebremichael M, Walker BD, Li JZ, Yu XG, Mathis D, Benoist C; MGH COVID-19 Collection & Processing Team. Profound Treg perturbations correlate with COVID-19 severity. Proc Natl Acad Sci U S A 2021;118:e2111315118. [PMID: 34433692 DOI: 10.1073/pnas.2111315118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
269 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
270 Herrera VLM, Walkey AJ, Nguyen MQ, Gromisch CM, Mosaddhegi JZ, Gromisch MS, Jundi B, Lukassen S, Carstensen S, Denis R, Belkina AC, Baron RM, Pinilla-Vera M, Muller M, Kimberly WT, Goldstein JN, Lehmann I, Shih AR, Eils R, Levy BD, Ruiz-Opazo N. Increased Neutrophil-Subset Associated With Severity/Mortality In ARDS And COVID19-ARDS Expresses The Dual Endothelin-1/VEGFsignal-Peptide Receptor (DEspR): An Actionable Therapeutic Target. Res Sq 2021:rs. [PMID: 34545358 DOI: 10.21203/rs.3.rs-846250/v1] [Reference Citation Analysis]
271 Musiu C, Caligola S, Fiore A, Lamolinara A, Frusteri C, Del Pizzo FD, De Sanctis F, Canè S, Adamo A, Hofer F, Barouni RM, Grilli A, Zilio S, Serafini P, Tacconelli E, Donadello K, Gottin L, Polati E, Girelli D, Polidoro I, Iezzi PA, Angelucci D, Capece A, Chen Y, Shi ZL, Murray PJ, Chilosi M, Amit I, Bicciato S, Iezzi M, Bronte V, Ugel S. Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis. Cell Death Differ 2021. [PMID: 34518653 DOI: 10.1038/s41418-021-00866-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
272 Garratt LW. Current Understanding of the Neutrophil Transcriptome in Health and Disease. Cells 2021;10:2406. [PMID: 34572056 DOI: 10.3390/cells10092406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
273 Liu Y, Wu Y, Liu B, Zhang Y, San D, Chen Y, Zhou Y, Yu L, Zeng H, Zhou Y, Zhou F, Yang H, Yin L, Huang Y. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19. Front Immunol 2021;12:677025. [PMID: 34504487 DOI: 10.3389/fimmu.2021.677025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 de Campos-Mata L, Tejedor Vaquero S, Tachó-Piñot R, Piñero J, Grasset EK, Arrieta Aldea I, Rodrigo Melero N, Carolis C, Horcajada JP, Cerutti A, Villar-García J, Magri G. SARS-CoV-2 sculpts the immune system to induce sustained virus-specific naïve-like and memory B-cell responses. Clin Transl Immunology 2021;10:e1339. [PMID: 34504693 DOI: 10.1002/cti2.1339] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
275 Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. An Interactive Single Cell Web Portal Identifies Gene and Cell Networks in COVID-19 Host Responses. iScience 2021;:103115. [PMID: 34522848 DOI: 10.1016/j.isci.2021.103115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
276 Farias GB, Badura R, Conceição CM, Gomes AMC, Godinho-Santos A, Laia J, Rosmaninho P, Santos DF, Mota C, Almeida ARM, Fernandes SM, Trombetta AC, Sousa AE. Acute HIV-1 and SARS-CoV-2 Infections Share Slan+ Monocyte Depletion-Evidence from an Hyperacute HIV-1 Case Report. Viruses 2021;13:1805. [PMID: 34578386 DOI: 10.3390/v13091805] [Reference Citation Analysis]
277 Clemente-Moragón A, Martínez-Milla J, Oliver E, Santos A, Flandes J, Fernández I, Rodríguez-González L, Serrano Del Castillo C, Ioan AM, López-Álvarez M, Gómez-Talavera S, Galán-Arriola C, Fuster V, Pérez-Calvo C, Ibáñez B. Metoprolol in Critically Ill Patients With COVID-19. J Am Coll Cardiol 2021;78:1001-11. [PMID: 34474731 DOI: 10.1016/j.jacc.2021.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
278 Lazarus HM, Ragsdale CE, Gale RP, Lyman GH. Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time? Front Immunol 2021;12:706186. [PMID: 34484202 DOI: 10.3389/fimmu.2021.706186] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
279 Huang W, Wang D, Yao YF. Understanding the pathogenesis of infectious diseases by single-cell RNA sequencing. Microb Cell 2021;8:208-22. [PMID: 34527720 DOI: 10.15698/mic2021.09.759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
280 Kwiecień I, Rutkowska E, Kulik K, Kłos K, Plewka K, Raniszewska A, Rzepecki P, Chciałowski A. Neutrophil Maturation, Reactivity and Granularity Research Parameters to Characterize and Differentiate Convalescent Patients from Active SARS-CoV-2 Infection. Cells 2021;10:2332. [PMID: 34571981 DOI: 10.3390/cells10092332] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
281 Hasan MZ, Islam S, Matsumoto K, Kawai T. Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients. Comput Biol Med 2021;137:104792. [PMID: 34478921 DOI: 10.1016/j.compbiomed.2021.104792] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
282 Peñaloza HF, Lee JS, Ray P. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease. PLoS Pathog 2021;17:e1009850. [PMID: 34473802 DOI: 10.1371/journal.ppat.1009850] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
283 Wang X, Xu G, Liu X, Liu Y, Zhang S, Zhang Z. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection. Cell Mol Immunol 2021;18:2313-24. [PMID: 34471261 DOI: 10.1038/s41423-021-00754-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
284 Ma Y, Zhang Y, Zhu L. Role of neutrophils in acute viral infection. Immun Inflamm Dis 2021;9:1186-96. [PMID: 34472718 DOI: 10.1002/iid3.500] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
285 Foulkes AS, Selvaggi C, Shinnick D, Lumish H, Kim E, Cao T, Thaweethai T, Qian J, Lu F, Yan J, Cheng D, He W, Clerkin KJ, Madhavan MV, Meigs JB, Triant VA, Lubitz SA, Gupta A, Bassett IV, Reilly MP. Understanding the link between obesity and severe COVID-19 outcomes: Causal mediation by systemic inflammatory response. J Clin Endocrinol Metab 2021:dgab629. [PMID: 34473294 DOI: 10.1210/clinem/dgab629] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
286 Chiang KC, Gupta A. To zinc or not to zinc for COVID-19 prophylaxis or treatment? J Med Microbiol 2021;70. [PMID: 34468306 DOI: 10.1099/jmm.0.001299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
287 Hachim A, Kavian N, Valkenburg SA. Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets. Curr Opin Virol 2021;50:139-46. [PMID: 34464844 DOI: 10.1016/j.coviro.2021.08.006] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
288 Lotfollahi M, Naghipourfar M, Luecken MD, Khajavi M, Büttner M, Wagenstetter M, Avsec Ž, Gayoso A, Yosef N, Interlandi M, Rybakov S, Misharin AV, Theis FJ. Mapping single-cell data to reference atlases by transfer learning. Nat Biotechnol 2021. [PMID: 34462589 DOI: 10.1038/s41587-021-01001-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
289 Zanoni I. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19? Curr Opin Virol 2021;50:119-27. [PMID: 34454352 DOI: 10.1016/j.coviro.2021.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
290 Shemesh M, Aktepe TE, Deerain JM, McAuley JL, Audsley MD, David CT, Purcell DFJ, Urin V, Hartmann R, Moseley GW, Mackenzie JM, Schreiber G, Harari D. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon. PLoS Pathog 2021;17:e1009800. [PMID: 34437657 DOI: 10.1371/journal.ppat.1009800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
291 Xu X, Xia J, Zhao S, Wang Q, Ge G, Xu F, Liu X, Zhang W, Yang Y. Qing-Fei-Pai-Du decoction and wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2. FASEB J 2021;35:e21870. [PMID: 34436790 DOI: 10.1096/fj.202100370RR] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
292 Kilic G, Bulut O, Jaeger M, Ter Horst R, Koeken VACM, Moorlag SJCFM, Mourits VP, de Bree C, Domínguez-Andrés J, Joosten LAB, Netea MG. The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men. Front Immunol 2021;12:720090. [PMID: 34434199 DOI: 10.3389/fimmu.2021.720090] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
293 Cai G, Du M, Bossé Y, Albrecht H, Qin F, Luo X, Androulakis XM, Cheng C, Nagarkatti M, Nagarkatti P, Christiani DC, Whitfield ML, Amos CI, Xiao F. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues. Int J Mol Sci 2021;22:9228. [PMID: 34502134 DOI: 10.3390/ijms22179228] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
294 Lam MTY, Duttke SH, Odish MF, Le HD, Hansen EA, Nguyen CT, Trescott S, Kim R, Deota S, Chang MW, Patel A, Hepokoski M, Alotaibi M, Rolfsen M, Perofsky K, Warden AS, Foley J, Ramirez SI, Dan JM, Abbott RK, Crotty S, Crotty Alexander LE, Malhotra A, Panda S, Benner CW, Coufal NG. Profiling Transcription Initiation in Peripheral Leukocytes Reveals Severity-Associated Cis-Regulatory Elements in Critical COVID-19. bioRxiv 2021:2021. [PMID: 34462742 DOI: 10.1101/2021.08.24.457187] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
295 Sureshchandra S, Zulu MZ, Doratt B, Jankeel A, Tifrea D, Edwards R, Rincon M, Marshall NE, Messaoudi I. Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 34462741 DOI: 10.1101/2021.08.23.457408] [Reference Citation Analysis]
296 Ruiz-Bedoya CA, Mota F, Ordonez AA, Foss CA, Singh AK, Praharaj M, Mahmud FJ, Ghayoor A, Flavahan K, De Jesus P, Bahr M, Dhakal S, Zhou R, Solis CV, Mulka KR, Bishai WR, Pekosz A, Mankowski JL, Villano J, Klein SL, Jain SK. 124I-Iodo-DPA-713 Positron Emission Tomography in a Hamster Model of SARS-CoV-2 Infection. Mol Imaging Biol 2021. [PMID: 34424479 DOI: 10.1007/s11307-021-01638-5] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
297 Schuurman AR, Reijnders TDY, Saris A, Ramirez Moral I, Schinkel M, de Brabander J, van Linge C, Vermeulen L, Scicluna BP, Wiersinga WJ, Vieira Braga FA, van der Poll T. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia. Elife 2021;10:e69661. [PMID: 34424199 DOI: 10.7554/eLife.69661] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
298 Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano AR, Gobbini A, Galeota E, Manara C, Bombaci M, Pesce E, Zagato E, Favalli A, Sarnicola ML, Curti S, Crosti M, Martinovic M, Fabbris T, Marini F, Donnici L, Lorenzo M, Mancino M, Ungaro R, Lombardi A, Mangioni D, Muscatello A, Aliberti S, Blasi F, De Feo T, Prati D, Manganaro L, Granucci F, Lanzavecchia A, De Francesco R, Gori A, Grifantini R, Abrignani S. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. Sci Immunol 2021;6:eabg5021. [PMID: 34376481 DOI: 10.1126/sciimmunol.abg5021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
299 Wagner C, Griesel M, Mikolajewska A, Mueller A, Nothacker M, Kley K, Metzendorf MI, Fischer AL, Kopp M, Stegemann M, Skoetz N, Fichtner F. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev 2021;8:CD014963. [PMID: 34396514 DOI: 10.1002/14651858.CD014963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
300 Suvarna K, Salkar A, Palanivel V, Bankar R, Banerjee N, Gayathri J Pai M, Srivastava A, Singh A, Khatri H, Agrawal S, Shrivastav O, Shastri J, Srivastava S. A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients. J Proteome Res 2021. [PMID: 34379420 DOI: 10.1021/acs.jproteome.1c00215] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
301 Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J, Pott F, Dietert K, Muelleder M, Farztdinov V, Obermayer B, Wienhold SM, Andreotti S, Hoefler T, Sawitzki B, Drosten C, Sander LE, Suttorp N, Ralser M, Beule D, Gruber AD, Goffinet C, Landthaler M, Trimpert J, Witzenrath M. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun 2021;12:4869. [PMID: 34381043 DOI: 10.1038/s41467-021-25030-7] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
302 Silva-Gomes R, Mapelli SN, Boutet MA, Mattiola I, Sironi M, Grizzi F, Colombo F, Supino D, Carnevale S, Pasqualini F, Stravalaci M, Porte R, Gianatti A, Pitzalis C, Locati M, Oliveira MJ, Bottazzi B, Mantovani A. Differential expression and regulation of MS4A family members in myeloid cells in physiological and pathological conditions. J Leukoc Biol 2021. [PMID: 34346525 DOI: 10.1002/JLB.2A0421-200R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
303 Wang X, Wen Y, Xie X, Liu Y, Tan X, Cai Q, Zhang Y, Cheng L, Xu G, Zhang S, Wang H, Wei L, Tang X, Qi F, Zhao J, Yuan J, Liu L, Zhu P, Ginhoux F, Zhang S, Cheng T, Zhang Z. Dysregulated hematopoiesis in bone marrow marks severe COVID-19. Cell Discov 2021;7:60. [PMID: 34349096 DOI: 10.1038/s41421-021-00296-9] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
304 Madonna G, Sale S, Capone M, De Falco C, Santocchio V, Di Matola T, Fiorentino G, Pirozzi C, D'Antonio A, Sabatino R, Atripaldi L, Atripaldi U, Raffone M, Curvietto M, Grimaldi AM, Vanella V, Festino L, Scarpato L, Palla M, Spatarella M, Perna F, Cerino P, Botti G, Parrella R, Montesarchio V, Ascierto PA, Atripaldi L. Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression. Biology (Basel) 2021;10:735. [PMID: 34439967 DOI: 10.3390/biology10080735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
305 Montano M. Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic. AIDS Res Hum Retroviruses 2021;37:589-600. [PMID: 33587013 DOI: 10.1089/AID.2021.0005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
306 Hou Y, Zhou Y, Gack MU, Lathia JD, Kallianpur A, Mehra R, Chan TA, Jung JU, Jehi L, Eng C, Cheng F. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19. Signal Transduct Target Ther 2021;6:292. [PMID: 34330889 DOI: 10.1038/s41392-021-00709-x] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
307 San Segundo D, Arnáiz de Las Revillas F, Lamadrid-Perojo P, Comins-Boo A, González-Rico C, Alonso-Peña M, Irure-Ventura J, Olmos JM, Fariñas MC, López-Hoyos M. Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients. Biomedicines 2021;9:917. [PMID: 34440121 DOI: 10.3390/biomedicines9080917] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
308 Chen G, Zhang Y, Zhang Y, Ai J, Yang B, Cui M, Liao Q, Chen H, Bai H, Shang D, Chen J, Sun C, Liu H, Liu F, Mao B, Sun G, Chen L, Lin JW, Li K. Differential immune responses in pregnant patients recovered from COVID-19. Signal Transduct Target Ther 2021;6:289. [PMID: 34326311 DOI: 10.1038/s41392-021-00703-3] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
309 Scherer AK, Hopke A, Sykes DB, Irimia D, Mansour MK. Host defense against fungal pathogens: Adaptable neutrophil responses and the promise of therapeutic opportunities? PLoS Pathog 2021;17:e1009691. [PMID: 34324592 DOI: 10.1371/journal.ppat.1009691] [Reference Citation Analysis]
310 Rodríguez de la Concepción ML, Ainsua-Enrich E, Reynaga E, Ávila-Nieto C, Santos JR, Roure S, Mateu L, Paredes R, Puig J, Jimenez JM, Izquierdo-Useros N, Clotet B, Pedro-Botet ML, Carrillo J. High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients. Life Sci Alliance 2021;4:e202001009. [PMID: 34321327 DOI: 10.26508/lsa.202001009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
311 Kramer KJ, Wilfong EM, Voss K, Barone SM, Shiakolas AR, Raju N, Roe CE, Suryadevara N, Walker L, Wall SC, Paulo A, Schaefer S, Dahunsi D, Westlake CS, Crowe JE, Carnahan RH, Rathmell JC, Bonami RH, Georgiev IS, Irish JM. Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine. bioRxiv 2021:2021. [PMID: 34341788 DOI: 10.1101/2021.07.28.453981] [Reference Citation Analysis]
312 Affandi AJ, Olesek K, Grabowska J, Nijen Twilhaar MK, Rodríguez E, Saris A, Zwart ES, Nossent EJ, Kalay H, de Kok M, Kazemier G, Stöckl J, van den Eertwegh AJM, de Gruijl TD, Garcia-Vallejo JJ, Storm G, van Kooyk Y, den Haan JMM. CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity. Front Immunol 2021;12:697840. [PMID: 34394090 DOI: 10.3389/fimmu.2021.697840] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
313 Siripurapu G, Samad SA, Fatima S, Wig N, Srivastava MVP. Successful management of post-COVID-19 acanthamoebic encephalitis. Int J Infect Dis 2021;110:226-8. [PMID: 34302963 DOI: 10.1016/j.ijid.2021.07.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Matsuo K, Lepinski A, Chavez RD, Barruet E, Pereira A, Moody TA, Ton AN, Sharma A, Hellman J, Tomoda K, Nakamura MC, Hsiao EC. ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages. Bone 2021;153:116129. [PMID: 34311122 DOI: 10.1016/j.bone.2021.116129] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
315 Cheon SY, Koo BN. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2. Int J Mol Sci 2021;22:7914. [PMID: 34360684 DOI: 10.3390/ijms22157914] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
316 Chitsike L, Duerksen-Hughes P. Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics. Virol J 2021;18:154. [PMID: 34301275 DOI: 10.1186/s12985-021-01624-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
317 Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell 2021:S0092-8674(21)00882-5. [PMID: 34352228 DOI: 10.1016/j.cell.2021.07.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 57] [Article Influence: 2.0] [Reference Citation Analysis]
318 Budinger GRS, Misharin AV, Ridge KM, Singer BD, Wunderink RG. Distinctive features of severe SARS-CoV-2 pneumonia. J Clin Invest 2021;131:149412. [PMID: 34263736 DOI: 10.1172/JCI149412] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
319 Fraccarollo D, Neuser J, Möller J, Riehle C, Galuppo P, Bauersachs J. Expansion of CD10neg neutrophils and CD14+HLA-DRneg/low monocytes driving proinflammatory responses in patients with acute myocardial infarction. Elife 2021;10:e66808. [PMID: 34289931 DOI: 10.7554/eLife.66808] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
320 Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and Macrophages in COVID-19. Front Immunol 2021;12:720109. [PMID: 34367190 DOI: 10.3389/fimmu.2021.720109] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
321 Jeyaraman M, Muthu S, Bapat A, Jain R, Sushmitha ES, Gulati A, Channaiah Anudeep T, Dilip SJ, Jha NK, Kumar D, Kesari KK, Ojha S, Dholpuria S, Gupta G, Dureja H, Chellappan DK, Singh SK, Dua K, Jha SK. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon 2021;7:e07635. [PMID: 34312598 DOI: 10.1016/j.heliyon.2021.e07635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
322 Niedźwiedzka-Rystwej P, Grywalska E, Hrynkiewicz R, Bębnowska D, Wołącewicz M, Majchrzak A, Parczewski M. Interplay between Neutrophils, NETs and T-Cells in SARS-CoV-2 Infection-A Missing Piece of the Puzzle in the COVID-19 Pathogenesis? Cells 2021;10:1817. [PMID: 34359987 DOI: 10.3390/cells10071817] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
323 Bhattacharya S, Agarwal S, Shrimali NM, Guchhait P. Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases. Mol Aspects Med 2021;:101000. [PMID: 34294412 DOI: 10.1016/j.mam.2021.101000] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
324 Rawat S, Vrati S, Banerjee A. Neutrophils at the crossroads of acute viral infections and severity. Mol Aspects Med 2021;:100996. [PMID: 34284874 DOI: 10.1016/j.mam.2021.100996] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
325 Zhao Y, Sun J, Li Y, Li Z, Xie Y, Feng R, Zhao J, Hu Y. The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir. iScience 2021;24:102857. [PMID: 34278249 DOI: 10.1016/j.isci.2021.102857] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
326 Arunachalam PS, Scott MKD, Hagan T, Li C, Feng Y, Wimmers F, Grigoryan L, Trisal M, Edara VV, Lai L, Chang SE, Feng A, Dhingra S, Shah M, Lee AS, Chinthrajah S, Sindher SB, Mallajosyula V, Gao F, Sigal N, Kowli S, Gupta S, Pellegrini K, Tharp G, Maysel-Auslender S, Hamilton S, Aoued H, Hrusovsky K, Roskey M, Bosinger SE, Maecker HT, Boyd SD, Davis MM, Utz PJ, Suthar MS, Khatri P, Nadeau KC, Pulendran B. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 2021. [PMID: 34252919 DOI: 10.1038/s41586-021-03791-x] [Cited by in F6Publishing: 75] [Reference Citation Analysis]
327 Li Y, Schneider AM, Mehta A, Sade-Feldman M, Kays KR, Gentili M, Charland NC, Gonye AL, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Parry BA, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Regan J, Flynn JP, Villani AC, Hacohen N, Goldberg MB, Filbin MR, Li JZ. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J Clin Invest 2021;131:148635. [PMID: 34196300 DOI: 10.1172/JCI148635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
328 Hou W, Ji Z, Chen Z, Wherry EJ, Hicks SC, Ji H. A statistical framework for differential pseudotime analysis with multiple single-cell RNA-seq samples. bioRxiv 2021:2021. [PMID: 34282418 DOI: 10.1101/2021.07.10.451910] [Reference Citation Analysis]
329 Russick J, Foy PE, Josseaume N, Meylan M, Hamouda NB, Kirilovsky A, Sissy CE, Tartour E, Smadja DM, Karras A, Hulot JS, Livrozet M, Fayol A, Arlet JB, Diehl JL, Dragon-Durey MA, Pagès F, Cremer I. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol 2021;12:701273. [PMID: 34322128 DOI: 10.3389/fimmu.2021.701273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther 2021;6:255. [PMID: 34234112 DOI: 10.1038/s41392-021-00679-0] [Cited by in F6Publishing: 112] [Reference Citation Analysis]
331 Park SH. An Impaired Inflammatory and Innate Immune Response in COVID-19. Mol Cells 2021;44:384-91. [PMID: 34098591 DOI: 10.14348/molcells.2021.0068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
332 Cabrera LE, Pekkarinen PT, Alander M, Nowlan KHA, Nguyen NA, Jokiranta S, Kuivanen S, Patjas A, Mero S, Pakkanen SH, Heinonen S, Kantele A, Vapalahti O, Kekäläinen E, Strandin T. Characterization of low-density granulocytes in COVID-19. PLoS Pathog 2021;17:e1009721. [PMID: 34228753 DOI: 10.1371/journal.ppat.1009721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
333 Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, Antoranz A, Arijs I, Boeckx B, Bosisio FM, Casaer M, Dauwe D, De Wever W, Dooms C, Dreesen E, Emmaneel A, Filtjens J, Gouwy M, Gunst J, Hermans G, Jansen S, Lagrou K, Liston A, Lorent N, Meersseman P, Mercier T, Neyts J, Odent J, Panovska D, Penttila PA, Pollet E, Proost P, Qian J, Quintelier K, Raes J, Rex S, Saeys Y, Sprooten J, Tejpar S, Testelmans D, Thevissen K, Van Buyten T, Vandenhaute J, Van Gassen S, Velásquez Pereira LC, Vos R, Weynand B, Wilmer A, Yserbyt J, Garg AD, Matthys P, Wouters C, Lambrechts D, Wauters E, Wauters J. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun 2021;12:4117. [PMID: 34226537 DOI: 10.1038/s41467-021-24360-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
334 Thakur M, Evans B, Schindewolf M, Baumgartner I, Döring Y. Neutrophil Extracellular Traps Affecting Cardiovascular Health in Infectious and Inflammatory Diseases. Cells 2021;10:1689. [PMID: 34359859 DOI: 10.3390/cells10071689] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
335 Alquicira-Hernandez J, Powell JE, Phan TG. No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID-19 disease. Clin Transl Immunology 2021;10:e1308. [PMID: 34221402 DOI: 10.1002/cti2.1308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Lung T, Sakem B, Hemmerle A, Nydegger M, Risch M, Risch L, Nydegger U. Autoimmune diseases - New insights into a troublesome field. J Transl Autoimmun 2021;4:100108. [PMID: 34179743 DOI: 10.1016/j.jtauto.2021.100108] [Reference Citation Analysis]
337 Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, Pons S, Diehl JL, Margadant C, Guerin C, Huijbers EJM, Philippe A, Chapuis N, Nowak-Sliwinska P, Karagiannidis C, Sanchez O, Kümpers P, Skurnik D, Randi AM, Griffioen AW. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 2021. [PMID: 34184164 DOI: 10.1007/s10456-021-09805-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 35] [Article Influence: 1.0] [Reference Citation Analysis]
338 Ulas T, Aschenbrenner AC. Neue Krankheiten mit Bluttranskriptomik entschlüsseln. Biospektrum (Heidelb) 2021;27:372-5. [PMID: 34219982 DOI: 10.1007/s12268-021-1590-8] [Reference Citation Analysis]
339 Wimmers F, Donato M, Kuo A, Ashuach T, Gupta S, Li C, Dvorak M, Foecke MH, Chang SE, Hagan T, De Jong SE, Maecker HT, van der Most R, Cheung P, Cortese M, Bosinger SE, Davis M, Rouphael N, Subramaniam S, Yosef N, Utz PJ, Khatri P, Pulendran B. The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. Cell 2021;184:3915-3935.e21. [PMID: 34174187 DOI: 10.1016/j.cell.2021.05.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
340 Sfera A, Osorio C, Zapata Martín Del Campo CM, Pereida S, Maurer S, Maldonado JC, Kozlakidis Z. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis. Front Cell Neurosci 2021;15:673217. [PMID: 34248502 DOI: 10.3389/fncel.2021.673217] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
341 Gupta A, Sharma A, Chakrabarti A. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it? Indian J Ophthalmol 2021;69:1645-7. [PMID: 34146000 DOI: 10.4103/ijo.IJO_1392_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
342 Trombetta AC, Farias GB, Gomes AMC, Godinho-Santos A, Rosmaninho P, Conceição CM, Laia J, Santos DF, Almeida ARM, Mota C, Gomes A, Serrano M, Veldhoen M, Sousa AE, Fernandes SM. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype. Front Immunol 2021;12:691725. [PMID: 34248984 DOI: 10.3389/fimmu.2021.691725] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
343 Ryu S, Shchukina I, Youm YH, Qing H, Hilliard B, Dlugos T, Zhang X, Yasumoto Y, Booth CJ, Fernández-Hernando C, Suárez Y, Khanna K, Horvath TL, Dietrich MO, Artyomov M, Wang A, Dixit VD. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. Elife 2021;10:e66522. [PMID: 34151773 DOI: 10.7554/eLife.66522] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
344 Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, Fehlmann T, Stein JA, Schaum N, Lee DP, Calcuttawala K, Vest RT, Berdnik D, Lu N, Hahn O, Gate D, McNerney MW, Channappa D, Cobos I, Ludwig N, Schulz-Schaeffer WJ, Keller A, Wyss-Coray T. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 2021;595:565-71. [PMID: 34153974 DOI: 10.1038/s41586-021-03710-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 143] [Article Influence: 17.0] [Reference Citation Analysis]
345 Juan Guardela BM, Sun J, Zhang T, Xu B, Balnis J, Huang Y, Ma SF, Molyneaux PL, Maher TM, Noth I, Michaud G, Jaitovich A, Herazo-Maya JD. 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study. EBioMedicine 2021;69:103439. [PMID: 34157486 DOI: 10.1016/j.ebiom.2021.103439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
346 Woo MS, Haag F, Nierhaus A, Jarczak D, Roedl K, Mayer C, Brehm TT, van der Meirschen M, Hennigs A, Christopeit M, Fiedler W, Karagiannis P, Burdelski C, Schultze A, Huber S, Addo MM, Schmiedel S, Friese MA, Kluge S, Schulze Zur Wiesch J. Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19. iScience 2021;24:102752. [PMID: 34179733 DOI: 10.1016/j.isci.2021.102752] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
347 Sattar Z, Lora A, Jundi B, Railwah C, Geraghty P. The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases. Pulm Med 2021;2021:5488591. [PMID: 34239729 DOI: 10.1155/2021/5488591] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
348 Rowlands M, Segal F, Hartl D. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19. Front Immunol 2021;12:697405. [PMID: 34220859 DOI: 10.3389/fimmu.2021.697405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
349 MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S, Paglionico A, Petricca L, Bosello SL, Carfì A, Sali M, Stigliano E, Cingolani A, Murri R, Arena V, Fantoni M, Antonelli M, Landi F, Franceschi F, Sanguinetti M, McInnes IB, McSharry C, Gasbarrini A, Otto TD, Kurowska-Stolarska M, Gremese E. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight 2021;6:147413. [PMID: 34143756 DOI: 10.1172/jci.insight.147413] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
350 Overholt KJ, Krog JR, Zanoni I, Bryson BD. Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution. iScience 2021;24:102738. [PMID: 34179732 DOI: 10.1016/j.isci.2021.102738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
351 Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal. bioRxiv 2021:2021. [PMID: 34127975 DOI: 10.1101/2021.06.07.447287] [Reference Citation Analysis]
352 Wilk AJ, Lee MJ, Wei B, Parks B, Pi R, Martínez-Colón GJ, Ranganath T, Zhao NQ, Taylor S, Becker W, Jimenez-Morales D, Blomkalns AL, O'Hara R, Ashley EA, Nadeau KC, Yang S, Holmes S, Rabinovitch M, Rogers AJ, Greenleaf WJ, Blish CA; Stanford COVID-19 Biobank. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J Exp Med 2021;218:e20210582. [PMID: 34128959 DOI: 10.1084/jem.20210582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
353 Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, Röhl A, Freiwald A, Szyrwiel L, Ludwig D, Correia-Melo C, Aulakh SK, Helbig ET, Stubbemann P, Lippert LJ, Grüning NM, Blyuss O, Vernardis S, White M, Messner CB, Joannidis M, Sonnweber T, Klein SJ, Pizzini A, Wohlfarter Y, Sahanic S, Hilbe R, Schaefer B, Wagner S, Mittermaier M, Machleidt F, Garcia C, Ruwwe-Glösenkamp C, Lingscheid T, Bosquillon de Jarcy L, Stegemann MS, Pfeiffer M, Jürgens L, Denker S, Zickler D, Enghard P, Zelezniak A, Campbell A, Hayward C, Porteous DJ, Marioni RE, Uhrig A, Müller-Redetzky H, Zoller H, Löffler-Ragg J, Keller MA, Tancevski I, Timms JF, Zaikin A, Hippenstiel S, Ramharter M, Witzenrath M, Suttorp N, Lilley K, Mülleder M, Sander LE, Ralser M, Kurth F; PA-COVID-19 Study group. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst 2021;12:780-794.e7. [PMID: 34139154 DOI: 10.1016/j.cels.2021.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
354 Kiani A, Roesch R, Wendtner CM, Kullmann F, Kubin T, Südhoff T, Augustin M, Schaich M, Müller-Naendrup C, Illerhaus G, Hartmann F, Hebart H, Seggewiss-Bernhardt R, Bentz M, Späth-Schwalbe E, Reimer P, Kaiser U, Kapp M, Graeven U, Chemnitz JM, Baesecke J, Lambertz H, Naumann R. Preinfection laboratory parameters may predict COVID-19 severity in tumor patients. Cancer Med 2021;10:4424-36. [PMID: 34121360 DOI: 10.1002/cam4.4023] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
355 Pesce M, Agostoni P, Bøtker HE, Brundel B, Davidson SM, De Caterina R, Ferdinandy P, Girao H, Gyöngyösi M, Hulot JS, Lecour S, Perrino C, Schulz R, Sluijter JPG, Steffens S, Tancevski I, Gollmann-Tepeköylü C, Tschöpe C, van Linthout S, Madonna R. COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2021:cvab201. [PMID: 34117887 DOI: 10.1093/cvr/cvab201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
356 Talla A, Vasaikar SV, Lemos MP, Moodie Z, Pebworth ML, Henderson KE, Cohen KW, Czartoski JL, Lai L, Suthar MS, Heubeck AT, Genge PC, Roll CR, Weiss M, Reading J, Kondza N, MacMillan H, Fong OC, Thomson ZJ, Graybuck LT, Newell EW, Coffey EM, Meijer P, Becker LA, De Rosa SC, Torgerson TR, Skene PJ, Li X, Szeto GL, McElrath MJ, Bumol TF. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv 2021:2021. [PMID: 34075380 DOI: 10.1101/2021.05.26.442666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
357 Chu X, Zhang B, Koeken VACM, Gupta MK, Li Y. Multi-Omics Approaches in Immunological Research. Front Immunol 2021;12:668045. [PMID: 34177908 DOI: 10.3389/fimmu.2021.668045] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
358 Aevarsson A, Kaczorowska AK, Adalsteinsson BT, Ahlqvist J, Al-Karadaghi S, Altenbuchner J, Arsin H, Átlasson ÚÁ, Brandt D, Cichowicz-Cieślak M, Cornish KAS, Courtin J, Dabrowski S, Dahle H, Djeffane S, Dorawa S, Dusaucy J, Enault F, Fedøy AE, Freitag-Pohl S, Fridjonsson OH, Galiez C, Glomsaker E, Guérin M, Gundesø SE, Gudmundsdóttir EE, Gudmundsson H, Håkansson M, Henke C, Helleux A, Henriksen JR, Hjörleifdóttir S, Hreggvidsson GO, Jasilionis A, Jochheim A, Jónsdóttir I, Jónsdóttir LB, Jurczak-Kurek A, Kaczorowski T, Kalinowski J, Kozlowski LP, Krupovic M, Kwiatkowska-Semrau K, Lanes O, Lange J, Lebrat J, Linares-Pastén J, Liu Y, Lorentsen SA, Lutterman T, Mas T, Merré W, Mirdita M, Morzywołek A, Ndela EO, Karlsson EN, Olgudóttir E, Pedersen C, Perler F, Pétursdóttir SK, Plotka M, Pohl E, Prangishvili D, Ray JL, Reynisson B, Róbertsdóttir T, Sandaa RA, Sczyrba A, Skírnisdóttir S, Söding J, Solstad T, Steen IH, Stefánsson SK, Steinegger M, Overå KS, Striberny B, Svensson A, Szadkowska M, Tarrant EJ, Terzian P, Tourigny M, Bergh TVD, Vanhalst J, Vincent J, Vroling B, Walse B, Wang L, Watzlawick H, Welin M, Werbowy O, Wons E, Zhang R. Going to extremes - a metagenomic journey into the dark matter of life. FEMS Microbiol Lett 2021;368:fnab067. [PMID: 34114607 DOI: 10.1093/femsle/fnab067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
359 Laudanski K, Jihane H, Antalosky B, Ghani D, Phan U, Hernandez R, Okeke T, Wu J, Rader D, Susztak K. Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics. Front Immunol 2021;12:650465. [PMID: 34177897 DOI: 10.3389/fimmu.2021.650465] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
360 Lévy Y, Wiedemann A, Hejblum BP, Durand M, Lefebvre C, Surénaud M, Lacabaratz C, Perreau M, Foucat E, Déchenaud M, Tisserand P, Blengio F, Hivert B, Gauthier M, Cervantes-Gonzalez M, Bachelet D, Laouénan C, Bouadma L, Timsit JF, Yazdanpanah Y, Pantaleo G, Hocini H, Thiébaut R; French COVID cohort study group. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death. iScience 2021;24:102711. [PMID: 34127958 DOI: 10.1016/j.isci.2021.102711] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
361 Reyes M, Filbin MR, Bhattacharyya RP, Sonny A, Mehta A, Billman K, Kays KR, Pinilla-Vera M, Benson ME, Cosimi LA, Hung DT, Levy BD, Villani AC, Sade-Feldman M, Baron RM, Goldberg MB, Blainey PC, Hacohen N. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro. Sci Transl Med 2021;13:eabe9599. [PMID: 34103408 DOI: 10.1126/scitranslmed.abe9599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
362 Ropa J, Trinh T, Aljoufi A, Broxmeyer HE. Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters. Curr Opin Hematol 2021;28:231-42. [PMID: 33656463 DOI: 10.1097/MOH.0000000000000645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Arunachalam PS. Immune responses to SARS-CoV-2 in the lung. Thorax 2021:thoraxjnl-2021-217231. [PMID: 34088785 DOI: 10.1136/thoraxjnl-2021-217231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
364 Praissman JL, Wells L. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research. Mol Cell Proteomics 2021;20:100103. [PMID: 34089862 DOI: 10.1016/j.mcpro.2021.100103] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
365 Christensen EE, Jørgensen MJ, Nore KG, Dahl TB, Yang K, Ranheim T, Huse C, Lind A, Nur S, Stiksrud B, Jenum S, Tonby K, Holter JC, Holten AR, Halvorsen B, Dyrhol-Riise AM. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns. J Intern Med 2021. [PMID: 34080738 DOI: 10.1111/joim.13310] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
366 Lange A, Lange J, Jaskuła E. Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients. Front Immunol 2021;12:658896. [PMID: 34149697 DOI: 10.3389/fimmu.2021.658896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
367 Hazeldine J, Lord JM. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets. Front Immunol 2021;12:680134. [PMID: 34149717 DOI: 10.3389/fimmu.2021.680134] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
368 Ciccocioppo R, Gibellini D, Astori G, Bernardi M, Bozza A, Chieregato K, Elice F, Ugel S, Caligola S, De Sanctis F, Canè S, Fiore A, Trovato R, Vella A, Petrova V, Amodeo G, Santimaria M, Mazzariol A, Frulloni L, Ruggeri M, Polati E, Bronte V. The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia. Stem Cell Res Ther 2021;12:316. [PMID: 34078447 DOI: 10.1186/s13287-021-02376-9] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
369 Dress RJ, Ginhoux F. Monocytes and macrophages in severe COVID-19 - friend, foe or both? Immunol Cell Biol 2021;99:561-4. [PMID: 34053124 DOI: 10.1111/imcb.12464] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
370 Synolaki E, Papadopoulos V, Divolis G, Tsahouridou O, Gavriilidis E, Loli G, Gavriil A, Tsigalou C, Tziolos NR, Sertaridou E, Kalra B, Kumar A, Rafailidis P, Pasternack A, Boumpas DT, Germanidis G, Ritvos O, Metallidis S, Skendros P, Sideras P. The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital Mortality. J Infect Dis 2021;223:1544-54. [PMID: 33625513 DOI: 10.1093/infdis/jiab108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
371 Warnat-Herresthal S, Schultze H, Shastry KL, Manamohan S, Mukherjee S, Garg V, Sarveswara R, Händler K, Pickkers P, Aziz NA, Ktena S, Tran F, Bitzer M, Ossowski S, Casadei N, Herr C, Petersheim D, Behrends U, Kern F, Fehlmann T, Schommers P, Lehmann C, Augustin M, Rybniker J, Altmüller J, Mishra N, Bernardes JP, Krämer B, Bonaguro L, Schulte-Schrepping J, De Domenico E, Siever C, Kraut M, Desai M, Monnet B, Saridaki M, Siegel CM, Drews A, Nuesch-Germano M, Theis H, Heyckendorf J, Schreiber S, Kim-Hellmuth S, Nattermann J, Skowasch D, Kurth I, Keller A, Bals R, Nürnberg P, Rieß O, Rosenstiel P, Netea MG, Theis F, Mukherjee S, Backes M, Aschenbrenner AC, Ulas T, Breteler MMB, Giamarellos-Bourboulis EJ, Kox M, Becker M, Cheran S, Woodacre MS, Goh EL, Schultze JL; COVID-19 Aachen Study (COVAS)., Deutsche COVID-19 Omics Initiative (DeCOI). Swarm Learning for decentralized and confidential clinical machine learning. Nature 2021;594:265-70. [PMID: 34040261 DOI: 10.1038/s41586-021-03583-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 61] [Article Influence: 4.0] [Reference Citation Analysis]
372 Yeo JG, Leong JY, Tay SH, Nadua KD, Anderson DE, Lim AJM, Ng XW, Poh SL, Guo D, Yaung KN, Kumar P, Wasser M, Hazirah SN, Sutamam N, Chua CJH, Qui M, Foo R, Gamage AM, Yeo KT, Ramakrishna L, Arkachaisri T, Young BE, Lye DC, Wang LF, Chong CY, Tan NWH, Li J, Kam KQ, Ginhoux F, Thoon KC, Chan JKY, Yung CF, Albani S. A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19. Front Immunol 2021;12:674279. [PMID: 34113347 DOI: 10.3389/fimmu.2021.674279] [Reference Citation Analysis]
373 Chilunda V, Martinez-Aguado P, Xia LC, Cheney L, Murphy A, Veksler V, Ruiz V, Calderon TM, Berman JW. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19. Front Immunol 2021;12:665773. [PMID: 34108966 DOI: 10.3389/fimmu.2021.665773] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
374 Szekely L, Bozoky B, Bendek M, Ostad M, Lavignasse P, Haag L, Wu J, Jing X, Gupta S, Saccon E, Sönnerborg A, Cao Y, Björnstedt M, Szakos A. Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death. Heliyon 2021;7:e07134. [PMID: 34056141 DOI: 10.1016/j.heliyon.2021.e07134] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
375 Freire PP, Marques AH, Baiocchi GC, Schimke LF, Fonseca DL, Salgado RC, Filgueiras IS, Napoleao SM, Plaça DR, Akashi KT, Hirata TDC, El Khawanky N, Giil LM, Cabral-Miranda G, Carvalho RF, Ferreira LCS, Condino-Neto A, Nakaya HI, Jurisica I, Ochs HD, Camara NOS, Calich VLG, Cabral-Marques O. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age. JCI Insight 2021;6:147535. [PMID: 34027897 DOI: 10.1172/jci.insight.147535] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
376 Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, Egeblad M, Henneck T, Hidalgo A, Hoffmann M, Hohberger B, Kanthi Y, Kaplan MJ, Knight JS, Knopf J, Kolaczkowska E, Kubes P, Leppkes M, Mahajan A, Manfredi AA, Maueröder C, Maugeri N, Mitroulis I, Muñoz LE, Narasaraju T, Naschberger E, Neeli I, Ng LG, Radic MZ, Ritis K, Rovere-Querini P, Schapher M, Schauer C, Simon HU, Singh J, Skendros P, Stark K, Stürzl M, van der Vlag J, Vandenabeele P, Vitkov L, von Köckritz-Blickwede M, Yanginlar C, Yousefi S, Zarbock A, Schett G, Herrmann M. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ 2021. [PMID: 34031543 DOI: 10.1038/s41418-021-00805-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 68] [Article Influence: 4.0] [Reference Citation Analysis]
377 Maecker HT. Immune profiling of COVID-19: preliminary findings and implications for the pandemic. J Immunother Cancer 2021;9:e002550. [PMID: 33963016 DOI: 10.1136/jitc-2021-002550] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
378 Wu D, Yang XO. Dysregulation of Pulmonary Responses in Severe COVID-19. Viruses 2021;13:957. [PMID: 34064104 DOI: 10.3390/v13060957] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
379 Reyes L, A Sanchez-Garcia M, Morrison T, Howden AJM, Watts ER, Arienti S, Sadiku P, Coelho P, Mirchandani AS, Zhang A, Hope D, Clark SK, Singleton J, Johnston S, Grecian R, Poon A, McNamara S, Harper I, Fourman MH, Brenes AJ, Pathak S, Lloyd A, Blanco GR, von Kriegsheim A, Ghesquiere B, Vermaelen W, Cologna CT, Dhaliwal K, Hirani N, Dockrell DH, Whyte MKB, Griffith D, Cantrell DA, Walmsley SR. -------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--. Wellcome Open Res 2021;6:38. [PMID: 33997298 DOI: 10.12688/wellcomeopenres.16584.2] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
380 Formiga RO, Amaral FC, Souza CF, Mendes DAGB, Wanderley CWS, Lorenzini CB, Santos AA, Antônia J, Faria LF, Natale CC, Paula NM, Silva PCS, Fonseca FR, Aires L, Heck N, Starick MR, Barroso SPC, Morrot A, Van Weyenbergh J, Sordi R, Alisson-Silva F, Mansur DS, Cunha FQ, Rocha EL, Witko-Sarsat V, Burgel PR, Martin C, Maurici R, Báfica A, Macauley MS, Spiller F. Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19. bioRxiv 2021:2020. [PMID: 33200130 DOI: 10.1101/2020.11.12.379115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
381 Park JH, Lee HK. Delivery Routes for COVID-19 Vaccines. Vaccines (Basel) 2021;9:524. [PMID: 34069359 DOI: 10.3390/vaccines9050524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
382 Berdnikovs S. The twilight zone: plasticity and mixed ontogeny of neutrophil and eosinophil granulocyte subsets. Semin Immunopathol 2021;43:337-46. [PMID: 34009400 DOI: 10.1007/s00281-021-00862-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
383 Wack A. Monocyte and dendritic cell defects in COVID-19. Nat Cell Biol 2021;23:445-7. [PMID: 33972732 DOI: 10.1038/s41556-021-00685-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
384 Cervantes-Barragan L, Vanderheiden A, Royer CJ, Davis-Gardner ME, Ralfs P, Chirkova T, Anderson LJ, Grakoui A, Suthar MS. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 34013278 DOI: 10.1101/2021.05.12.443948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
385 Ahluwalia P, Vaibhav K, Ahluwalia M, Mondal AK, Sahajpal N, Rojiani AM, Kolhe R. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2. Front Immunol 2021;12:660019. [PMID: 34046033 DOI: 10.3389/fimmu.2021.660019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
386 Schultze JL. Deutsche COVID-19 Omics Initiative (DeCOI). Biospektrum (Heidelb) 2021;27:227. [PMID: 33994671 DOI: 10.1007/s12268-021-1586-4] [Reference Citation Analysis]
387 Saichi M, Ladjemi MZ, Korniotis S, Rousseau C, Ait Hamou Z, Massenet-Regad L, Amblard E, Noel F, Marie Y, Bouteiller D, Medvedovic J, Pène F, Soumelis V. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol 2021;23:538-51. [PMID: 33972731 DOI: 10.1038/s41556-021-00681-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
388 Morrissey SM, Geller AE, Hu X, Tieri D, Ding C, Klaes CK, Cooke EA, Woeste MR, Martin ZC, Chen O, Bush SE, Zhang HG, Cavallazzi R, Clifford SP, Chen J, Ghare S, Barve SS, Cai L, Kong M, Rouchka EC, McLeish KR, Uriarte SM, Watson CT, Huang J, Yan J. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients. JCI Insight 2021;6:148435. [PMID: 33986193 DOI: 10.1172/jci.insight.148435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
389 Kreutmair S, Unger S, Núñez NG, Ingelfinger F, Alberti C, De Feo D, Krishnarajah S, Kauffmann M, Friebel E, Babaei S, Gaborit B, Lutz M, Jurado NP, Malek NP, Goepel S, Rosenberger P, Häberle HA, Ayoub I, Al-Hajj S, Nilsson J, Claassen M, Liblau R, Martin-Blondel G, Bitzer M, Roquilly A, Becher B. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity 2021;54:1578-1593.e5. [PMID: 34051147 DOI: 10.1016/j.immuni.2021.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
390 Townsend L, Dyer AH, Naughton A, Kiersey R, Holden D, Gardiner M, Dowds J, O'Brien K, Bannan C, Nadarajan P, Dunne J, Martin-Loeches I, Fallon PG, Bergin C, O'Farrelly C, Cheallaigh CN, Bourke NM, Conlon N. Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health. Front Immunol 2021;12:676932. [PMID: 34025675 DOI: 10.3389/fimmu.2021.676932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
391 Roussel M, Ferrant J, Reizine F, Le Gallou S, Dulong J, Carl S, Lesouhaitier M, Gregoire M, Bescher N, Verdy C, Latour M, Bézier I, Cornic M, Vinit A, Monvoisin C, Sawitzki B, Leonard S, Paul S, Feuillard J, Jeannet R, Daix T, Tiwari VK, Tadié JM, Cogné M, Tarte K. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection. Cell Rep Med 2021;2:100291. [PMID: 33977279 DOI: 10.1016/j.xcrm.2021.100291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
392 Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021;9:622-42. [PMID: 33965003 DOI: 10.1016/S2213-2600(21)00218-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 129] [Article Influence: 17.0] [Reference Citation Analysis]
393 Vanderheiden A, Thomas J, Soung AL, Davis-Gardner ME, Floyd K, Jin F, Cowan DA, Pellegrini K, Creanga A, Pegu A, Derrien-Colemyn A, Shi PY, Grakoui A, Klein RS, Bosinger SE, Kohlmeier JE, Menachery VD, Suthar MS. CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 33972938 DOI: 10.1101/2021.05.03.442538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
394 Ashokkumar C, Rohan V, Kroemer AH, Rao S, Mazariegos G, Higgs BW, Nadig S, Almeda J, Dhani H, Khan K, Yazigi N, Ekong U, Kaufman S, Betancourt-Garcia MM, Mukund K, Sethi P, Mehrotra S, Soltys K, Singh MS, Bond G, Khanna A, Ningappa M, Spishock B, Sindhi E, Atale N, Saunders M, Baliga P, Fishbein T, Subramaniam S, Sindhi R. Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients. bioRxiv 2021:2021. [PMID: 33972936 DOI: 10.1101/2021.05.03.442371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
395 Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, Fenyves BG, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Gerszten RE, Heimberg GS, Hoover PJ, Lieb DJ, Lin B, Ngo D, Pelka K, Reyes M, Smillie CS, Waghray A, Wood TE, Zajac AS, Jennings LL, Grundberg I, Bhattacharyya RP, Parry BA, Villani AC, Sade-Feldman M, Hacohen N, Goldberg MB. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep Med 2021;2:100287. [PMID: 33969320 DOI: 10.1016/j.xcrm.2021.100287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
396 Krämer A, Billaud JN, Tugendreich S, Shiffman D, Jones M, Green J. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function. BMC Bioinformatics 2021;22:229. [PMID: 33941085 DOI: 10.1186/s12859-021-04148-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
397 Martín-Sánchez E, Garcés JJ, Maia C, Inogés S, López-Díaz de Cerio A, Carmona-Torre F, Marin-Oto M, Alegre F, Molano E, Fernandez-Alonso M, Perez C, Botta C, Zabaleta A, Alcaide AB, Landecho MF, Rua M, Pérez-Warnisher T, Blanco L, Sarvide S, Vilas-Zornoza A, Alignani D, Moreno C, Pineda I, Sogbe M, Argemi J, Paiva B, Yuste JR. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients. Front Immunol 2021;12:659018. [PMID: 34012444 DOI: 10.3389/fimmu.2021.659018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
398 Zhou X, Ye Q. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front Immunol 2021;12:646333. [PMID: 33995364 DOI: 10.3389/fimmu.2021.646333] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
399 Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, Katsyv I, Rendeiro AF, Amin AD, Schapiro D, Frangieh CJ, Luoma AM, Filliol A, Fang Y, Ravichandran H, Clausi MG, Alba GA, Rogava M, Chen SW, Ho P, Montoro DT, Kornberg AE, Han AS, Bakhoum MF, Anandasabapathy N, Suárez-Fariñas M, Bakhoum SF, Bram Y, Borczuk A, Guo XV, Lefkowitch JH, Marboe C, Lagana SM, Del Portillo A, Zorn E, Markowitz GS, Schwabe RF, Schwartz RE, Elemento O, Saqi A, Hibshoosh H, Que J, Izar B. A molecular single-cell lung atlas of lethal COVID-19. Nature 2021;595:114-9. [PMID: 33915568 DOI: 10.1038/s41586-021-03569-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 75] [Article Influence: 14.0] [Reference Citation Analysis]
400 Metzemaekers M, Cambier S, Blanter M, Vandooren J, de Carvalho AC, Malengier-Devlies B, Vanderbeke L, Jacobs C, Coenen S, Martens E, Pörtner N, Vanbrabant L, Van Mol P, Van Herck Y, Van Aerde N, Hermans G, Gunst J, Borin A, Toledo N Pereira B, Dos Sp Gomes AB, Primon Muraro S, Fabiano de Souza G, S Farias A, Proenca-Modena JL, R Vinolo MA, Marques PE, Wouters C, Wauters E, Struyf S, Matthys P, Opdenakker G, Marques RE, Wauters J, Gouwy M, Proost P; CONTAGIOUS Consortium. Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019. Clin Transl Immunology 2021;10:e1271. [PMID: 33968405 DOI: 10.1002/cti2.1271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
401 González LA, Melo-González F, Sebastián VP, Vallejos OP, Noguera LP, Suazo ID, Schultz BM, Manosalva AH, Peñaloza HF, Soto JA, Parker D, Riedel CA, González PA, Kalergis AM, Bueno SM. Characterization of the Anti-Inflammatory Capacity of IL-10-Producing Neutrophils in Response to Streptococcus pneumoniae Infection. Front Immunol 2021;12:638917. [PMID: 33995357 DOI: 10.3389/fimmu.2021.638917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
402 Delaveris CS, Wilk AJ, Riley NM, Stark JC, Yang SS, Rogers AJ, Ranganath T, Nadeau KC, Blish CA, Bertozzi CR; Stanford COVID-19 Biobank. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. ACS Cent Sci 2021;7:650-7. [PMID: 34056095 DOI: 10.1021/acscentsci.0c01669] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
403 Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia (Nathan) 2021;13:5. [PMID: 33894790 DOI: 10.1186/s41479-021-00083-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
404 Mangaonkar AA, Tande AJ, Bekele DI. Differential Diagnosis and Workup of Monocytosis: A Systematic Approach to a Common Hematologic Finding. Curr Hematol Malig Rep 2021;16:267-75. [PMID: 33880680 DOI: 10.1007/s11899-021-00618-4] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
405 Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, Bach K, Sungnak W, Worlock KB, Yoshida M, Kumasaka N, Kania K, Engelbert J, Olabi B, Spegarova JS, Wilson NK, Mende N, Jardine L, Gardner LCS, Goh I, Horsfall D, McGrath J, Webb S, Mather MW, Lindeboom RGH, Dann E, Huang N, Polanski K, Prigmore E, Gothe F, Scott J, Payne RP, Baker KF, Hanrath AT, Schim van der Loeff ICD, Barr AS, Sanchez-Gonzalez A, Bergamaschi L, Mescia F, Barnes JL, Kilich E, de Wilton A, Saigal A, Saleh A, Janes SM, Smith CM, Gopee N, Wilson C, Coupland P, Coxhead JM, Kiselev VY, van Dongen S, Bacardit J, King HW, Rostron AJ, Simpson AJ, Hambleton S, Laurenti E, Lyons PA, Meyer KB, Nikolić MZ, Duncan CJA, Smith KGC, Teichmann SA, Clatworthy MR, Marioni JC, Göttgens B, Haniffa M; Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID-19 BioResource Collaboration. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med 2021;27:904-16. [PMID: 33879890 DOI: 10.1038/s41591-021-01329-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 102] [Article Influence: 18.0] [Reference Citation Analysis]
406 van der Toorn W, Oh DY, Bourquain D, Michel J, Krause E, Nitsche A, von Kleist M; Working Group on SARS-CoV-2 Diagnostics at RKI. An intra-host SARS-CoV-2 dynamics model to assess testing and quarantine strategies for incoming travelers, contact management, and de-isolation. Patterns (N Y) 2021;2:100262. [PMID: 33899034 DOI: 10.1016/j.patter.2021.100262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
407 Oguz SH, Koca M, Yildiz BO. Aging versus youth: Endocrine aspects of vulnerability for COVID-19. Rev Endocr Metab Disord 2021. [PMID: 33860905 DOI: 10.1007/s11154-021-09656-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
408 Qi F, Zhang W, Huang J, Fu L, Zhao J. Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019. Front Immunol 2021;12:651656. [PMID: 33936072 DOI: 10.3389/fimmu.2021.651656] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
409 Degauque N, Haziot A, Brouard S, Mooney N. Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection. FASEB J 2021;35:e21577. [PMID: 33831263 DOI: 10.1096/fj.202100024R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
410 Yu C, Littleton S, Giroux NS, Mathew R, Ding S, Kalnitsky J, Yang Y, Petzold E, Chung HA, Rivera GO, Rotstein T, Xi R, Ko ER, Tsalik EL, Sempowski GD, Denny TN, Burke TW, McClain MT, Woods CW, Shen X, Saban DR. Mucosal-associated invariant T cell responses differ by sex in COVID-19. Med (N Y) 2021;2:755-772.e5. [PMID: 33870241 DOI: 10.1016/j.medj.2021.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
411 Ramaswamy A, Brodsky NN, Sumida TS, Comi M, Asashima H, Hoehn KB, Li N, Liu Y, Shah A, Ravindra NG, Bishai J, Khan A, Lau W, Sellers B, Bansal N, Guerrerio P, Unterman A, Habet V, Rice AJ, Catanzaro J, Chandnani H, Lopez M, Kaminski N, Dela Cruz CS, Tsang JS, Wang Z, Yan X, Kleinstein SH, van Dijk D, Pierce RW, Hafler DA, Lucas CL. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Immunity 2021;54:1083-1095.e7. [PMID: 33891889 DOI: 10.1016/j.immuni.2021.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
412 Takano T, Matsumura T, Adachi Y, Terahara K, Moriyama S, Onodera T, Nishiyama A, Kawana-Tachikawa A, Miki S, Hosoya-Nakayama K, Nakamura-Hoshi M, Seki S, Tachikawa N, Yoshimura Y, Miyata N, Horiuchi H, Sasaki H, Miyazaki K, Kinoshita N, Sudo T, Akiyama Y, Sato R, Suzuki T, Matano T, Takahashi Y. Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan. Int Immunol 2021;33:241-7. [PMID: 33538817 DOI: 10.1093/intimm/dxab005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
413 Venet F, Cour M, Rimmelé T, Viel S, Yonis H, Coudereau R, Amaz C, Abraham P, Monard C, Casalegno JS, Brengel-Pesce K, Lukaszewicz AC, Argaud L, Monneret G; RICO study group. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome. Crit Care 2021;25:140. [PMID: 33845874 DOI: 10.1186/s13054-021-03558-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
414 Ashkenazi-Preiser H, Mikula I Jr, Baniyash M. The diverse roles of myeloid derived suppressor cells in mucosal immunity. Cell Immunol 2021;365:104361. [PMID: 33984533 DOI: 10.1016/j.cellimm.2021.104361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
415 Hu Y, Li B, Zhang W, Liu N, Cai P, Chen F, Qu K. WEDGE: imputation of gene expression values from single-cell RNA-seq datasets using biased matrix decomposition. Brief Bioinform 2021:bbab085. [PMID: 33834202 DOI: 10.1093/bib/bbab085] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
416 Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence 2021;12:918-36. [PMID: 33757410 DOI: 10.1080/21505594.2021.1898790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
417 De Sanctis JB, García AH, Moreno D, Hajduch M. Coronavirus infection: An immunologists' perspective. Scand J Immunol 2021;93:e13043. [PMID: 33783027 DOI: 10.1111/sji.13043] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
418 de Leeuw AJM, Oude Luttikhuis MAM, Wellen AC, Müller C, Calkhoven CF. Obesity and its impact on COVID-19. J Mol Med (Berl) 2021;99:899-915. [PMID: 33824998 DOI: 10.1007/s00109-021-02072-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
419 Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health 2021;14:100251. [PMID: 33842898 DOI: 10.1016/j.bbih.2021.100251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
420 Garcia-Flores V, Romero R, Xu Y, Theis K, Arenas-Hernandez M, Miller D, Peyvandipour A, Galaz J, Levenson D, Bhatti G, Gershater M, Pusod E, Kracht D, Florova V, Leng Y, Tao L, Faucett M, Para R, Hsu CD, Zhang G, Tarca A, Pique-Regi R, Gomez-Lopez N. Maternal-Fetal Immune Responses in Pregnant Women Infected with SARS-CoV-2. Res Sq 2021:rs. [PMID: 33821263 DOI: 10.21203/rs.3.rs-362886/v1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
421 Coopersmith CM, Antonelli M, Bauer SR, Deutschman CS, Evans LE, Ferrer R, Hellman J, Jog S, Kesecioglu J, Kissoon N, Martin-Loeches I, Nunnally ME, Prescott HC, Rhodes A, Talmor D, Tissieres P, De Backer D. The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness. Crit Care Med 2021;49:598-622. [PMID: 33591008 DOI: 10.1097/CCM.0000000000004895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
422 Huang K, Wang C, Vagts C, Raguveer V, Finn PW, Perkins DL. LncRNAs NEAT1 and MALAT1 Differentiate Inflammation in Severe COVID-19 Patients. medRxiv 2021:2021. [PMID: 33821282 DOI: 10.1101/2021.03.26.21254445] [Reference Citation Analysis]
423 Daamen AR, Bachali P, Owen KA, Kingsmore KM, Hubbard EL, Labonte AC, Robl R, Shrotri S, Grammer AC, Lipsky PE. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway. Sci Rep 2021;11:7052. [PMID: 33782412 DOI: 10.1038/s41598-021-86002-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 41] [Article Influence: 17.0] [Reference Citation Analysis]
424 Lutz MB, Eckert IN. Comments on the ambiguity of selected surface markers, signaling pathways and omics profiles hampering the identification of myeloid-derived suppressor cells. Cell Immunol 2021;364:104347. [PMID: 33838447 DOI: 10.1016/j.cellimm.2021.104347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
425 Falck-Jones S, Vangeti S, Yu M, Falck-Jones R, Cagigi A, Badolati I, Österberg B, Lautenbach MJ, Åhlberg E, Lin A, Lepzien R, Szurgot I, Lenart K, Hellgren F, Maecker H, Sälde J, Albert J, Johansson N, Bell M, Loré K, Färnert A, Smed-Sörensen A. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. J Clin Invest 2021;131:144734. [PMID: 33492309 DOI: 10.1172/JCI144734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 39] [Article Influence: 15.0] [Reference Citation Analysis]
426 Reusch N, De Domenico E, Bonaguro L, Schulte-Schrepping J, Baßler K, Schultze JL, Aschenbrenner AC. Neutrophils in COVID-19. Front Immunol 2021;12:652470. [PMID: 33841435 DOI: 10.3389/fimmu.2021.652470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
427 Efimov SV, Matsiyeuskaya NV, Boytsova OV, Akhieva LY, Kvasova EI, Harrison F, Karpova YS, Tikhonov A, Khomyakova NF, Hardman T, Rossi JF. The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study. Drugs Context 2021;10:2020-11-1. [PMID: 33828607 DOI: 10.7573/dic.2020-11-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
428 Seddiki N, French M. COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire. Front Immunol 2021;12:649567. [PMID: 33841434 DOI: 10.3389/fimmu.2021.649567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
429 Zheng H, Rao AM, Dermadi D, Toh J, Murphy Jones L, Donato M, Liu Y, Su Y, Dai CL, Kornilov SA, Karagiannis M, Marantos T, Hasin-Brumshtein Y, He YD, Giamarellos-Bourboulis EJ, Heath JR, Khatri P. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity 2021;54:753-768.e5. [PMID: 33765435 DOI: 10.1016/j.immuni.2021.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
430 Chioh FW, Fong SW, Young BE, Wu KX, Siau A, Krishnan S, Chan YH, Carissimo G, Teo LL, Gao F, Tan RS, Zhong L, Koh AS, Tan SY, Tambyah PA, Renia L, Ng LF, Lye DC, Cheung C. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife 2021;10:e64909. [PMID: 33752798 DOI: 10.7554/eLife.64909] [Cited by in Crossref: 12] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
431 Li W, Yue H. Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner. Front Med (Lausanne) 2021;8:653773. [PMID: 33829029 DOI: 10.3389/fmed.2021.653773] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
432 Courjon J, Dufies O, Robert A, Bailly L, Torre C, Chirio D, Contenti J, Vitale S, Loubatier C, Doye A, Pomares-Estran C, Gonfrier G, Lotte R, Munro P, Visvikis O, Dellamonica J, Giordanengo V, Carles M, Yvan-Charvet L, Ivanov S, Auberger P, Jacquel A, Boyer L. Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity. Blood Adv 2021;5:1523-34. [PMID: 33683342 DOI: 10.1182/bloodadvances.2020003918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
433 Matute J, Finander B, Pepin D, Ai X, Smith N, Li J, Edlow A, Villani A, Lerou P, Kalish B. Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation. Res Sq 2021:rs. [PMID: 33758834 DOI: 10.21203/rs.3.rs-311000/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
434 Sun C, Sun Y, Wu P, Ding W, Wang S, Li J, Liang L, Chai C, Fu Y, Li Z, Zhu L, Ju J, Liao X, Huang X, Feng L, Ma D, He L, Chen D, Chen G, Jin X, Wu P. Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients. Intensive Care Med Exp 2021;9:13. [PMID: 33721144 DOI: 10.1186/s40635-021-00373-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
435 Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, Krupska I, Matsumoto R, Poon MML, Idzikowski E, Morris SE, Pasin C, Yates AJ, Ku A, Chait M, Davis-Porada J, Guo XV, Zhou J, Steinle M, Mackay S, Saqi A, Baldwin MR, Sims PA, Farber DL. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 2021;54:797-814.e6. [PMID: 33765436 DOI: 10.1016/j.immuni.2021.03.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 90] [Article Influence: 33.0] [Reference Citation Analysis]
436 Zenarruzabeitia O, Astarloa-Pando G, Terrén I, Orrantia A, Pérez-Garay R, Seijas-Betolaza I, Nieto-Arana J, Imaz-Ayo N, Pérez-Fernández S, Arana-Arri E, Borrego F. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19. Front Immunol 2021;12:655934. [PMID: 33777054 DOI: 10.3389/fimmu.2021.655934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
437 Danlos FX, Grajeda-Iglesias C, Durand S, Sauvat A, Roumier M, Cantin D, Colomba E, Rohmer J, Pommeret F, Baciarello G, Willekens C, Vasse M, Griscelli F, Fahrner JE, Goubet AG, Dubuisson A, Derosa L, Nirmalathasan N, Bredel D, Mouraud S, Pradon C, Stoclin A, Rozenberg F, Duchemin J, Jourdi G, Ellouze S, Levavasseur F, Albigès L, Soria JC, Barlesi F, Solary E, André F, Pène F, Ackerman F, Mouthon L, Zitvogel L, Marabelle A, Michot JM, Fontenay M, Kroemer G. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis 2021;12:258. [PMID: 33707411 DOI: 10.1038/s41419-021-03540-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
438 Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Matsuda K, Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, Mitsuya H. Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. Sci Rep 2021;11:5563. [PMID: 33692457 DOI: 10.1038/s41598-021-84733-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
439 van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Mann SA, Lynch KL, Yun C, Havlir DV, Chamie G, Marquez C, Greenhouse B, Lionakis MS, Norris PJ, Dumont LJ, Kelly K, Zhang P, Zhang Q, Gervais A, Voyer TL, Whatley A, Si Y, Byrne A, Combes AJ, Rao AA, Song YS, Fragiadakis GK, Kangelaris K, Calfee CS, Erle DJ, Hendrickson C, Krummel MF, Woodruff PG, Langelier CR, Casanova JL, Derisi JL, Anderson MS, Ye CJ; UCSF COMET consortium. Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19. bioRxiv 2021:2021. [PMID: 33758859 DOI: 10.1101/2021.03.09.434529] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
440 Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz C, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun HJ. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv 2021;5:1164-77. [PMID: 33635335 DOI: 10.1182/bloodadvances.2020003568] [Cited by in Crossref: 30] [Cited by in F6Publishing: 99] [Article Influence: 30.0] [Reference Citation Analysis]
441 Najm A, Alunno A, Mariette X, Terrier B, De Marco G, Emmel J, Mason L, McGonagle DG, Machado PM. Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider. RMD Open 2021;7:e001549. [PMID: 33574116 DOI: 10.1136/rmdopen-2020-001549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
442 Dauletova M, Hafsan H, Mahhengam N, Zekiy AO, Ahmadi M, Siahmansouri H. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study. Clin Immunol 2021;226:108712. [PMID: 33684527 DOI: 10.1016/j.clim.2021.108712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
443 Rosa BA, Ahmed M, Singh DK, Choreño-Parra JA, Cole J, Jiménez-Álvarez LA, Rodríguez-Reyna TS, Singh B, Gonzalez O, Carrion R Jr, Schlesinger LS, Martin J, Zúñiga J, Mitreva M, Kaushal D, Khader SA. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun Biol 2021;4:290. [PMID: 33674719 DOI: 10.1038/s42003-021-01829-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
444 Bost P, De Sanctis F, Canè S, Ugel S, Donadello K, Castellucci M, Eyal D, Fiore A, Anselmi C, Barouni RM, Trovato R, Caligola S, Lamolinara A, Iezzi M, Facciotti F, Mazzariol A, Gibellini D, De Nardo P, Tacconelli E, Gottin L, Polati E, Schwikowski B, Amit I, Bronte V. Deciphering the state of immune silence in fatal COVID-19 patients. Nat Commun 2021;12:1428. [PMID: 33674591 DOI: 10.1038/s41467-021-21702-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
445 Yanaoka H, Nagafuchi Y, Hanata N, Takeshima Y, Ota M, Suwa Y, Shirai H, Sugimori Y, Okubo M, Kobayashi S, Hatano H, Yamada S, Tsuchida Y, Iwasaki Y, Sumitomo S, Shoda H, Okada M, Okamura T, Yamamoto K, Fujio K. Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls. J Autoimmun 2021;119:102617. [PMID: 33677398 DOI: 10.1016/j.jaut.2021.102617] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
446 Lindner HA, Velásquez SY, Thiel M, Kirschning T. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19. Front Immunol 2021;12:602130. [PMID: 33746948 DOI: 10.3389/fimmu.2021.602130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
447 Manunta MDI, Lamorte G, Ferrari F, Trombetta E, Tirone M, Bianco C, Cattaneo A, Santoro L, Baselli G, Brasca M, Ostadreza M, Erba E, Gori A, Bandera A, Porretti L, Valenti LVC, Prati D. Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient. Sci Rep 2021;11:4904. [PMID: 33649400 DOI: 10.1038/s41598-021-83950-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
448 Amann K, Boor P, Wiech T, Singh J, Vonbrunn E, Knöll A, Hermann M, Büttner-Herold M, Daniel C, Hartmann A. COVID-19 effects on the kidney. Pathologe 2021. [PMID: 33646362 DOI: 10.1007/s00292-020-00900-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
449 Thompson EA, Cascino K, Ordonez AA, Zhou W, Vaghasia A, Hamacher-Brady A, Brady NR, Sun IH, Wang R, Rosenberg AZ, Delannoy M, Rothman R, Fenstermacher K, Sauer L, Shaw-Saliba K, Bloch EM, Redd AD, Tobian AAR, Horton M, Smith K, Pekosz A, D'Alessio FR, Yegnasubramanian S, Ji H, Cox AL, Powell JD. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep 2021;34:108863. [PMID: 33691089 DOI: 10.1016/j.celrep.2021.108863] [Cited by in Crossref: 9] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
450 Xue G, Jiang M, Zhao R, Le A, Li J. Elevated frequencies of CD14+HLA-DRlo/neg MDSCs in COVID-19 patients. Aging (Albany NY) 2021;13:6236-46. [PMID: 33640878 DOI: 10.18632/aging.202571] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
451 Ma H, Lim XC, Yu Q, Li Y, Li Y, Jia W. Ratios between circulating myeloid cells and lymphocytes are associated with mortality in severe COVID-19 patients. Open Medicine 2021;16:351-60. [DOI: 10.1515/med-2021-0237] [Reference Citation Analysis]
452 Youn YJ, Lee YB, Kim SH, Jin HK, Bae JS, Hong CW. Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation. Immune Netw 2021;21:e16. [PMID: 33996172 DOI: 10.4110/in.2021.21.e16] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
453 Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, Lotfy P, Sloan M, Laird H, Williams HB, George M, Drake RS, Christian T, Parker A, Sindel CB, Burger MW, Pride Y, Hasan M, Abraham GE 3rd, Senitko M, Robinson TO, Shalek AK, Glover SC, Horwitz BH, Ordovas-Montanes J. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. bioRxiv 2021:2021. [PMID: 33619488 DOI: 10.1101/2021.02.20.431155] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
454 Weidinger C, Hegazy AN, Glauben R, Siegmund B. COVID-19-from mucosal immunology to IBD patients. Mucosal Immunol 2021;14:566-73. [PMID: 33608656 DOI: 10.1038/s41385-021-00384-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
455 Neeland MR, Bannister S, Clifford V, Dohle K, Mulholland K, Sutton P, Curtis N, Steer AC, Burgner DP, Crawford NW, Tosif S, Saffery R. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children. Nat Commun 2021;12:1084. [PMID: 33597531 DOI: 10.1038/s41467-021-21414-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
456 Turnbull I, Fuchs A, Remy K, Kelly M, Frazier E, Ghosh S, Chang SW, Mazer M, Hess A, Leonard J, Hoofnagle M, Colonna M, Hotchkiss R. Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19. Res Sq 2021:rs. [PMID: 33619472 DOI: 10.21203/rs.3.rs-244150/v1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell 2021;184:1671-92. [PMID: 33743212 DOI: 10.1016/j.cell.2021.02.029] [Cited by in Crossref: 49] [Cited by in F6Publishing: 191] [Article Influence: 49.0] [Reference Citation Analysis]
458 Zhou Z, Huang C, Zhou Z, Huang Z, Su L, Kang S, Chen X, Chen Q, He S, Rong X, Xiao F, Chen J, Chen S. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes. iScience 2021;24:102187. [PMID: 33615195 DOI: 10.1016/j.isci.2021.102187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
459 Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Chong Z, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, Head RD, Ross TM, Crowe JE Jr, Diamond MS. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell 2021;184:1804-1820.e16. [PMID: 33691139 DOI: 10.1016/j.cell.2021.02.026] [Cited by in Crossref: 49] [Cited by in F6Publishing: 129] [Article Influence: 49.0] [Reference Citation Analysis]
460 Feyaerts D, Hedou J, Gillard J, Chen H, Tsai ES, Peterson LS, Ando K, Manohar M, Do E, Dhondalay GKR, Fitzpatrick J, Artandi M, Chang I, Snow TT, Chinthrajah RS, Warren CM, Wittman R, Meyerowitz JG, Ganio EA, Stelzer IA, Han X, Verdonk F, Gaudilliere DK, Mukherjee N, Tsai AS, Rumer KK, Jiang SJ, Valdes-Ferrer SI, Kelly JD, Furman D, Aghaeepour N, Angst MS, Boyd SD, Pinsky BA, Nolan GP, Nadeau KC, Gaudilliere B, McIlwain DR. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19. bioRxiv 2021:2021. [PMID: 33594362 DOI: 10.1101/2021.02.09.430269] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
461 Liu C, Martins AJ, Lau WW, Rachmaninoff N, Chen J, Imberti L, Mostaghimi D, Fink DL, Burbelo PD, Dobbs K, Delmonte OM, Bansal N, Failla L, Sottini A, Quiros-Roldan E, Han KL, Sellers BA, Cheung F, Sparks R, Chun TW, Moir S, Lionakis MS, Rossi C, Su HC, Kuhns DB, Cohen JI, Notarangelo LD, Tsang JS; NIAID COVID Consortium., COVID Clinicians. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell 2021;184:1836-1857.e22. [PMID: 33713619 DOI: 10.1016/j.cell.2021.02.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 68] [Article Influence: 19.0] [Reference Citation Analysis]
462 Caronni N, Montaldo E, Mezzanzanica L, Cilenti F, Genua M, Ostuni R. Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer. Immunol Rev 2021;300:220-36. [PMID: 33565148 DOI: 10.1111/imr.12944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
463 Pontali E, Volpi S, Signori A, Antonucci G, Castellaneta M, Buzzi D, Montale A, Bustaffa M, Angelelli A, Caorsi R, Giambruno E, Bobbio N, Feasi M, Gueli I, Tricerri F, Calautti F, Castagnola E, Moscatelli A, Rollandi GA, Ravelli A, Cassola G, Sormani MP, Gattorno M. Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia. J Allergy Clin Immunol 2021;147:1217-25. [PMID: 33556464 DOI: 10.1016/j.jaci.2021.01.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
464 Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes I, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Ann Rheum Dis 2021:annrheumdis-2020-219724. [PMID: 33547062 DOI: 10.1136/annrheumdis-2020-219724] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
465 Xie X, Cheng X, Wang G, Zhang B, Liu M, Chen L, Cheng H, Hao S, Zhou J, Zhu P, Cheng T. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19. Sci China Life Sci 2021. [PMID: 33564978 DOI: 10.1007/s11427-020-1880-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
466 Ren X, Wen W, Fan X, Hou W, Su B, Cai P, Li J, Liu Y, Tang F, Zhang F, Yang Y, He J, Ma W, He J, Wang P, Cao Q, Chen F, Chen Y, Cheng X, Deng G, Deng X, Ding W, Feng Y, Gan R, Guo C, Guo W, He S, Jiang C, Liang J, Li YM, Lin J, Ling Y, Liu H, Liu J, Liu N, Liu SQ, Luo M, Ma Q, Song Q, Sun W, Wang G, Wang F, Wang Y, Wen X, Wu Q, Xu G, Xie X, Xiong X, Xing X, Xu H, Yin C, Yu D, Yu K, Yuan J, Zhang B, Zhang P, Zhang T, Zhao J, Zhao P, Zhou J, Zhou W, Zhong S, Zhong X, Zhang S, Zhu L, Zhu P, Zou B, Zou J, Zuo Z, Bai F, Huang X, Zhou P, Jiang Q, Huang Z, Bei JX, Wei L, Bian XW, Liu X, Cheng T, Li X, Zhao P, Wang FS, Wang H, Su B, Zhang Z, Qu K, Wang X, Chen J, Jin R, Zhang Z. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 2021;184:1895-1913.e19. [PMID: 33657410 DOI: 10.1016/j.cell.2021.01.053] [Cited by in Crossref: 236] [Cited by in F6Publishing: 153] [Article Influence: 236.0] [Reference Citation Analysis]
467 Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol 2021;21:485-98. [PMID: 33526920 DOI: 10.1038/s41577-020-00490-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 192] [Article Influence: 41.0] [Reference Citation Analysis]
468 Agostinis P, Vianello V, Dereani E, Caruso G, Montessoro B, Taurian M, Di Chiara A, Patruno V, Cavallin F, Fadini GP, Aldovini A, Baritussio A, Curcio F, Tascini C, Baritussio A. Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center. Aging Clin Exp Res 2021;33:443-50. [PMID: 33506312 DOI: 10.1007/s40520-020-01784-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
469 Louie RH, Luciani F. Recent advances in single-cell multimodal analysis to study immune cells. Immunol Cell Biol 2021;99:157-67. [PMID: 33314406 DOI: 10.1111/imcb.12432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
470 Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, Chew NW, Cleary SJ, Kushnoor D, Reeder GC, Shen A, Tsui J, Hiam-Galvez KJ, Muñoz-Sandoval P, Zhu WS, Lee DS, Sun Y, You R, Magnen M, Rodriguez L, Im KW, Serwas NK, Leligdowicz A, Zamecnik CR, Loudermilk RP, Wilson MR, Ye CJ, Fragiadakis GK, Looney MR, Chan V, Ward A, Carrillo S, Matthay M, Erle DJ, Woodruff PG, Langelier C, Kangelaris K, Hendrickson CM, Calfee C, Rao AA, Krummel MF; UCSF COMET Consortium. Global absence and targeting of protective immune states in severe COVID-19. Nature 2021;591:124-30. [PMID: 33494096 DOI: 10.1038/s41586-021-03234-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 81] [Article Influence: 47.0] [Reference Citation Analysis]
471 Karhadkar TR, Pilling D, Gomer RH. Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice. PLoS One 2021;16:e0245924. [PMID: 33481950 DOI: 10.1371/journal.pone.0245924] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
472 Strzelecka PM, Damm F. Haematopoietic ageing through the lens of single-cell technologies. Dis Model Mech 2021;14:dmm047340. [PMID: 33735102 DOI: 10.1242/dmm.047340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
473 Wauters E, Van Mol P, Garg AD, Jansen S, Van Herck Y, Vanderbeke L, Bassez A, Boeckx B, Malengier-Devlies B, Timmerman A, Van Brussel T, Van Buyten T, Schepers R, Heylen E, Dauwe D, Dooms C, Gunst J, Hermans G, Meersseman P, Testelmans D, Yserbyt J, Tejpar S, De Wever W, Matthys P, Neyts J, Wauters J, Qian J, Lambrechts D; CONTAGIOUS collaborators. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages. Cell Res 2021;31:272-90. [PMID: 33473155 DOI: 10.1038/s41422-020-00455-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 82] [Article Influence: 34.0] [Reference Citation Analysis]
474 Jaskuła E, Lange J, Sędzimirska M, Suchnicki K, Mordak-Domagała M, Pakos H, Lange A. CD14 + HLADR - blood values in patients after alloHSCT are highly predictive of survival and infectious complications. Transpl Immunol 2021;65:101370. [PMID: 33484872 DOI: 10.1016/j.trim.2021.101370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
475 Meidaninikjeh S, Sabouni N, Marzouni HZ, Bengar S, Khalili A, Jafari R. Monocytes and macrophages in COVID-19: Friends and foes. Life Sci 2021;269:119010. [PMID: 33454368 DOI: 10.1016/j.lfs.2020.119010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
476 Aschenbrenner AC, Mouktaroudi M, Krämer B, Oestreich M, Antonakos N, Nuesch-Germano M, Gkizeli K, Bonaguro L, Reusch N, Baßler K, Saridaki M, Knoll R, Pecht T, Kapellos TS, Doulou S, Kröger C, Herbert M, Holsten L, Horne A, Gemünd ID, Rovina N, Agrawal S, Dahm K, van Uelft M, Drews A, Lenkeit L, Bruse N, Gerretsen J, Gierlich J, Becker M, Händler K, Kraut M, Theis H, Mengiste S, De Domenico E, Schulte-Schrepping J, Seep L, Raabe J, Hoffmeister C, ToVinh M, Keitel V, Rieke G, Talevi V, Skowasch D, Aziz NA, Pickkers P, van de Veerdonk FL, Netea MG, Schultze JL, Kox M, Breteler MMB, Nattermann J, Koutsoukou A, Giamarellos-Bourboulis EJ, Ulas T; German COVID-19 Omics Initiative (DeCOI). Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med 2021;13:7. [PMID: 33441124 DOI: 10.1186/s13073-020-00823-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 79] [Article Influence: 25.0] [Reference Citation Analysis]
477 Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, Canna SW, Shakoory B, Dobbs K, Imberti L, Sottini A, Quiros-Roldan E, Castelli F, Rossi C, Brugnoni D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Castagnoli R, Montagna D, Licari A, Marseglia GL, Gliniewicz EF, Shaw E, Kahle DE, Rastegar AT, Stack M, Myint-Hpu K, Levinson SL, DiNubile MJ, Chertow DW, Burbelo PD, Cohen JI, Calvo KR, Tsang JS, Su HC, Gallin JI, Kuhns DB, Goldbach-Mansky R, Lionakis MS, Notarangelo LD; NIAID COVID-19 Consortium. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 2021;6:144455. [PMID: 33232303 DOI: 10.1172/jci.insight.144455] [Cited by in Crossref: 53] [Cited by in F6Publishing: 117] [Article Influence: 53.0] [Reference Citation Analysis]
478 Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Querrey M, Guzman ER, Abbott DA, Donnelly HK, Donayre A, Goldberg IA, Klug ZM, Borkowski N, Lu Z, Kihshen H, Politanska Y, Sichizya L, Kang M, Shilatifard A, Qi C, Lomasney JW, Argento AC, Kruser JM, Malsin ES, Pickens CO, Smith SB, Walter JM, Pawlowski AE, Schneider D, Nannapaneni P, Abdala-Valencia H, Bharat A, Gottardi CJ, Budinger GRS, Misharin AV, Singer BD, Wunderink RG; NU SCRIPT Study Investigators. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature 2021;590:635-41. [PMID: 33429418 DOI: 10.1038/s41586-020-03148-w] [Cited by in Crossref: 107] [Cited by in F6Publishing: 209] [Article Influence: 107.0] [Reference Citation Analysis]
479 Paget C, Trottein F. COVID-19 and flu: conserved or specific immune signature? Cell Mol Immunol 2021;18:245-6. [PMID: 33432063 DOI: 10.1038/s41423-020-00595-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
480 Zarinsefat A, Hartoularos G, Rychkov D, Rashmi P, Chandran S, Vincenti F, Yee CJ, Sarwal MM. Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation. Front Genet 2020;11:610682. [PMID: 33469465 DOI: 10.3389/fgene.2020.610682] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
481 Han J, Sun J, Zhang G, Chen H. DCs-based therapies: potential strategies in severe SARS-CoV-2 infection. Int J Med Sci 2021;18:406-18. [PMID: 33390810 DOI: 10.7150/ijms.47706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
482 Evren E, Ringqvist E, Tripathi KP, Sleiers N, Rives IC, Alisjahbana A, Gao Y, Sarhan D, Halle T, Sorini C, Lepzien R, Marquardt N, Michaëlsson J, Smed-Sörensen A, Botling J, Karlsson MCI, Villablanca EJ, Willinger T. Distinct developmental pathways from blood monocytes generate human lung macrophage diversity. Immunity 2021;54:259-275.e7. [PMID: 33382972 DOI: 10.1016/j.immuni.2020.12.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
483 Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, Head RD, Ross TM, Crowe JE, Diamond MS. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection. bioRxiv 2020:2020. [PMID: 33398272 DOI: 10.1101/2020.12.28.424554] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
484 Chevrier S, Zurbuchen Y, Cervia C, Adamo S, Raeber ME, de Souza N, Sivapatham S, Jacobs A, Bachli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Nilsson J, Boyman O, Bodenmiller B. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep Med 2021;2:100166. [PMID: 33521697 DOI: 10.1016/j.xcrm.2020.100166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 51] [Article Influence: 13.5] [Reference Citation Analysis]
485 Innamarato P, Pilon-Thomas S. Reactive myelopoiesis and the onset of myeloid-mediated immune suppression: Implications for adoptive cell therapy. Cell Immunol 2021;361:104277. [PMID: 33476931 DOI: 10.1016/j.cellimm.2020.104277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
486 Guo Q, Zhao Y, Li J, Liu J, Yang X, Guo X, Kuang M, Xia H, Zhang Z, Cao L, Luo Y, Bao L, Wang X, Wei X, Deng W, Wang N, Chen L, Chen J, Zhu H, Gao R, Qin C, Wang X, You F. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe 2021;29:222-235.e4. [PMID: 33388094 DOI: 10.1016/j.chom.2020.12.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 61] [Article Influence: 10.5] [Reference Citation Analysis]
487 Rendeiro AF, Casano J, Vorkas CK, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chiu S, Cappelli LV, Cacciapuoti MT, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Life Sci Alliance 2021;4:e202000955. [PMID: 33361110 DOI: 10.26508/lsa.202000955] [Cited by in Crossref: 11] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
488 Heming M, Li X, Räuber S, Mausberg AK, Börsch AL, Hartlehnert M, Singhal A, Lu IN, Fleischer M, Szepanowski F, Witzke O, Brenner T, Dittmer U, Yosef N, Kleinschnitz C, Wiendl H, Stettner M, Meyer Zu Hörste G. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity 2021;54:164-175.e6. [PMID: 33382973 DOI: 10.1016/j.immuni.2020.12.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 51] [Article Influence: 10.5] [Reference Citation Analysis]
489 Schmidt N, Lareau CA, Keshishian H, Ganskih S, Schneider C, Hennig T, Melanson R, Werner S, Wei Y, Zimmer M, Ade J, Kirschner L, Zielinski S, Dölken L, Lander ES, Caliskan N, Fischer U, Vogel J, Carr SA, Bodem J, Munschauer M. The SARS-CoV-2 RNA-protein interactome in infected human cells. Nat Microbiol 2021;6:339-53. [PMID: 33349665 DOI: 10.1038/s41564-020-00846-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 99] [Article Influence: 23.5] [Reference Citation Analysis]
490 Nicolai L, Leunig A, Brambs S, Kaiser R, Joppich M, Hoffknecht ML, Gold C, Engel A, Polewka V, Muenchhoff M, Hellmuth JC, Ruhle A, Ledderose S, Weinberger T, Schulz H, Scherer C, Rudelius M, Zoller M, Keppler OT, Zwißler B, von Bergwelt-Baildon M, Kääb S, Zimmer R, Bülow RD, von Stillfried S, Boor P, Massberg S, Pekayvaz K, Stark K. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. J Thromb Haemost 2021;19:574-81. [PMID: 33217134 DOI: 10.1111/jth.15179] [Cited by in Crossref: 20] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
491 Delaveris CS, Wilk AJ, Riley NM, Stark JC, Yang SS, Rogers AJ, Ranganath T, Nadeau KC, Blish CA, Bertozzi CR; Stanford COVID-19 Biobank. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. ChemRxiv 2020. [PMID: 33469569 DOI: 10.26434/chemrxiv.13378148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
492 De Domenico E, Bonaguro L, Schulte-Schrepping J, Becker M, Händler K, Schultze JL. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19. STAR Protoc 2020;1:100233. [PMID: 33377120 DOI: 10.1016/j.xpro.2020.100233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
493 Carsetti R, Zaffina S, Piano Mortari E, Terreri S, Corrente F, Capponi C, Palomba P, Mirabella M, Cascioli S, Palange P, Cuccaro I, Milito C, Zumla A, Maeurer M, Camisa V, Vinci MR, Santoro A, Cimini E, Marchioni L, Nicastri E, Palmieri F, Agrati C, Ippolito G, Porzio O, Concato C, Onetti Muda A, Raponi M, Quintarelli C, Quinti I, Locatelli F. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol 2020;11:610300. [PMID: 33391280 DOI: 10.3389/fimmu.2020.610300] [Cited by in Crossref: 27] [Cited by in F6Publishing: 67] [Article Influence: 13.5] [Reference Citation Analysis]
494 D'Alessio FR, Heller NM. COVID-19 and myeloid cells: complex interplay correlates with lung severity. J Clin Invest 2020;130:6214-7. [PMID: 33021506 DOI: 10.1172/JCI143361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
495 Galvan-Pena S, Leon J, Chowdhary K, Michelson DA, Vijaykumar B, Yang L, Magnuson A, Manickas-Hill Z, Piechocka-Trocha A, Worrall DP, Hall KE, Ghebremichael M, Walker BD, Li JZ, Yu XG, Mathis D, Benoist C. Profound Treg perturbations correlate with COVID-19 severity. bioRxiv 2020:2020. [PMID: 33330871 DOI: 10.1101/2020.12.11.416180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
496 Gessain G, Blériot C, Ginhoux F. Non-genetic Heterogeneity of Macrophages in Diseases-A Medical Perspective. Front Cell Dev Biol 2020;8:613116. [PMID: 33381508 DOI: 10.3389/fcell.2020.613116] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
497 Lopez L, Sang PC, Tian Y, Sang Y. Dysregulated Interferon Response Underlying Severe COVID-19. Viruses 2020;12:E1433. [PMID: 33322160 DOI: 10.3390/v12121433] [Cited by in Crossref: 15] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
498 Amann K, Boor P, Wiech T. [COVID-19 and kidney involvement]. Nephrologe 2020;:1-6. [PMID: 33343740 DOI: 10.1007/s11560-020-00469-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
499 Mohamed Khosroshahi L, Rezaei N. Dysregulation of the immune response in coronavirus disease 2019. Cell Biol Int 2021;45:702-7. [PMID: 33289192 DOI: 10.1002/cbin.11517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
500 Rodrigues PRS, Alrubayyi A, Pring E, Bart VMT, Jones R, Coveney C, Lu F, Tellier M, Maleki-Toyserkani S, Richter FC, Scourfield DO, Gea-Mallorquí E, Davies LC. Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology. Oxf Open Immunol 2020;1:iqaa005. [PMID: 34192268 DOI: 10.1093/oxfimm/iqaa005] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
501 Wang P, Sha J, Meng M, Wang C, Yao Q, Zhang Z, Sun W, Wang X, Qie G, Bai X, Liu K, Chu Y. Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study. J Transl Med 2020;18:461. [PMID: 33287826 DOI: 10.1186/s12967-020-02655-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
502 Williams TL, Rada B, Tandon E, Gestal MC. "NETs and EETs, a Whole Web of Mess". Microorganisms 2020;8:E1925. [PMID: 33291570 DOI: 10.3390/microorganisms8121925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
503 Caporale N, Testa G. COVID-19 lessons from the dish: Dissecting CNS manifestations through brain organoids. EMBO J 2021;40:e107213. [PMID: 33175425 DOI: 10.15252/embj.2020107213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
504 Costantini C, van de Veerdonk FL, Romani L. Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin. Vaccines (Basel) 2020;8:E713. [PMID: 33271780 DOI: 10.3390/vaccines8040713] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
505 Cavalcante-Silva LHA, Carvalho DCM, Lima ÉA, Galvão JGFM, da Silva JSF, Sales-Neto JM, Rodrigues-Mascarenhas S. Neutrophils and COVID-19: The road so far. Int Immunopharmacol 2021;90:107233. [PMID: 33290963 DOI: 10.1016/j.intimp.2020.107233] [Cited by in Crossref: 20] [Cited by in F6Publishing: 65] [Article Influence: 10.0] [Reference Citation Analysis]
506 Fahlberg MD, Blair RV, Doyle-Meyers LA, Midkiff CC, Zenere G, Russell-Lodrigue KE, Monjure CJ, Haupt EH, Penney TP, Lehmicke G, Threeton BM, Golden N, Datta PK, Roy CJ, Bohm RP, Maness NJ, Fischer T, Rappaport J, Vaccari M. Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates. Nat Commun 2020;11:6078. [PMID: 33247138 DOI: 10.1038/s41467-020-19967-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 42] [Article Influence: 12.5] [Reference Citation Analysis]
507 Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, Bordoni D, Franzenburg J, Geisen U, Josephs-Spaulding J, Köhler P, Künstner A, Rosati E, Aschenbrenner AC, Bacher P, Baran N, Boysen T, Brandt B, Bruse N, Dörr J, Dräger A, Elke G, Ellinghaus D, Fischer J, Forster M, Franke A, Franzenburg S, Frey N, Friedrichs A, Fuß J, Glück A, Hamm J, Hinrichsen F, Hoeppner MP, Imm S, Junker R, Kaiser S, Kan YH, Knoll R, Lange C, Laue G, Lier C, Lindner M, Marinos G, Markewitz R, Nattermann J, Noth R, Pickkers P, Rabe KF, Renz A, Röcken C, Rupp J, Schaffarzyk A, Scheffold A, Schulte-Schrepping J, Schunk D, Skowasch D, Ulas T, Wandinger KP, Wittig M, Zimmermann J, Busch H, Hoyer BF, Kaleta C, Heyckendorf J, Kox M, Rybniker J, Schreiber S, Schultze JL, Rosenstiel P; HCA Lung Biological Network., Deutsche COVID-19 Omics Initiative (DeCOI). Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity 2020;53:1296-1314.e9. [PMID: 33296687 DOI: 10.1016/j.immuni.2020.11.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 125] [Article Influence: 25.0] [Reference Citation Analysis]
508 Pence BD. Atypical monocytes in COVID-19: Lighting the fire of cytokine storm? J Leukoc Biol 2021;109:7-8. [PMID: 33211354 DOI: 10.1002/JLB.5CE0920-613R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
509 Grigoryan L, Pulendran B. The immunology of SARS-CoV-2 infections and vaccines. Semin Immunol 2020;50:101422. [PMID: 33262067 DOI: 10.1016/j.smim.2020.101422] [Cited by in Crossref: 25] [Cited by in F6Publishing: 41] [Article Influence: 12.5] [Reference Citation Analysis]
510 Vadillo E, Taniguchi-Ponciano K, Lopez-Macias C, Carvente-Garcia R, Mayani H, Ferat-Osorio E, Flores-Padilla G, Torres J, Gonzalez-Bonilla CR, Majluf A, Albarran-Sanchez A, Galan JC, Peña-Martínez E, Silva-Román G, Vela-Patiño S, Ferreira-Hermosillo A, Ramirez-Renteria C, Espinoza-Sanchez NA, Pelayo-Camacho R, Bonifaz L, Arriaga-Pizano L, Mata-Lozano C, Andonegui-Elguera S, Wacher N, Blanco-Favela F, De-Lira-Barraza R, Villanueva-Compean H, Esquivel-Pineda A, Ramírez-Montes-de-Oca R, Anda-Garay C, Noyola-García M, Guizar-García L, Cerbulo-Vazquez A, Zamudio-Meza H, Marrero-Rodríguez D, Mercado M. A Shift Towards an Immature Myeloid Profile in Peripheral Blood of Critically Ill COVID-19 Patients. Arch Med Res 2021;52:311-23. [PMID: 33248817 DOI: 10.1016/j.arcmed.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
511 de Candia P, Prattichizzo F, Garavelli S, Matarese G. T Cells: Warriors of SARS-CoV-2 Infection. Trends Immunol 2021;42:18-30. [PMID: 33277181 DOI: 10.1016/j.it.2020.11.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 72] [Article Influence: 15.5] [Reference Citation Analysis]
512 Rother N, Yanginlar C, Lindeboom RGH, Bekkering S, van Leent MMT, Buijsers B, Jonkman I, de Graaf M, Baltissen M, Lamers LA, Riksen NP, Fayad ZA, Mulder WJM, Hilbrands LB, Joosten LAB, Netea MG, Vermeulen M, van der Vlag J, Duivenvoorden R. Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons. Cell Rep Med 2020;1:100146. [PMID: 33377122 DOI: 10.1016/j.xcrm.2020.100146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
513 Hoang TN, Pino M, Boddapati AK, Viox EG, Starke CE, Upadhyay AA, Gumber S, Nekorchuk M, Busman-Sahay K, Strongin Z, Harper JL, Tharp GK, Pellegrini KL, Kirejczyk S, Zandi K, Tao S, Horton TR, Beagle EN, Mahar EA, Lee MYH, Cohen J, Jean SM, Wood JS, Connor-Stroud F, Stammen RL, Delmas OM, Wang S, Cooney KA, Sayegh MN, Wang L, Filev PD, Weiskopf D, Silvestri G, Waggoner J, Piantadosi A, Kasturi SP, Al-Shakhshir H, Ribeiro SP, Sekaly RP, Levit RD, Estes JD, Vanderford TH, Schinazi RF, Bosinger SE, Paiardini M. Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques. Cell 2021;184:460-475.e21. [PMID: 33278358 DOI: 10.1016/j.cell.2020.11.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 77] [Article Influence: 14.5] [Reference Citation Analysis]
514 Kaneko N, Satta S, Komuro Y, Muthukrishnan SD, Kakarla V, Guo L, An J, Elahi F, Kornblum HI, Liebeskind DS, Hsiai T, Hinman JD. Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection. Stroke 2021;52:260-70. [PMID: 33161843 DOI: 10.1161/STROKEAHA.120.032764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
515 Gibellini L, De Biasi S, Paolini A, Borella R, Boraldi F, Mattioli M, Lo Tartaro D, Fidanza L, Caro-Maldonado A, Meschiari M, Iadisernia V, Bacca E, Riva G, Cicchetti L, Quaglino D, Guaraldi G, Busani S, Girardis M, Mussini C, Cossarizza A. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med 2020;12:e13001. [PMID: 33078545 DOI: 10.15252/emmm.202013001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 62] [Article Influence: 10.0] [Reference Citation Analysis]
516 Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, Agarwal K. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol 2021;320:C57-65. [PMID: 33151090 DOI: 10.1152/ajpcell.00426.2020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 55] [Article Influence: 9.0] [Reference Citation Analysis]
517 Benlyamani I, Venet F, Coudereau R, Gossez M, Monneret G. Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review. Cytometry A 2020;97:1217-21. [PMID: 33125816 DOI: 10.1002/cyto.a.24249] [Cited by in Crossref: 18] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
518 Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, Fenyves BG, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilly BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Gerszten RE, Heimberg GS, Hoover PJ, Lieb DJ, Lin B, Ngo D, Pelka K, Reyes M, Smillie CS, Waghray A, Wood TE, Zajac AS, Jennings LL, Grundberg I, Bhattacharyya RP, Parry BA, Villani AC, Sade-Feldman M, Hacohen N, Goldberg MB. Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients. bioRxiv 2020:2020. [PMID: 33173871 DOI: 10.1101/2020.11.02.365536] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 12.5] [Reference Citation Analysis]
519 Broxmeyer HE, Liu Y, Kapur R, Orschell CM, Aljoufi A, Ropa JP, Trinh T, Burns S, Capitano ML. Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications? Stem Cell Rev Rep 2020;16:1020-48. [PMID: 33145673 DOI: 10.1007/s12015-020-10065-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
520 Shi Z, Puyo CA. N-Acetylcysteine to Combat COVID-19: An Evidence Review. Ther Clin Risk Manag 2020;16:1047-55. [PMID: 33177829 DOI: 10.2147/TCRM.S273700] [Cited by in Crossref: 19] [Cited by in F6Publishing: 41] [Article Influence: 9.5] [Reference Citation Analysis]
521 Greco S, Madè A, Gaetano C, Devaux Y, Emanueli C, Martelli F. Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era. J Transl Med 2020;18:408. [PMID: 33129318 DOI: 10.1186/s12967-020-02582-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
522 Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, Cleary SJ, Chew NW, Kushnoor D, Reeder GC, Shen A, Tsui J, Hiam-Galvez KJ, Muñoz-Sandoval P, Zhu WS, Lee DS, Sun Y, You R, Magnen M, Rodriguez L, Leligdowicz A, Zamecnik CR, Loudermilk RP, Wilson MR, Ye CJ, Fragiadakis GK, Looney MR, Chan V, Ward A, Carrillo S, Matthay M, Erle DJ, Woodruff PG, Langelier C, Kangelaris K, Hendrickson CM, Calfee C, Rao AA, Krummel MF. Global Absence and Targeting of Protective Immune States in Severe COVID-19. bioRxiv 2020:2020. [PMID: 33140050 DOI: 10.1101/2020.10.28.359935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
523 Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, Voillet V, Duvvuri VR, Scherler K, Troisch P, Baloni P, Qin G, Smith B, Kornilov SA, Rostomily C, Xu A, Li J, Dong S, Rothchild A, Zhou J, Murray K, Edmark R, Hong S, Heath JE, Earls J, Zhang R, Xie J, Li S, Roper R, Jones L, Zhou Y, Rowen L, Liu R, Mackay S, O'Mahony DS, Dale CR, Wallick JA, Algren HA, Zager MA, Wei W, Price ND, Huang S, Subramanian N, Wang K, Magis AT, Hadlock JJ, Hood L, Aderem A, Bluestone JA, Lanier LL, Greenberg PD, Gottardo R, Davis MM, Goldman JD, Heath JR; ISB-Swedish COVID19 Biobanking Unit. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell 2020;183:1479-1495.e20. [PMID: 33171100 DOI: 10.1016/j.cell.2020.10.037] [Cited by in Crossref: 85] [Cited by in F6Publishing: 190] [Article Influence: 42.5] [Reference Citation Analysis]
524 Mukherjee S. Before Virus, After Virus: A Reckoning. Cell 2020;183:308-14. [PMID: 33064987 DOI: 10.1016/j.cell.2020.09.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
525 Xu G, Qi F, Li H, Yang Q, Wang H, Wang X, Liu X, Zhao J, Liao X, Liu Y, Liu L, Zhang S, Zhang Z. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. Cell Discov 2020;6:73. [PMID: 33101705 DOI: 10.1038/s41421-020-00225-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 84] [Article Influence: 22.5] [Reference Citation Analysis]
526 Heller RA, Sun Q, Hackler J, Seelig J, Seibert L, Cherkezov A, Minich WB, Seemann P, Diegmann J, Pilz M, Bachmann M, Ranjbar A, Moghaddam A, Schomburg L. Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker. Redox Biol 2021;38:101764. [PMID: 33126054 DOI: 10.1016/j.redox.2020.101764] [Cited by in Crossref: 26] [Cited by in F6Publishing: 70] [Article Influence: 13.0] [Reference Citation Analysis]
527 Wu M, Chen Y, Xia H, Wang C, Tan CY, Cai X, Liu Y, Ji F, Xiong P, Liu R, Guan Y, Duan Y, Kuang D, Xu S, Cai H, Xia Q, Yang D, Wang MW, Chiu IM, Cheng C, Ahern PP, Liu L, Wang G, Surana NK, Xia T, Kasper DL. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Proc Natl Acad Sci U S A 2020;117:28336-43. [PMID: 33082228 DOI: 10.1073/pnas.2018030117] [Cited by in Crossref: 38] [Cited by in F6Publishing: 71] [Article Influence: 19.0] [Reference Citation Analysis]
528 Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, Krupska I, Matsumoto R, Poon MML, Idzikowski E, Morris SE, Pasin C, Yates AJ, Ku A, Chait M, Davis-Porada J, Zhou J, Steinle M, Mackay S, Saqi A, Baldwin M, Sims PA, Farber DL. Analysis of respiratory and systemic immune responses in COVID-19 reveals mechanisms of disease pathogenesis. medRxiv 2020:2020. [PMID: 33106817 DOI: 10.1101/2020.10.15.20208041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
529 Carissimo G, Xu W, Kwok I, Abdad MY, Chan YH, Fong SW, Puan KJ, Lee CY, Yeo NK, Amrun SN, Chee RS, How W, Chan S, Fan BE, Andiappan AK, Lee B, Rötzschke O, Young BE, Leo YS, Lye DC, Renia L, Ng LG, Larbi A, Ng LF. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat Commun 2020;11:5243. [PMID: 33067472 DOI: 10.1038/s41467-020-19080-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 73] [Article Influence: 21.0] [Reference Citation Analysis]
530 Parackova Z, Zentsova I, Bloomfield M, Vrabcova P, Smetanova J, Klocperk A, Mesežnikov G, Casas Mendez LF, Vymazal T, Sediva A. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness. Cells 2020;9:E2206. [PMID: 33003471 DOI: 10.3390/cells9102206] [Cited by in Crossref: 27] [Cited by in F6Publishing: 62] [Article Influence: 13.5] [Reference Citation Analysis]
531 Hoang TN, Pino M, Boddapati AK, Viox EG, Starke CE, Upadhyay AA, Gumber S, Busman-Sahay K, Strongin Z, Harper JL, Tharp GK, Pellegrini KL, Kirejczyk S, Zandi K, Tao S, Horton TR, Beagle EN, Mahar EA, Lee MY, Cohen J, Jean SM, Wood JS, Connor-Stroud F, Stammen RL, Delmas OM, Wang S, Cooney KA, Sayegh MN, Wang L, Weiskopf D, Filev PD, Waggoner J, Piantadosi A, Kasturi SP, Al-Shakhshir H, Ribeiro SP, Sekaly RP, Levit RD, Estes JD, Vanderford TH, Schinazi RF, Bosinger SE, Paiardini M. Baricitinib treatment resolves lower airway inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques. bioRxiv 2020:2020. [PMID: 32995780 DOI: 10.1101/2020.09.16.300277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
532 Ryu S, Shchukina I, Youm YH, Qing H, Hilliard BK, Dlugos T, Zhang X, Yasumoto Y, Booth CJ, Fernández-Hernando C, Suárez Y, Khanna KM, Horvath TL, Dietrich MO, Artyomov MN, Wang A, Dixit VD. Ketogenesis restrains aging-induced exacerbation of COVID in a mouse model. bioRxiv 2020:2020. [PMID: 33236006 DOI: 10.1101/2020.09.11.294363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
533 Maucourant C, Filipovic I, Ponzetta A, Aleman S, Cornillet M, Hertwig L, Strunz B, Lentini A, Reinius B, Brownlie D, Cuapio A, Ask EH, Hull RM, Haroun-Izquierdo A, Schaffer M, Klingström J, Folkesson E, Buggert M, Sandberg JK, Eriksson LI, Rooyackers O, Ljunggren HG, Malmberg KJ, Michaëlsson J, Marquardt N, Hammer Q, Strålin K, Björkström NK; Karolinska COVID-19 Study Group. Natural killer cell immunotypes related to COVID-19 disease severity. Sci Immunol 2020;5:eabd6832. [PMID: 32826343 DOI: 10.1126/sciimmunol.abd6832] [Cited by in Crossref: 93] [Cited by in F6Publishing: 177] [Article Influence: 46.5] [Reference Citation Analysis]
534 Rendeiro AF, Casano J, Vorkas CK, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chui S, Cappelli L, Cacciapuoti MT, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G. Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression. medRxiv 2020:2020. [PMID: 32935114 DOI: 10.1101/2020.09.08.20189092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
535 Jacobs JL, Mellors JW. Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean? Clin Infect Dis 2020:ciaa1316. [PMID: 32898242 DOI: 10.1093/cid/ciaa1316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
536 Reyes M, Filbin MR, Bhattacharyya RP, Sonny A, Mehta A, Billman K, Kays KR, Pinilla-Vera M, Benson ME, Cosimi LA, Hung DT, Levy BD, Villani AC, Sade-Feldman M, Baron RM, Goldberg MB, Blainey PC, Hacohen N. Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19. bioRxiv 2020:2020. [PMID: 32908980 DOI: 10.1101/2020.09.02.280180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
537 Melenotte C, Silvin A, Goubet AG, Lahmar I, Dubuisson A, Zumla A, Raoult D, Merad M, Gachot B, Hénon C, Solary E, Fontenay M, André F, Maeurer M, Ippolito G, Piacentini M, Wang FS, Ginhoux F, Marabelle A, Kroemer G, Derosa L, Zitvogel L. Immune responses during COVID-19 infection. Oncoimmunology 2020;9:1807836. [PMID: 32939324 DOI: 10.1080/2162402X.2020.1807836] [Cited by in Crossref: 24] [Cited by in F6Publishing: 56] [Article Influence: 12.0] [Reference Citation Analysis]
538 [DOI: 10.1101/2021.04.14.21255475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
539 [DOI: 10.1101/2020.09.15.20195305] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
540 [DOI: 10.1101/2020.10.15.325050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
541 [DOI: 10.1101/2020.12.18.423363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
542 [DOI: 10.1101/2020.08.31.20185082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
543 [DOI: 10.1101/2020.11.09.20228015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
544 [DOI: 10.1101/2021.01.13.21249725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
545 [DOI: 10.1101/2020.12.23.20247379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
546 [DOI: 10.1101/2021.01.25.21250189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]